Tag Archives: cancer prevention

What Is Our Greatest Health Risk?

Are electromagnetic fields from cell towers. cell phones, WiFi, 4G and soon 5G, computers, electrical appliances making us sick and tired? Are we just living longer or are we living better? Why is there an epidemic in cancer, autism, depression, heart disease, etc.,?
electromagnetic-radiation

“The World is not dangerous because of those who do harm, but because of those who look at it and do nothing.” – Albert Einstein

The biggest health threat to the Human Body is electromagnetic pollution. The explosion of Samsung phones, iPhones WiFi, WiMax, 4G network, video game consoles, remote-control toys, electric cars and the soon to be released the 5G network, has fundamentally changed our electrical environment. You can’t see it, you can’t taste it, you can’t touch it, you can’t smell it; but the air all around us is increasingly filled with electromagnetic radiation (EMR) that is penetrating our bodies and disrupting our body chemistry – perhaps forever.

Every moment of every day, invisible fields of toxic fields of energy are striking our bodies like tiny darts, triggering dozens of bio-chemical reactions, which undermine our health and stealthily lay the groundwork for sickness and disease.

Screen Shot 2018-07-02 at 3.28.13 PM

How does this happen?

As Nobel-prize nominee, Dr. Robert Becker described in “The Body Electric,” our brains; our hearts and every one of the seventy trillion cells in our bodies operate on electrical impulses. These minuscule electrical fields can easily be disrupted by the electropollution around us, especially when frequency wavelength is in the brainwave region (0-33 hertz), or matches up with and resonates with electrically-charged particles like ions and chemicals or organs of the body.

Dr. Becker also found that healing only takes place if the current at the point of injury is negatively charged. When it turns positive, the healing process shuts down. So, even our ability to heal is fundamentally dependent upon electrical fields and thus subject to interference from ambient EMR.

In the 1960s NASA found that astronauts would lose up to 50% of their bone mass in just weeks without the presence of the earth’s natural electromagnetic field. Later an artificial version of the earth’s electromagnetic field was added to the spacecraft, which reduced the problem.

Human life could not exist without the presence of natural electromagnetic fields. But what about the explosion of artificial magnetic fields around us, how are these burgeoning signals affecting us? Since the early 1960s, there has been an ongoing debate between scientists, government, industry and the military as to the health impacts on humans from electromagnetic radiation. In fact more than 16,000 studies have tackled the issue. Now, more than 6000 studies connect wireless and other EMR with more than 122 biological effects.

Another 10,000 fail to find the connection. US regulators and policy-makers are using these numbers as a rationale to continue to approve the deployment of unproven technologies. They typically claim that there is no consensus in the science. Despite the science showing a better than 1 in 3 chance (38%) that wireless technologies are causing harmful bio-effects, these regulators and policy-makers are betting that these ‘untested’ technologies won’t make us sick.

But how do they know?

The US government is neither tracking the health effects of these newly adopted technologies nor has it funded a single non-classified study on the biological effects of wireless technologies since the late 1990’s. During that time twelve new ubiquitous technologies have been rolled-out, including public WiFi, 3rd generation (3G) cell phones, 3G Cellular networks, Bluetooth, WiMax, DECT cordless phones, 4G and 5G cell phones have now been deployed in cars with GPS, phones and devices. Meanwhile the fourteen international scientists, who produced the BioInitiative Report (www.bioinitiative.org) document more than two thousand, mostly independent studies, which connect wireless and other EMR with the following: DNA damage, brain cancer, Alzheimer’s, breast cancer, children’s cancers (leukemia), immune system dysfunction, cardiac symptoms, alteration of melatonin production, inflammation and electromagnetic sensitivity. The 630 page report also links numerous modern age symptoms such as headaches, sleep disturbances, concentration issues, fuzzy thinking, joint and muscle pain and memory loss to wireless.

As science is often crippled by abstract experiments with unproven simplifying assumptions, a better way to judge and validate scientific findings may be to look at the key health trends:

Beginning in the 1980’s at the advent of the ‘wireless revolution’ a profound change in our national health began to quietly unfold. It began with the emergence of a bevy of previously-unknown auto-immune diseases like chronic fatigue (CFS), lupus, environmental illness (EI) and fibromyalgia. Soon an explosion in neurological disorders began with Lou Gehrig’s disease (ALS), Multiple Sclerosis (MS), Parkinson’s and Alzheimer’s all showing a dramatic increase. Next, the incidence of certain cancers began to suddenly rise such as melanoma, testicular, lymphoma, breast and prostate cancers. Then, in the 1990s, ailments like diabetes, attention deficit disorder (ADD/ ADHD) and Autism began to explode.

In the past fifteen years sleep disturbances and mood disorders have sky-rocketed. In the 1970s only about 4% suffered from sleep issues. It is now closer to 60%.

Meanwhile more than 18 million Americans are clinically diagnosed as depressed. Depression in children is growing at 23%. It should be no surprise that the top selling pharmaceutical drugs are for pain, depression, and sleep.

What has happened to our health?

It might surprise you to know that the 1950s, when there were few health clubs; the American diet was loaded with fat; vitamin supplements were rare; executives downed three martinis at lunch and everyone smoked like a smokestack, may have been the healthiest decade ever. Expectations for getting cancer were only 1 in 6; it is now 1 in 2 for men. Alzheimer’s, Multiple Sclerosis and most modern autoimmune diseases were unheard of. Neurological disorders like Parkinson’s and ALS were rare. Diabetes was only beginning to emerge and heart disease for young people was unusual.

In the previous three decades, we had extended the average life expectancy from 55 to 72 years – a 31% gain. Well here’s the good news: we now live to 80 – 8 more years. But more than half of that eight year gain is spent in a nursing home, suffering from either dementia, or Alzheimer’s.

What has happened to our health?

Despite the many advances in medicine during the 20th century and the beginning of the 21st century, the US and other industrialized nations have been experiencing explosions in disease and pervasive ill-health. While many scientists and the pharmaceutical industry are rushing to find drugs to manage the symptoms of these illnesses, almost no progress has been made to find root causes. Theories abound on the causes and underlying factors for the big six diseases: cancer, heart disease, diabetes, neurological disorders (Alzheimer’s et al), autoimmune disorders and allergies (asthma).

We’ve gotten really good at managing symptoms the past two decades but no one can explain the spontaneous explosion of the six major disease groups with no obvious connection that began in the 1980’s. Almost everyone agrees that these diseases are closely associated with environmental, and/or lifestyle and dietary choices. This has been the basis of my research that all sickness and disease is the result of an acidic way of living, breathing, eating and thinking. www.drrobertyoung.com

We hear incessantly about the importance of an alkaline diet and daily exercise; the impacts from smoking; and exposures to chemicals and other toxins in our environment. When you add highly acidic electromagnetic fields of energy you have the main actors in the emerging health drama!

Millions are spent each year on research, attacking the possible causation of the big six diseases. Most of this research is approached from either a purely biological or chemical angle. Sometimes there is an interdisciplinary approach, involving experts in biology and chemistry. Yet the human organism is clearly much more than simply the sum of body parts, operating in a bio-chemical paradigm. The missing factor is the role of electrical energy and the tiny electromagnetic fields that are triggering our heart, our brain, our endocrine system and constantly transmitting messages to every cell in our body. More importantly we are blinded by continuing to ignore the pivotal role of electrical disturbances transmitted from our environment that is setting off a chain of bio-chemical events that are leading to an epidemic of disease.

Is electro pollution a unifying factor in the exploding diseases that are making us all so sick?

snapshot-1492021953486-1

The Evidence

There has been two landmark events that shed new light on the science, linking EMR from wireless technologies to broad health impacts, dozens of biological effects and virtually all of the currently exploding diseases.

In July 2010, a previously unrecognized collection of nearly 5000 studies linking low-level wireless signals to bioeffects was discovered by noted scientist, Magda Havas, PhD of Trent University in Ontario, Canada. More than 2300 of these studies, concerned with radio-frequency and microwave radiation, were compiled by Dr. Zorach Glaser, PhD, an officer in the US Navy at the request of the Naval Medical Research Institute. Many of these studies were previously classified and others originated in Eastern Block nations such as the USSR, Poland and Czechoslovakia and have only recently been translated. Here is a sampling from Dr. Glaser’s report on the 122 biological phenomena (effects) and clinical manifestations attributed to microwave and radio-frequency radiation:

This treasure trove of “lost” science that was compiled at the request of the US Navy opens the door for a real renaissance in research for scientists, who are examining the link between wireless technologies and impacts to our health. But will it be enough to awaken the US government to this call to action?

Meanwhile in a spectacular announcement that received very little coverage in August 2010, noted epidemiologist, Samuel Milham, MD makes the link between the growth of electrification and the incidence of four of the big six diseases. In “Dirty Electricity: Electrification and the Diseases of Civilization.” Dr. Milham connects dirty electricity with heart disease, cancer, diabetes, neurological disorders like ALS and suicide.

Dirty electricity refers to unusable electrical energy, which is caused by the interference of electronics on the power lines within your home, office or public building. It is virtually everywhere. Dirty electricity is created by fluorescent lights, dimmer switches, cell phone chargers, plasma TVs, laptop computers and the dramatic increase of electronics all around us. Seven studies have shown that what is considered electrical noise on power lines is also biologically-active. (Havas, Milham, Morgan et al). These studies, many of which were performed in schools, shows that this electrical noise may be causing, or worsening health conditions such as Attention Deficit Disorder (ADD), chronic fatigue, diabetes (glucose rise) and asthma.

Four of the dis-eases most associated with inflammation – cancer, heart disease, diabetes and neurological disorders are directly linked to dirty electricity. Both Dr. Zorach Glaser’s bibliography and the BioInitiative Report (www.bioinitiative.org) separately connect electrical fields from wireless technologies with inflammation.

“Inflammation is a symptom of increased metabolic, dietary and environmental acidity, such as lactic acid, which can be measured in the extracellular fluids including the blood and the interstitial fluids which makes up more than 66 percent of all body fluids,” according to Robert O Young PhD.

 

In addition, Dr. Young states, “the inflammation connection can be confirmed through pH and chemistry testing of the body fluids and is the most important health issue of our time.” Electromagnetic frequencies from wireless technologies according to Dr. Young causes inflammation and inflammation leads to:

Cancer

Heart disease

Autoimmune disease

Diabetes

Neurological disorders like Alzheimer’s, Parkinson’s, ALS and MS

Attention Deficit Disorder, as TIME Magazine proposed in “The Fires Within,” then the mystery of these diseases, which have been exploding since the advent of the wireless revolution in the 1980’s has been finally solved!

Meanwhile a World of the smart grid, super WiFi, 4G and 5G even a more toxic cellular network of electromagnetic pollution is all around us and flooding our body. With these powerful and ‘untested’ wireless technologies which have been deployed Worldwide, the time has never been better to pause and ask the question:

Are YOU willing to continue to use these wireless technologies when WE now KNOW they are making us sick and tired?

To learn more about the research, discoveries and findings of Robert O Young go to: www.drrobertyoung.com

To attend a health and fitness Retreat go to: www.phmiracleretreat.com

Attend a World Conference in San Antonio, Texas November 14th and 15th

The World Congress on Cancer Science and Therapy this November 14th & 15, in San Antonio, Texas

Join Robert O Young CPT, MSc, DSc, PhD, Naturopathic Practitioner and Galina Migalko MSc, MD, NMD as they share their break-through research, discoveries and findings in the early detection, prevention and treatment of all cancerous conditions.

Sign-up before July 31st and YOU will receive an additional 10 percent discount off the Early Bird discounted registration fee.

 

To receive the additional 10 percent off the published registration fees please give us a call at: 760 751 8321 or email us at: phmiraclelife@gmail.com

Only Registration Includes:

Access to all conference sessions

Coffee breaks during the conference

Handbook & Conference Kit

Lunch during the conference

Certificate of Presentation/Participation

Package A Includes:

Above features including the following…

2 Nights’ Accommodation i.e. on November 14th, 2018 and November 15th, 2018

Package B Includes:

Above features including the following…

1 Extra Night Accommodation i.e. on November 16th, 2018

For Student Delegates

Access to All Sessions

Coffee breaks during the conference

Conference Kit and Souvenir

Lunch during the conference

Could Sodium or Potassium Bicarbonate save your life? Low levels of bicarbonate ‘are linked to a 24 % higher risk of early death!

Could Sodium or Potassium Bicarbonate save your life? Low levels of bicarbonate 'are linked to a 24 % higher risk of early death!

Robert Young PhD

Naturopathic Practitioner – The pH Miracle Ti Sana Detox Medical Spa

Could Sodium or Potassium Bicarbonate save your life? Low levels of bicarbonate ‘are linked to a 24 % higher risk of early death!

  • Compound in baking soda – bicarbonate – reduces early death, study found
  • Baking soda – or sodium bicarbonate – helps regulate pH levels  
  • People with low bicarbonate levels have 24% higher risk of early death
  • People should ingest fruit and green vegetables to get more bicarbonate!

Many of us think of baking soda as little more than a vital part of the recipe to making a cake or baking cookies.

But two new studies have found that the ingredients of sodium and/or potassium bicarbonate plays a far more important role in human health: It can help save lives.

Older people with low levels of sodium and/or potassiumbicarbonate – which is found in baking soda – have a 24 per cent higher risk of dying an early death!

The findings suggest increasing bicarbonate levels can prolong a person’s life.

Study author Dr Kalani Raphael, of the University of Utah, said: ‘What we found was that generally healthy older people with low levels of bicarbonate had a higher risk of death.’

Sodium bicarbonate, a main component of baking powder, reduces the risk of premature death, scientists revealed. Older people with low bicarbonate levels are 24 per cent more likely to die young, a study found

The kidneys and lungs work together by varying the levels of sodium and/or potassium bicarbonate – a base or alkaline compound – and carbon dioxide – an acid – in the blood, interstitial fluids and intracellular fluids.

Sodium and potassium bicarbonate helps keep the body’s pH in a healthy range (7.365), which allows the body cells that make up our organs to work properly.

Critically ill patients with severe acid-base abnormalities have very low levels of sodium and/or potassium bicarbonate and are very unlikely of surviving their illness, according to the study.

RELATED ARTICLES

  • Using Sodium and Potassium Bicarbonate in the Prevention and Treatment of ALL Sickness and Disease – Dr. Robert O. Young – www.phoreveryoung.com 

SHARE THIS ARTICLE

Yet, it has been unclear whether more subtle changes to the body’s acid-base status affect the longevity of relatively healthy older people.

A team of scientists investigated how measurements of pH, carbon dioxide and bicarbonate are associated with long-term survival in healthy older people.

They analyzed data from 2,287 participants in the health, aging and body composition study.

That data focused on well-functioning black and white adults between the ages of 70 and 79.

Data started being collected in 1997 – with collection efforts extending through February 2014.

Each of the participants were followed for an average of 10.3 years.

Scientists recommend people with low levels of sodium and/or potassium bicarbonate should increase their intake of foods that produce it in the body, including fruit and green vegetables.

Because of the study’s results, blood bicarbonate concentrations – which are already commonly measured – may allow clinicians to better identify people with a higher risk of premature death.

Those with low sodium and potassium bicarbonate levels may benefit from increasing their intake of foods that produce bicarbonate in the body – including fruit and vegetables, according to the scientists.

The study was published in the Clinical Journal of American Nephrology.  The study by Dr. Robert O. Young has been approved for publication in The International Journal of Complementary and Alternative Medicine.

Read more: http://www.phoreveryoung.wordpress.com

Using Alkalizing Herbs in the Prevention, Treatment and Reversal of Any Cancerous Condition

Dr. Robert O. Young MSc., DSc., Ph.D, ND

“The cure for cancer is found in its prevention NOT in its treatment”  Dr. Robert O. Young

Abstract

An anti-cancer lifestyle and diet is an important strategy you can use to reduce your risk for ANY cancerous condition. The American Cancer Society recommends, for example, that you eat at least five servings of fruit and vegetables daily and eat the right amount of (alkaline) food to stay at a healthy weight. In addition, researchers are finding that certain plant foods or herbs may be particularly useful in protecting and reversing many cancerous condition. The following article covers several of these medicinal herbs and their benefits in the prevention and treatment of brain cancer, lung cancer, breast cancer,  blood cancers,  prostate cancer, oral cancer, liver cancer thyroid cancer, kidney cancer, bowel cancer, stomach cancer, skin cancer and pancreatic cancer.

[Key words; cancer, chemotherapy, herbs, spices, natural cancer treatments, garlic, turmeric, ginger, cayenne, alkalizing, liver disease, oral cancer, prostate cancer, blood cancer, breast cancer, thyroid cancer, stomach cancer, skin cancer, pancreatic cancer, lung cancer, bowel cancer]

Introduction

Make room in your diet for the following foods and drinks to prevent cancer.  Why?  Because an ounce of prevention is worth more than a pound of cure.  The following are eleven herbs or spices that have been shown to be effective in the prevention, treatment and reversal of many cancerous conditions.

Garlic

[Figure 1: Cloves of garlic]

Several large studies have found that those who eat more garlic are less likely to develop various kinds of cancer, especially in digestive organs such as the esophagus, stomach, and colon. Ingredients in the pungent bulbs may keep cancer-causing substances in your body from working, or they may keep cancer cells from multiplying. I recommend a clove a day may be helpful.[1=22 ]

Cayenne Pepper

Most people know cayenne pepper for its spice. But it is actually an extraordinarily strong antioxidant and vaso-dialator. Studies have shown that by consuming cayenne pepper is highly alkaline and a powerful buffer of dietary and metabolic acids that cause cells to become cancerous. If you consume it regularly you can neutralize the acids that cause body cells to become cancerous.[23-29 ]

{Figure 2: Cyenne pepper]

Milk Thistle

Milk thistle is a crucial plant when it comes to liver health and cancer prevention. Milk thistle and the seeds from the plant can be used to eliminate acidic toxins that can bind to the liver, causing damage to the liver setting the stage for a cancerous condition. It protects the alkaline interstitial fluids that surround every body cell protecting them and indirectly preventing the formation of tumors, calcifications and/or cysts which make milk thistle a powerful antioxidant in the chelation of dietary and/or metabolic acids that cause cancer.[30-64 ]

[Figure 3: Milk Thistle]

Turmeric

 [Figure 4: Turmeric root and spice]

This orange-colored spice, a staple in Indian curries, contains an ingredient called curcumin (not the same as cumin) that might be useful in reducing cancer risk. According to the American Cancer Society, curcumin can inhibit some kinds of cancer cells in laboratory studies and slow the spread of cancer or shrink tumors in some animals. Turmeric is easy to find in grocery stores, and you can use it in a variety of recipes.[65-130 ]

Bloodroot

Bloodroot is actually used in a medicine for treating cancer named Black Salve. You can use bloodroot on its own, because it has been shown in tests to be effective in shrinking of tumors.[131-159]

[Figure 5: Bloodroot plant and flower]

Feverfew

Feverfew was used in a study at a university in New York. The study found that it was great at killing off leukemia cells, even better than the actual cancer medication.[160-191]

[Figure 6: Feverfew plant and flower]

Wheatgrass

Consuming one tiny glass of wheatgrass a day either orally or even-better rectally has shown to dramatically increase the health of cancer patients and non-cancer patients alike. It is particularly useful for people who are suffering from the side effects of chemotherapy. It will help purify the blood from dietary and/or metabolic acids, improve blood and lymph circulation, increase the oxygen levels in the microenvironments, and help the body repair and continue to reduce acids loads in the extracellular fluids, interstitial fluids and intracellular fluids to prevent and/or reverse and spoiling of the body cells.[192-204]

[Figure 7: Wheatgrass}

Ruscus Aculeatus

This herb is always known as Butchers Broom and it is great at fighting cancer due to its active ingredient, ruscogenins. The active ingredient has been proven to shrink tumors and increase the cancer fighting cells in the body.[205-221 ]

[Figure 8: Ruscus Aculeatus or Butchers Broom]

Sheep’s Sorrell

Sheep’s Sorrell can be used in people who are suffering the harmful effects of cancer medications. It helps the tissues rebuild and get back to the condition that they were in before the cancer and medication to use it was introduced. Some have suggested that it can be used to ward off cancer cells and keep them from growing.[222-224]

[Figure 9: Sheep’s Sorrel}

Astragalus

This herb is grown in China and has been proven to help with cancer on a couple of different levels. First it boosts your body’s immune system, which in turn helps it identify cancer cells. A study showed that cancer patients who took this herb survived twice as long.[225-250 ]

[Figure 10: Astragalus}

Ginger


[Figure 11: Ginger root]

A new study reveals ginger contains a pungent compound that could be up to 10,000 times more effective than conventional chemotherapy in targeting the cancer stem cells at the root of cancer malignancy. [251]

[Figure 12: Research Shows The Efficacy of Ginger Root as a non-toxic form of chemotherapy]

The authors of the study further affirm these points:

“Cancer stem cells pose serious obstacle to cancer therapy as they can be responsible for poor prognosis and tumour relapse. To add into the misery, very few chemotherapeutic compounds show promise to kill these cells. Several researchers have shown that cancer stem cells are resistant to paclitaxel, doxorubicin, 5-fluorouracil, and platinum drugs [8, 16]. CSCs are thus an almost unreachable population in tumours for chemotherapy. Therefore any compound, that shows promise towards cancer stem cells, is a highly desirable step towards cancer treatment and should be followed up for further development.”

The researchers identified a variety of ways by which 6-shagoal targets breast cancer:

  • It reduces the expression of CD44/CD24 cancer stem cell surface markers in breast cancer spheroids (3-dimensional cultures of cells modeling stem cell like cancer)
  • It significantly affects the cell cycle, resulting in increased cancer cell death
  • It induces programmed cell death primarily through the induction of autophagy, with apoptosis a secondary inducer
  • It inhibits breast cancer spheroid formation by altering Notch signaling pathway through γ-secretase inhibition.
  • It exhibits cytotoxicity (cell killing properties) against monolayer (1-dimensional cancer model) and spheroid cells (3-dimensional cancer model)

It was in evaluating the last mode of 6-shagoal’s chemotherapeutic activity and comparing it to the activity of the conventional chemotherapeutic agent taxol that the researchers discovered an astounding difference. Whereas taxol exhibited clear cytotoxicity in the one-dimensional (flat) monolayer experimental model, it had virtually no effect on the spheroid model, which is a more “real world” model reflecting the 3-dimensionality of tumors and their stem cell subpopulations. Amazingly, this held true even when the concentration of taxol was increased by four orders of magnitude:

 “In contrast [to 6-shagoal], taxol, even though was highly active in monolayer cells, did not show activity against the spheroids even at 10000 fold higher concentration compared to 6-shogoal.”

This is a highly significant finding, as it affirms a common theme in cancer research that acknowledges the primarily role of cancer stem cells: namely, while conventional techniques like surgery, radiation, and chemotherapy are effective at reducing a tumor’s size, sometimes to the point where it is “debulked,” burned,” or “poisoned” out of the body even below the threshold of re-detection, the appearance of “winning the battle” often comes at a steep price, as ultimately the cancer stem cell population regrows the tumors, now with increased vengeance and metastastic invasiveness, resulting in the cancer “winning the war.”

The monolayer model, which does not account for the complex immunity of actual cancer stem-cell based tumors against chemoagents like taxol, represents the old preclinical model of testing cancer treatments. The spheroid model, on the other hand, clearly shows that even 10,000 times higher concentrations of taxol are not capable of beating this ginger component at selectively targeting the root cause of the tumor malignancy.

In their concluding remarks, the authors point out a hugely important distinction between natural anti-cancer agents and conventional ones that have only been introduced in the past half century or so, namely, “Dietary compounds are welcome options for human diseases due to their time-tested acceptability by human bodies.”  

Unlike modern synthetically produced and patented chemicals, ginger, curcumin, garlic, and hundreds of other compounds naturally found in the human diet, have been “time-tested” as acceptable to the human body in the largest and longest running “clinical trials” known: the tens of thousands of years of direct human experience, spanning thousands of different cultures from around the world, that constitute human prehistory. These experientially-based “trials” are validated not by RCTs, or a peer-reviewed publication process, but by the fact that we all made it through this incalculably vast span of time to be alive here today. Consider also that if our ancestors made the wrong dietary choice by simply mistaking an edible berry for a poisonous one, the consequences could be deadly. This places even greater emphasis on how the “time testing” of dietary compounds was not an academic but a life-death affair, and by implication, how the information contained within various cultural traditions as “recipes” passed down from generation to generation are “epigenetic inheritance systems” no less important to our health and optimal gene expression as the DNA in our own bodies.

Ultimately, this new study adds to a growing body of research indicating that cancer stem cell targeting approaches using natural substances present in the human diet for thousands of years are far superior than chemotherapy and radiation, both of which actually increase the relative populations of cancer stem cells versus non-tumorigenic ones.[251]

Cannabis

[Figure 11: Cannabis plant with buds]

Cannabis has been making a lot of noise lately. Multiple states across the United States and countries around the world have successfully legalized medical Marijuana, and the Uruguay parliament recently voted to create the world’s first legal marijuana market.[252-256] This is good news as the health benefits of Cannabis are vast, with multiple medical and scientific studies that confirm them. On the other hand, arguments against the use of marijuana is usually published in Psychiatric journals, which show no scientific evidence that Cannabis is harmful to human health. All psychological evaluations from the intake of cannabis are largely based on assumptions, suggestions and observations (257). When we look at the actual science behind Cannabis, the health benefits can be overwhelming. So what does one who opposes the use of cannabis base their belief on? Nothing, not scientific evidence anyways. The negative stigmatism attached to marijuana is due to it’s supposed psychotropic effects, yet again, there is no scientific evidence to show that marijuana has any psychotropic effects. Nonetheless, cannabis has recently been the focus of medical research and considered as a potential therapeutic treatment and cure for cancer.Cannabis is a great example of how the human mind is programmed and conditioned to believe something. Growing up, we are told drugs are bad, which is true, however not all substances that have been labelled as “drugs” by the government are harmful. Multiple substances are labelled as a “drug” in order to protect corporate interests. One example is the automobile and energy industry, a car made from hemp is stronger than steel, and can be fuelled from hemp alone. Henry Ford demonstrated this many years ago. Hemp actually has over 50,000 uses![258]Let’s take a look at the science behind Cannabis and Cancer. Although Cannabis has been proven to be effective for a large range of ailments, this article will focus mainly on it’s effectiveness in the treatment of cancer. Cannabinoids may very well be one of the best disease and cancer fighting treatments out there. Cannabinoids refer to any of a group of related compounds that include cannabinol and the active constituents of cannabis. They activate cannabinoid receptors in the body. The body itself produces compounds called endocannabinoids and they play a role in many processes within the body that help to create a healthy environment. Cannabinoids also play a role in immune system generation and re-generation. The body regenerates best when it’s saturated with Phyto-Cannabinoids. Cannabinoids can also be found in Cannabis. It is important to note that the cannabinoids are plentiful in both hemp and cannabis. One of the main differentiations between hemp and cannabis is simply that hemp only contains 0.3% THC while cannabis is 0.4% THC or higher. (Technically they are both strains of Cannabis Sativa.)  Cannabinoids have been proven to reduce cancer cells as they have a great impact on the rebuilding of the immune system. While not every strain of cannabis has the same effect, more and more patients are seeing success in cancer reduction in a short period of time by using cannabis.While taking a look at these studies, keep in mind that cannabis can be much more effective for medicinal purposes when we eat it rather than smoking it. Below are 20 medical studies that prove cannabis can be an effective treatment and possible cure for cancer.[ [259-288] Please keep in mind that this is a very short list of studies that support the use of medicinal marijuana. Please feel free to further your research, hopefully this is a good starting point.

Brain Cancer

A study published in the British Journal of Cancerconducted by the Department of Biochemistry and Molecular Biology at Complutense University in Madrid, this study determined that Tetrahydrocannabinol (THC) and other cannabinoids inhibit tumour growth. They were responsible for the first clinical study aimed at assessing cannabinoid antitumoral action. Cannabinoid delivery was safe and was achieved with zero psychoactive effects. THC was found to decrease tumour cells in two out of the nine patients.[289]A study published in The Journal of Neuroscience examined the biochemical events in both acute neuronal damage and in slowly progressive, neurodegenerative diseases. They conducted a magnetic resonance imaging study that looked at THC (the main active compound in marijuana) and found that it reduced neuronal injury in rats. The results of this study provide evidence that the cannabinoid system can serve to protect the brain against neurodegeneration.[290]A study published in The Journal of Pharmacology And Experimental Therapeutics already acknowledged the fact that cannabinoids have been shown to possess antitumor properties. This study examined the effect of cannabidiol (CBD, non psychoactive cannabinoid compound) on human glioma cell lines. The addition of cannabidiol led to a dramatic drop in the viability of glioma cells. Glioma is the word used to describe brain tumour.  The study concluded that cannabidiol was able to produce a significant antitumor activity.[291]A study published in the journal Molecular Cancer Therapeutics outlines how brain tumours are highly resistant to current anticancer treatments, which makes it crucial to find new therapeutic strategies aimed at improving the poor prognosis of patients suffering from this disease. This study also demonstrated the reversal of tumour activity in Glioblastoma multiforme.[292]

Breast Cancer

A study published in the US National Library of Medicine, conducted by the California Pacific Medical Centre determined that cannabidiol (CBD) inhibits human breast cancer cell proliferation and invasion. They also demonstrated that CBD significantly reduces tumour mass.[293]A study published in The Journal of Pharmacology and Experimental Therapeutics determined that THC as well as cannabidiol dramatically reduced breast cancer cell growth. They confirmed the potency and effectiveness of these compounds.[294]A study published in the Journal Molecular Cancer showed that THC reduced tumour growth and tumour numbers. They determined that cannabinoids inhibit cancer cell proliferation, induce cancer cell apoptosis and impair tumour angiogenesis (all good things). This study provides strong evidence for the use of cannabinoid based therapies for the management of breast cancer.[295]A study published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) determined that cannabinoids inhibit human breast cancer cell proliferation.[296]

Lung Cancer

A study published in the journal Oncogeneby Harvard Medical Schools Experimental Medicine Department determined that THC inhibits epithelial growth factor induced lung cancer cell migration and more. They go on to state that THC should be explored as novel therapeutic molecules in controlling the growth and metastasis of certain lung cancers.[297 ]A study published by the US National Library of Medicine by the Institute of Toxicology and Pharmacology, from the Department of General Surgery in Germany determined that cannabinoids inhibit cancer cell invasion. Effects were confirmed in primary tumour cells from a lung cancer patient.  Overall, data indicated that cannabinoids decrease cancer cell invasiveness.[298 ]A study published by the US National Library of Medicine, conducted by Harvard Medical School investigated the role of cannabinoid receptors in lung cancer cells. They determined its effectiveness and suggested that it should be used for treatment against lung cancer cells.[299 ]

Prostate Cancer

A study published in the US National Library of Medicine illustrates a decrease in prostatic cancer cells by acting through cannabinoid receptors.[300]A study published in the US National Library of Medicine outlined multiple studies proving the effectiveness of cannabis on prostate cancer.[301]Another study published by the US National Library of Medicine determined that clinical testing of CBD against prostate carcinoma is a must. That cannabinoid receptor activation induces prostate carcinoma cell apoptosis. They determined that cannabidiol significantly inhibited cell viability.[302]

Blood Cancer

A study published in the journal Molecular Pharmacology recently showed that cannabinoids induce growth inhibition and apoptosis in matle cell lymphoma. The study was supported by grants from the Swedish Cancer Society, The Swedish Research Council and the Cancer Society in Stockholm.[303]A study published in the International Journal of Cancer also determined and illustrated that cannabinoids exert antiproliferative and proapoptotic effects in various types of cancer and in mantle cell lymphoma.[304]A study published in the US National Library of Medicine conducted by the Department of Pharmacology and Toxicology by Virginia Commonwealth University determined that cannabinoids induce apoptosis in leukemia cells.[305]

Oral Cancer

A study published by the US National Library of Medicine results show cannabinoids are potent inhibitors of cellular respiration and are toxic to highly malignant oral Tumours. [306]

Liver Cancer

A study published by the US National Library of Medicine determined that that THC reduces the viability of human HCC cell lines (Human hepatocellular liver carcinoma cell line) and reduced the growth.[307]

Pancreatic Cancer

A study published in The American Journal of Cancer determined that cannabinoid receptors are expressed in human pancreatic tumor cell lines and tumour biopsies at much higher levels than in normal pancreatic tissue. Results showed that cannabinoid administration induced apoptosis. They also reduced the growth of tumour cells, and inhibited the spreading of pancreatic tumour cells.[308]

Conclusion

According to a 2004 report by Morgan, Ward, and Barton: “The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. … survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA.”Jun 16, 2014[309]

Medical oncologists are a long way from using medicinal herbs as an alternative or primary treatment for cancer.  The research is significant and shows that the medicinal herbs discussed in this article are extraordinary plants and have shown excellent results in the prevention, treatment and reversal of many cancerous conditions.

References:

  1. Milner JA. Garlic: Its anticarcinogenic and antitumorigenic properties. Nutrition Reviews1996; 54:S82–S86.
  2. Ross SA, Finley JW, Milner JA. Allyl sulfur compounds from garlic modulate aberrant crypt formation. Journal of Nutrition 2006; 136(3 Suppl):852S–854S.
  3. Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y. Intake of garlic and its bioactive components. Journal of Nutrition 2001; 131(3s):955S–962S.
  4. Amagase H. Clarifying the real bioactive constituents of garlic. Journal of Nutrition 2006; 136(3 Suppl):716S–725S.
  5. Fleischauer AT, Arab L. Garlic and cancer: A critical review of the epidemiologic literature. Journal of Nutrition 2001; 131(3s):1032S–1040S.
  6. Gonzalez CA, Pera G, Agudo A, et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). International Journal of Cancer 2006; 118(10): 2559–2566.
  7. Steinmetz KA, Kushi LH, Bostick RM, Folsom AR, Potter JD. Vegetables, fruit, and colon cancer in the Iowa Women’s Health Study. American Journal of Epidemiology 1994; 139(1):1–15.
  8. Gao CM, Takezaki T, Ding JH, Li MS, Tajima K. Protective effect of allium vegetables against both esophageal and stomach cancer: A simultaneous case-referent study of a high-epidemic area in Jiangsu Province, China. Japanese Journal of Cancer Research1999; 90(6):614–621.
  9. Setiawan VW, Yu GP, Lu QY, et al. Allium vegetables and stomach cancer risk in China. Asian Pacific Journal of Cancer Prevention 2005; 6(3):387–395.
  10. Hsing AW, Chokkalingam AP, Gao YT, et al. Allium vegetables and risk of prostate cancer: A population-based study. Journal of the National Cancer Institute 2002; 94(21):1648–1651.
  11. Chan JM, Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiology Biomarkers & Prevention 2005; 14(9):2093–2097.
  12. Challier B, Perarnau JM, Viel JF. Garlic, onion and cereal fibre as protective factors for breast cancer: A French case-control study. European Journal of Epidemiology 1998; 14(8):737–747.
  13. Li H, Li HQ, Wang Y, et al. An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum. Chinese Medical Journal (English) 2004; 117(8):1155–1160.
  14. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. Journal of the National Cancer Institute 2006; 98(14):974–983.
  15. Tanaka S, Haruma K, Kunihiro M, et al. Effects of aged garlic extract (AGE) on colorectal adenomas: A double-blinded study. Hiroshima Journal of Medical Sciences 2004; 53(3–4):39–45.
  16. Tilli CM, Stavast-Kooy AJ, Vuerstaek JD, et al. The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis. Archives of Dermatological Research 2003; 295(3):117–123.
  17. Ruddock PS, Liao M, Foster BC, et al. Garlic natural health products exhibit variable constituent levels and antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis. Phytotherapy Research 2005; 19(4):327–334.
  18. Shenoy NR, Choughuley AS. Inhibitory effect of diet related sulphydryl compounds on the formation of carcinogenic nitrosamines. Cancer Letters 1992; 65(3):227–232.
  19. Milner JA. Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Advances in Experimental Medicine and Biology2001; 492:69–81.
  20. L’vova GN, Zasukhina GD. Modification of repair DNA synthesis in mutagen-treated human fibroblasts during adaptive response and the antimutagenic effect of garlic extract. Genetika 2002; 38(3):306–309.
  21. Boon H, Wong J. Botanical medicine and cancer: A review of the safety and efficacy. Expert Opinion on Pharmacotherapy 2004; 5(12):2485–2501.
  22. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clinical Infectious Diseases 2002; 34(2):234–238.Athanasiou A., et al. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death. Biochem Biophys Res Commun 2007 Mar 2; 354(1): 50-55.
  23. Athanasiou A., et al. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death.  2007 Mar 2; 354(1): 50-55.
  24. Christensen, Jon. (December 12, 2005). Retrieved from The New York Times. Scientist at work: John Reed; running hot in pursuit of cancer treatment).
  25. Hu, Janny.  (October 12, 2004). Lakers Suite Tomjanovich to a T. San Francisco Chronicle on The Web. Retrieved from http://www.sfgate.com/sports/article/Lakers-suit-coach-Tomjanovich-to-a-T-2641695.php.
  26. Mori, Akio, et al. (March 15, 2006). Capsaicin, A Component of Red Peppers, Inhibits The Growth of Androgen-Independent, p53 Mutant Prostate Cancer Cells. American Association of Cancer Research.
  27. Samid, Dvorit. (1997). Compositions and methods for treating and preventing pathologies including cancer. The USA Dept. of HHS; pg. 56.
  28. Sanchez AM et al. Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation. Apoptosis 2007; 12(11): 2013-24.
  29. Thoennissen NH, O’Kelly J, Lu D, et al. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway. Oncogene. 2010, Jan 14;29(2):285-96.  
  30. PDR® for Herbal Medicines™. 2nd ed. Montvale, NJ: Medical Economics, 2000.
  31. Lee DY, Liu Y: Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, Isolated from Silybum marianum (milk thistle). J Nat Prod 66 (9): 1171-4, 2003. [PUBMED Abstract]
  32. Napolitano JG, Lankin DC, Graf TN, et al.: HiFSA fingerprinting applied to isomers with near-identical NMR spectra: the silybin/isosilybin case. J Org Chem 78 (7): 2827-39, 2013. [PUBMED Abstract]
  33. Hruby K, Csomos G, Fuhrmann M, et al.: Chemotherapy of Amanita phalloides poisoning with intravenous silibinin. Hum Toxicol 2 (2): 183-95, 1983. [PUBMED Abstract]
  34. Wagner H, Hörhammer L, Münster R: [On the chemistry of silymarin (silybin), the active principle of the fruits from Silybum marianum (L.) Gaertn. (Carduus marianus L.)] Arzneimittelforschung 18 (6): 688-96, 1968. [PUBMED Abstract]
  35. Campos R, Garrido A, Guerra R, et al.: Silybin dihemisuccinate protects against glutathione depletion and lipid peroxidation induced by acetaminophen on rat liver. Planta Med 55 (5): 417-9, 1989. [PUBMED Abstract]
  36. Farghali H, Kameniková L, Hynie S, et al.: Silymarin effects on intracellular calcuim and cytotoxicity: a study in perfused rat hepatocytes after oxidative stress injury. Pharmacol Res 41 (2): 231-7, 2000. [PUBMED Abstract]
  37. Lettéron P, Labbe G, Degott C, et al.: Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem Pharmacol 39 (12): 2027-34, 1990. [PUBMED Abstract]
  38. Zhao J, Agarwal R: Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention. Carcinogenesis 20 (11): 2101-8, 1999. [PUBMED Abstract]
  39. Valenzuela A, Guerra R, Videla LA: Antioxidant properties of the flavonoids silybin and (+)-cyanidanol-3: comparison with butylated hydroxyanisole and butylated hydroxytoluene. Planta Med (6): 438-40, 1986. [PUBMED Abstract]
  40. Valenzuela A, Guerra R, Garrido A: Silybin dihemisuccinate protects rat erythrocytes against phenylhydrazine-induced lipid peroxidation and hemolysis. Planta Med 53 (5): 402-5, 1987. [PUBMED Abstract]
  41. Valenzuela A, Aspillaga M, Vial S, et al.: Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat. Planta Med 55 (5): 420-2, 1989. [PUBMED Abstract]
  42. Mira ML, Azevedo MS, Manso C: The neutralization of hydroxyl radical by silibin, sorbinil and bendazac. Free Radic Res Commun 4 (2): 125-9, 1987. [PUBMED Abstract]
  43. Mira L, Silva M, Manso CF: Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochem Pharmacol 48 (4): 753-9, 1994. [PUBMED Abstract]
  44. Koch HP, Löffler E: Influence of silymarin and some flavonoids on lipid peroxidation in human platelets. Methods Find Exp Clin Pharmacol 7 (1): 13-8, 1985. [PUBMED Abstract]
  45. Garrido A, Arancibia C, Campos R, et al.: Acetaminophen does not induce oxidative stress in isolated rat hepatocytes: its probable antioxidant effect is potentiated by the flavonoid silybin. Pharmacol Toxicol 69 (1): 9-12, 1991. [PUBMED Abstract]
  46. Bosisio E, Benelli C, Pirola O: Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacol Res 25 (2): 147-54, 1992 Feb-Mar. [PUBMED Abstract]
  47. Altorjay I, Dalmi L, Sári B, et al.: The effect of silibinin (Legalon) on the the free radical scavenger mechanisms of human erythrocytes in vitro. Acta Physiol Hung 80 (1-4): 375-80, 1992. [PUBMED Abstract]
  48. El-Shitany NA, Hegazy S, El-Desoky K: Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats. Phytomedicine 17 (2): 116-25, 2010. [PUBMED Abstract]
  49. Scambia G, De Vincenzo R, Ranelletti FO, et al.: Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin. Eur J Cancer 32A (5): 877-82, 1996. [PUBMED Abstract]
  50. Bhatia N, Zhao J, Wolf DM, et al.: Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin. Cancer Lett 147 (1-2): 77-84, 1999. [PUBMED Abstract]
  51. Zi X, Agarwal R: Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. Proc Natl Acad Sci U S A 96 (13): 7490-5, 1999. [PUBMED Abstract]
  52. Duthie SJ, Johnson W, Dobson VL: The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimdines) and growth in human cells. Mutat Res 390 (1-2): 141-51, 1997. [PUBMED Abstract]
  53. Vailati A, Aristia L, Sozzé E, et al.: Randomized open study of the dose-effect relationship of a short course of IdB 1016 in patients with viral or alcoholic hepatitis. Fitoterapia 64 (3), 219-28, 1993.
  54. Salmi HA, Sarna S: Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study. Scand J Gastroenterol 17 (4): 517-21, 1982. [PUBMED Abstract]
  55. Parés A, Planas R, Torres M, et al.: Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol 28 (4): 615-21, 1998. [PUBMED Abstract]
  56. Moscarella S, Giusti A, Marra F, et al.: Therapeutic and antilipoperoxidant effects of silybin-phosphatidylcholine complex in chronic liver disease: preliminary results. Current Therapeutic Research 53 (1): 98-102.
  57. Marena C, Lampertico M: Preliminary clinical development of silipide: a new complex of silybin in toxic liver disorders. Planta Med 57 (Suppl 2): A124-5, 1991.
  58. Marcelli R, Bizzoni P, Conte D, et al.: Randomized controlled study of the efficacy and tolerability of a short course of IdB 1016 in the treatment of chronic persistent hepatitis. European Bulletin of Drug Research 1 (3): 131-5, 1992.
  59. Flisiak R, Prokopowicz D: Effect of misoprostol on the course of viral hepatitis B. Hepatogastroenterology 44 (17): 1419-25, 1997 Sep-Oct. [PUBMED Abstract]
  60. Ferenci P: [Therapy of chronic hepatitis C] Wien Med Wochenschr 150 (23-24): 481-5, 2000. [PUBMED Abstract]
  61. Buzzelli G, Moscarella S, Giusti A, et al.: Therapeutic effects of a new silybin complex in chronic active hepatitis (CAH). [Abstract] Hellenic Journal of Gastroenterology 5 (Suppl): A-151, 38, 1992.
  62. Albrecht M, Frerick H, Kuhn U, et al.: Therapy of toxic liver pathologies with Legalon®. Z Klin Med 47: 87-92, 1992.
  63. Rambaldi A, Jacobs BP, Gluud C: Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev (4): CD003620, 2007. [PUBMED Abstract]
  64. Yang Z, Zhuang L, Lu Y, et al.: Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials. Biomed Res Int 2014: 941085, 2014. [PUBMED Abstract]
  65. Bachmeier BE, Mirisola V, Romeo F, et al. Reference profile correlation reveals estrogen-like trancriptional activity of Curcumin. Cell Physiol Biochem. 2010;26(3):471-482.
  66. Cemil B, Topuz K, Demircan MN, et al. Curcumin improves early functional results after experimental spinal cord injury. Acta Neurochir (Wien). Sep 2010;152(9):1583-1590; discussion 1590.
  67. Seehofer D, Schirmeier A, Bengmark S, et al. Inhibitory effect of curcumin on early liver regeneration following partial hepatectomy in rats. J Surg Res. Aug 2009;155(2):195-200.
  68. Yun JM, Jialal I, Devaraj S. Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. J Nutr Biochem. May 2011;22(5):450-458.
  69. Jantan I, Bukhari SN, Lajis NH, et al. Effects of diarylpentanoid analogues of curcumin on chemiluminescence and chemotactic activities of phagocytes. J Pharm Pharmacol.Mar 2012;64(3):404-412.
  70. Chang KW, Hung PS, Lin IY, et al. Curcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C/EBPalpha during oral cancer suppression. Int J Cancer. Jul 1 2010;127(1):9-20.
  71. Siwak DR, Shishodia S, Aggarwal BB, et al. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.Cancer. Aug 15 2005;104(4):879-890.
  72. Uddin S, Hussain AR, Manogaran PS, et al. Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene. Oct 27 2005;24(47):7022-7030.
  73. Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. Apr 15 2007;67(8):3853-3861.
  74. Selvendiran K, Ahmed S, Dayton A, et al. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition. Cancer Biol Ther. Nov 1 2011;12(9):837-845.
  75. Sreekanth CN, Bava SV, Sreekumar E, et al. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer. Oncogene. Jul 14 2011;30(28):3139-3152.
  76. Qiao Q, Jiang Y, Li G. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-kappaB pathway: an in-vitro study of lymphoma. Anticancer Drugs.Jan 23 2012
  77. Kunnumakkara AB, Diagaradjane P, Guha S, et al. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Clin Cancer Res. Apr 1 2008;14(7):2128-2136.
  78. Ng TP, Chiam PC, Lee T, et al. Curry consumption and cognitive function in the elderly.Am J Epidemiol. Nov 1 2006;164(9):898-906.
  79. Baum L, Lam CW, Cheung SK, et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol. Feb 2008;28(1):110-113.
  80. Bundy R, Walker AF, Middleton RW, et al. Turmeric extract may improve irritable bowel syndrome symptomatology in otherwise healthy adults: a pilot study. J Altern Complement Med. Dec 2004;10(6):1015-1018.
  81. Hanai H, Iida T, Takeuchi K, et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clinical Gastroenterol Hepatol. Dec 2006;4(12):1502-1506.
  82. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging. 2014 Mar 20;9:451-8.
  83. Pungcharoenkul K, Thongnopnua P. Effect of different curcuminoid supplement dosages on total in vivo antioxidant capacity and cholesterol levels of healthy human subjects. Phytother Res. Nov 2011;25(11):1721-1726
  84. Baum L, Cheung SK, Mok VC, et al. Curcumin effects on blood lipid profile in a 6-month human study. Pharmacol Res. Dec 2007;56(6):509-514.
  85. expression in patients with colorectal cancer by administration of curcumin. Cancer Invest. Mar 2011;29(3):208-213.
  86. Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. Jul 15 2008;14(14):4491-4499.
  87. Bayet-Robert M, Kwiatkowski F, Leheurteur M, et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer.Cancer Biol Ther. Jan 2010;9(1):8-14.
  88. Kanai M, Yoshimura K, Asada M, et al. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol. Jul 2011;68(1):157-164.
  89. Epelbaum R, Schaffer M, Vizel B, et al. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer. 2010;62(8):1137-1141.
  90. Zhang W, Lim LY. Effects of spice constituents on P-glycoprotein-mediated transport and CYP3A4-mediated metabolism in vitro. Drug Metab Dispos. Jul 2008;36(7):1283-1290.
  91. Chen Y, Liu WH, Chen BL, et al. Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers. Ann Pharmacother.Jun 2010;44(6):1038-1045.
  92. Somasundaram S, Edmund NA, Moore DT, et al. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. Jul 1 2002;62(13):3868-3875.
  93. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons; 1996.
  94. Morsy MA, Abdalla AM, Mahmoud AM, et al. Protective effects of curcumin, alpha-lipoic acid, and N-acetylcysteine against carbon tetrachloride-induced liver fibrosis in rats. J Physiol Biochem. Oct 11 2011.
  95. Bulku E, Stohs SJ, Cicero L, et al. Curcumin exposure modulates multiple pro-apoptotic and anti-apoptotic signaling pathways to antagonize acetaminophen-induced toxicity. Curr Neurovasc Res. Feb 1 2012;9(1):58-71.
  96. Alexandrow MG, Song LJ, Altiok S, et al. Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer. Eur J Cancer Prev. Dec 7 2011.
  97. Lin SS, Lai KC, Hsu SC, et al. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF). Cancer Lett. Nov 28 2009;285(2):127-133.
  98. Chen QY, Lu GH, Wu YQ, et al. Curcumin induces mitochondria pathway mediated cell apoptosis in A549 lung adenocarcinoma cells. Oncol Rep. May 2010;23(5):1285-1292.
  99. Wu SH, Hang LW, Yang JS, et al. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways. Anticancer Res. Jun 2010;30(6):2125-2133.
  100. de H, Tokiwa S, Sakamaki K, et al. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Prostate. Jul 1 2010;70(10):1127-1133.
  101. Wong TF, Takeda T, Li B, et al. Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition. Gynecol Oncol. Jul 2011;122(1):141-148
  102. Bartik L, Whitfield GK, Kaczmarska M, et al. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.J Nutr Biochem. Dec 2010;21(12):1153-1161.
  103. Watson JL, Hill R, Lee PW, et al. Curcumin induces apoptosis in HCT-116 human colon cancer cells in a p21-independent manner. Exp Mol Pathol. Jun 2008;84(3):230-233.
  104. Yang KY, Lin LC, Tseng TY, et al. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. Jun 15 2007;853(1-2):183-189.
  105. Garcea G, Berry DP, Jones DJ, et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev. Jan 2005;14(1):120-125.
  106. Bishnoi M, Chopra K, Rongzhu L, et al. Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence. Neurotox Res. Oct 2011;20(3):215-225.
  107. Tsai YM, Chien CF, Lin LC, et al. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm. Sep 15 2011;416(1):331-338.
  108. Orr WS, Denbo JW, Saab KR, et al. Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition. Surgery. Jan 26 2012.
  109. Asai A, Miyazawa T. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sci. Oct 27 2000;67(23):2785-2793.
  110. Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology. 1980;16(3):259-265.
  111. Hou XL, Takahashi K, Tanaka K, et al. Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. Int J Pharm. Jun 24 2008;358(1-2):224-229.
  112. Zhang W, Tan TM, Lim LY. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab Dispos. Jan 2007;35(1):110-115.
  113. Appiah-Opong R, Commandeur JN, van Vugt-Lussenburg B, et al. Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products.Toxicology. Jun 3 2007;235(1-2):83-91.
  114. Tang M, Larson-Meyer DE, Liebman M. Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr. May 2008;87(5):1262-1267.
  115. Ulbricht CE, Basch, EM. Natual Standard Herb & Supplement Reference: Evidence-Based Clinical Reviews St. Louis, MO: Elsevier Mosby; 2005.
  116. Lamb SR, Wilkinson SM. Contact allergy to tetrahydrocurcumin. Contact Dermatitis.Apr 2003;48(4):227.
  117. Liddle M, Hull C, Liu C, et al. Contact urticaria from curcumin. Dermatitis. Dec 2006;17(4):196-197.
  118. Prakash P, Misra A, Surin WR, et al. Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb Res. Feb 2011;127(2):111-118.
  119. Jantan I, Raweh SM, Sirat HM, et al. Inhibitory effect of compounds from Zingiberaceae species on human platelet aggregation. Phytomedicine. Apr 2008;15(4):306-309.
  120. Pavithra BH, Prakash N, Jayakumar K. Modification of pharmacokinetics of norfloxacin following oral administration of curcumin in rabbits. J Vet Sci. Dec 2009;10(4):293-297.
  121. Kudva AK, Manoj, MN, Swamy, BM, et al. Complexation of amphotericin B and curcumin with serum albumins: solubility and effect on erythrocyte membrane damage. J Exp Pharmacol. 2011;2011(3):1-6.
  122. Hudson SA, Ecroyd H, Kee TW, et al. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J. Oct 2009;276(20):5960-5972.
  123. Egashira K, Sasaki H, Higuchi S, Ieiri I. Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats. Drug Metab Pharmacokinet. 2012 Apr 25;27(2):242-7.
  124. Choi HA, Kim MR, Park KA, Hong J. Interaction of over-the-counter drugs with curcumin: influence on stability and bioactivities in intestinal cells. J Agric Food Chem.2012 Oct 24;60(42):10578-84.
  125. Akazawa N, Choi Y, Miyaki A, et al. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women. Nutr Res. 2012 Oct;32(10):795-9.
  126. Sanmukhani J, Satodia V, Trivedi J, et al. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res. 2014 Apr;28(4):579-85.
  127. Niu M, Wu S, Mao L, Yang Y. CRM1 is a cellular target of curcumin: new insights for the myriad of biological effects of an ancient spice. Traffic. 2013 Oct;14(10):1042-52.
  128. Palatty PL, Azmidah A, Rao S, et al. Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study. Br J Radiol. 2014 Jun;87(1038):20130490.
  129. Thomas R, Williams M, Sharma H, Chaudry A, Bellamy P. A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the U.K. NCRN Pomi-T study. Prostate Cancer Prostatic Dis. 2014 Jun;17(2):180-6.
  130. Daveluy A, Geniaux H, Thibaud L, et al. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa). Therapie. Nov-Dec 2014;69(6):519-520.
  131. Doctor Accused of Aiding Man Who Disfigured Cancer Patients. The Washinton Post.http://www.washingtonpost.com/wp-dyn/content/article/2005/08/13/AR2005081301016.html. Accessed August 17, 2015.
  132. Adhami VM, Aziz MH, Mukhtar H, et al. Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin Cancer Res 2003;9(8):3176-82.
  133. Adhami VM, Aziz MH, Reagan-Shaw SR, et al. Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol Cancer Ther 2004;3(8):933-40.
  134. Basini G, Santini SE, Bussolati S, et al. The plant alkaloid sanguinarine is a potential inhibitor of follicular angiogenesis. J Reprod Dev 2007;53(3):573-9.
  135. Basini G, Santini SE, Bussolati S, et al. Sanguinarine inhibits VEGF-induced Akt phosphorylation. Ann N Y Acad Sci 2007;1095:371-6.
  136. Chaturvedi MM, Kumar A, Darnay BG, et al. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. J Biol Chem 1997;272(48):30129-34.
  137. Ding Z, Tang SC, Weerasinghe P, et al. The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death. Biochem Pharmacol 2002;63(8):1415-21.
  138. Dzink JL, Socransky SS. Comparative in vitro activity of sanguinarine against oral microbial isolates. Antimicrob Agents Chemother 1985;27(4):663-5.
  139. Eun JP, Koh GY. Suppression of angiogenesis by the plant alkaloid, sanguinarine.Biochem Biophys Res Commun 2004;317(2):618-24.
  140. Eversole LR, Eversole GM, Kopcik J. Sanguinaria-associated oral leukoplakia: comparison with other benign and dysplastic leukoplakic lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89(4):455-64.
  141. Fetrow C. Professional’s handbook of complementary and alternative medicines 2nd ed. 2001, Springhouse, PA: Springhouse Corp.
  142. Hakim SA, Sanguinarine and hypothalamic glaucoma. J All India Ophthalmol Soc. 1962 Dec;10:83-102.
  143. Jeng JH, Wu HL, Lin BR, et al. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Atherosclerosis2007;191(2):250-8.
  144. Mascarenhas AK, Allen CM, Loudon J. The association between Viadent use and oral leukoplakia. Epidemiology. 2001;12(6):741-3.
  145. McDaniel S, Goldman GD. Consequences of using escharotic agents as primary treatment for nonmelanoma skin cancer. Arch Dermatol 2002;138(12):1593-6.
  146. Munro IC, Delzell ES, Nestmann ER, et al. Viadent usage and oral leukoplakia: a spurious association. Regul Toxicol Pharmacol 1999;30(3):182-96.
  147. Nandi R, Maiti M. Binding of sanguinarine to deoxyribonucleic acids of differing base composition. Biochem Pharmacol 1985;34(3):321-4.
  148. Scheiner-Bobis G. Sanguinarine induces K+ outflow from yeast cells expressing mammalian sodium pumps. Naunyn Schmiedebergs Arch Pharmacol 2001;363(2):203-8.
  149. Seifen E, Adams RJ, Riemer RK. Sanguinarine: a positive inotropic alkaloid which inhibits cardiac Na+,K+-ATPase. Eur J Pharmacol 1979;60(4):373-7.
  150. Suchomelova J, Bochorakova H, Paulova H, et al. HPLC quantification of seven quaternary benzo[c]phenanthridine alkaloids in six species of the family Papaveraceae. J Pharm Biomed Anal 2007;44(1):283-7.
  151. Wolff J, Knipling L. Antimicrotubule properties of benzophenanthridine alkaloids.Biochemistry 1993;32(48):13334-9.
  152. Mazzio EA, Soliman KF. In vitro screening for the tumoricidal properties of international medicinal herbs. Phytother Res. 2009 Mar;23(3):385-98.
  153. Han MH, Yoo YH, Choi YH. Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. Chemotherapy.2008;54(3):157-65.
  154. Saltzberg F, Barron G, Fenske N. Deforming self-treatment with herbal “black salve”.Dermatol Surg. 2009 Jul;35(7):1152-4.
  155. Sun M, Liu C, Nadiminty N, et al. Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. Prostate. 2011 May 2. doi: 10.1002/pros.21409.
  156. Cienki JJ, Zaret L. An Internet misadventure: bloodroot salve toxicity. J Altern Complement Med. 2010 Oct;16(10):1125-7.
  157. Lee JS, Jung WK, Jeong MH, Yoon TR, Kim HK. Sanguinarine induces apoptosis of HT-29 human colon cancer cells via the regulation of Bax/Bcl-2 ratio and caspase-9-dependent pathway. Int J Toxicol. 2012 Jan-Feb;31(1):70-7.
  158. Eastman KL, McFarland LV, Raugi GJ. Buyer beware: a black salve caution. J Am Acad Dermatol. 2011 Nov;65(5):e154-5.
  159. Schlichte MJ, Downing CP, Ramirez-Fort M, Gordon R, Tyring S. Bloodroot associated eschar. Dermatol Online J. 2014 Jul 15;20(7). pii: 13030/qt05r0r2wr
  160. Martin K, Sur R, Liebel F, et al. Parthenolide-depleted feverfew (Tanacetum parthenium) protects skin from UV irradiation and external aggression. Arch Dermatol Res. Feb 2008;300(2):69-80. doi: 10.1007/s00403-007-0818-x
  161. Izumi E, Morello LG, Ueda-Nakamura T, et al. Trypanosoma cruzi: antiprotozoal activity of parthenolide obtained from Tanacetum parthenium (L.) Schultz Bip. (Asteraceae, Compositae) against epimastigote and amastigote forms. Exp Parasitol. Mar 2008;118(3):324-330. doi: 10.1016/j.exppara.2007.08.015
  162. Mohsenzadeh F, Chehregani A, Amiri H. Chemical composition, antibacterial activity and cytotoxicity of essential oils of Tanacetum parthenium in different developmental stages. Pharm Biol. Sep 2011;49(9):920-926. doi: 10.3109/13880209.2011.556650
  163. Mathema VB, Koh YS, Thakuri BC, et al. Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities. Inflammation. Apr 2012;35(2):560-565. doi: 10.1007/s10753-011-9346-0
  164. Wu C, Chen F, Wang X, et al. Identification of antioxidant phenolic compounds in feverfew (Tanacetum parthenium) by HPLC-ESI-MS/MS and NMR. Phytochem Anal.Sep-Oct 2007;18(5):401-410. doi: 10.1002/pca.995
  165. Diener HC, Pfaffenrath V, Schnitker J, et al. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention – A randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia. Nov 2005;25(11):1031-1041. doi: 10.1111/j.1468-2982.2005.00950.x
  166. Cady RK, Goldstein J, Nett R, et al. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic M) in the treatment of migraine. Headache.Jul-Aug 2011;51(7):1078-1086. doi: 10.1111/j.1526-4610.2011.01910.x
  167. Ferro EC, Biagini AP, da Silva IE, et al. The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study.Acupunct Med. Dec 2012;30(4):252-257. doi: 10.1136/acupmed-2012-010195
  168. Pattrick M, Heptinstall S, Doherty M. Feverfew in rheumatoid arthritis: a double blind, placebo controlled study. Ann Rheum Dis. Jul 1989;48(7):547-549.
  169. Kim SL, Lee ST, Trang KT, et al. Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer. Int J Mol Med. May 2014;33(5):1261-1267. doi: 10.3892/ijmm.2014.1669
  170. Al-Fatlawi AA, Al-Fatlawi AA, Irshad M, et al. Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines. Pharm Biol. Jan 2015;53(1):104-109. doi: 10.3109/13880209.2014.911919
  171. Lu C, Wang W, Jia Y, et al. Inhibition of AMPK/autophagy potentiates parthenolide-induced apoptosis in human breast cancer cells. J Cell Biochem. Aug 2014;115(8):1458-1466. doi: 10.1002/jcb.24808
  172. Yip-Schneider MT, Nakshatri H, Sweeney CJ, et al. Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells. Mol Cancer Ther. Apr 2005;4(4):587-594. doi: 10.1158/1535-7163.MCT-04-0215
  173. Zhang S, Ong CN, Shen HM. Involvement of proapoptotic Bcl-2 family members in parthenolide-induced mitochondrial dysfunction and apoptosis. Cancer Lett. Aug 10 2004;211(2):175-188. doi: 10.1016/j.canlet.2004.03.033
  174. Parada-Turska J, Paduch R, Majdan M, et al. Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells.Pharmacol Rep. Mar-Apr 2007;59(2):233-237.
  175. Lesiak K, Koprowska K, Zalesna I, et al. Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro. Melanoma Res. Feb 2010;20(1):21-34. doi: 10.1097/CMR.0b013e328333bbe4
  176. Carlisi D, D’Anneo A, Angileri L, et al. Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation. J Cell Physiol. Jun 2011;226(6):1632-1641. doi: 10.1002/jcp.22494
  177. Curry EA, 3rd, Murry DJ, Yoder C, et al. Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer. Invest New Drugs. Aug 2004;22(3):299-305. doi: 10.1023/B:DRUG.0000026256.38560.be
  178. Guzman ML, Rossi RM, Neelakantan S, et al. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood.Dec 15 2007;110(13):4427-4435. doi: 10.1182/blood-2007-05-090621
  179. Pareek A, Suthar M, Rathore GS, et al. Feverfew (Tanacetum parthenium L.): A systematic review. Pharmacogn Rev. Jan 2011;5(9):103-110. doi: 10.4103/0973-7847.79105
  180. Reuter U, Chiarugi A, Bolay H, et al. Nuclear factor-kappaB as a molecular target for migraine therapy. Ann Neurol. Apr 2002;51(4):507-516.
  181. Sahler J, Bernard JJ, Spinelli SL, et al. The feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-kappaB inhibition. Thromb Res. May 2011;127(5):426-434. doi: 10.1016/j.thromres.2010.12.013
  182. Groenewegen WA, Heptinstall S. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro. J Pharm Pharmacol. Aug 1990;42(8):553-557.
  183. Heptinstall S, White A, Williamson L, et al. Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet. May 11 1985;1(8437):1071-1074.
  184. Johnson ES, Kadam NP, Hylands DM, et al. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J (Clin Res Ed). Aug 31 1985;291(6495):569-573.
  185. Williams CA, Hoult JR, Harborne JB, et al. A biologically active lipophilic flavonol from Tanacetum parthenium. Phytochemistry. Jan 1995;38(1):267-270.
  186. Anderson KN, Bejcek BE. Parthenolide induces apoptosis in glioblastomas without affecting NF-kappaB. J Pharmacol Sci. Feb 2008;106(2):318-320.
  187. Paulsen E, Christensen LP, Andersen KE. Compositae dermatitis from airborne parthenolide. Br J Dermatol. Mar 2007;156(3):510-515. doi: 10.1111/j.1365-2133.2006.07674.x
  188. Killoran CE, Crawford GH, Pedvis-Leftick A. Two cases of compositae dermatitis exacerbated by moisturizer containing feverfew. Dermatitis. Dec 2007;18(4):225-229.
  189. Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom. 2004;18(19):2273-2281. doi: 10.1002/rcm.1621
  190. Collins SC, Dufresne RG, Jr. Dietary supplements in the setting of mohs surgery.Dermatol Surg. Jun 2002;28(6):447-452.
  191. Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet. Jul 23 1988;2(8604):189-192.
  192. Kothari S, Jain AK, Mehta SC, et al. Hypolipidemic effect of fresh Triticum aestivum (wheat) grass juice in hypercholesterolemic rats. Acta Pol Pharm. Mar-Apr 2011;68(2):291-294.
  193. Sethi J, Yadav M, Dahiya K, et al. Antioxidant effect of Triticum aestivium (wheat grass) in high-fat diet-induced oxidative stress in rabbits. Methods Find Exp Clin Pharmacol. May 2010;32(4):233-235.
  194. Shyam R, Singh SN, Vats P, et al. Wheat grass supplementation decreases oxidative stress in healthy subjects: a comparative study with spirulina. J Altern Complement Med. Oct 2007;13(8):789-791.
  195. Ben-Arye E, Goldin E, Wengrower D, et al. Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol. Apr 2002;37(4):444-449.
  196. Ng SC, Lam YT, Tsoi KK, et al. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther. Oct 2013;38(8):854-863.
  197. Marawaha RK, Bansal D, Kaur S, et al. Wheat grass juice reduces transfusion requirement in patients with thalassemia major: a pilot study. Indian Pediatr. Jul 2004;41(7):716-720.
  198. Choudhary DR, Naithani R, Panigrahi I, et al. Effect of wheat grass therapy on transfusion requirement in beta-thalassemia major. Indian J Pediatr. Apr 2009;76(4):375-376.
  199. Singh K, Pannu MS, Singh P, et al. Effect of wheat grass tablets on the frequency of blood transfusions in Thalassemia Major. Indian J Pediatr. Jan 2010;77(1):90-91.
  200. Bar-Sela G, Tsalic M, Fried G, et al. Wheat grass juice may improve hematological toxicity related to chemotherapy in breast cancer patients: a pilot study. Nutr Cancer.2007;58(1):43-48.
  201. Das A, Raychaudhuri U, Chakraborty R. Effect of freeze drying and oven drying on antioxidant properties of fresh wheatgrass. Int J Food Sci Nutr. Sep 2012;63(6):718-721.
  202. Shukla V, Vashistha M, Singh SN. Evaluation of antioxidant profile and activity of amalaki (Emblica officinalis), spirulina and wheat grass. Indian J Clin Biochem. Jan 2009;24(1):70-75.
  203. Gerritsen ME, Carley WW, Ranges GE, et al. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol. Aug 1995;147(2):278-292.
  204. Mukhopadhyay S, et al. The role of iron chelation activity of wheat grass juice in patients with myelodysplastic syndrome. Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27, No 15S (May 20 Supplement), 2009: 7012
  205. Blumenthal M, et al. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council; 1998
  206. Foster S, et al. Tyler’s Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies, 3rd ed. New York: Haworth Herbal Press; 1993.
  207. Blumenthal M, et al. Herbal Medicine Expanded Commission E Monographs, 1st ed. Austin: American Botanical Council; 2000.
  208. Vanscheidt W, et al. Efficacy and safety of a Butcher’s broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiencyArzneimittelforschung 2002;52:243-50.
  209. Cluzan RV, et al. Treatment of secondary lymphedema of the upper limb with CYCLO 3 FORT. Lymphology 1996 Mar;29(1):29-35.
  210. Cappelli R, Nicora M, DiPerri T. Use of extract of Ruscus aculeatus in venous disease in the lower limbs. Drugs Exp Clin Res 1988;14(4):277-83.
  211. Thomas-Anterion C, et al. Unexplained chronic diarrhea, apropos of 4 new cases under Cyclo 3 fort and review of the literature. Rev Med Interne 1993 Apr;14(4):215-7. Review.
  212. Boyle P, Diehm C, Robertson C. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency. Int Angiol. 2003 Sep;22(3):250-62.
  213. Guex JJ, Enriquez Vega DM, Avril L, Boussetta S, Taïeb C. Assessment of quality of life in Mexican patients suffering from chronic venous disorder – impact of oral Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid treatment – ’QUALITY Study’.Phlebology. 2009 Aug;24(4):157-65.
  214. Huang YL, Kou JP, Ma L, et al. Possible mechanism of the anti-inflammatory activity of ruscogenin: role of intercellular adhesion molecule-1 and nuclear factor-kappaB. J Pharmacol Sci. 2008 Oct;108(2):198-205.
  215. Guex JJ, Avril L, Enrici E, et al. Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study). Int Angiol. 2010 Dec;29(6):525-32.
  216. De Marino S, Festa C, Zollo F, Iorizzi M. Novel steroidal components from the underground parts of Ruscus aculeatus L. Molecules. 2012 Nov 26;17(12):14002-14.
  217. Longo L, Vasapollo G. Determination of anthocyanins in Ruscus aculeatus L. berries. J Agric Food Chem. 2005 Jan 26;53(2):475-9.
  218. Barbič M, Schmidt TJ, Jürgenliemk G. Novel phenyl-1-benzoxepinols from butcher’s broom (Rusci rhizoma). Chem Biodivers. 2012 Jun;9(6):1077-83.
  219. Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Arch Pharm (Weinheim). 1995 Oct;328(10):720-4.
  220. Barbič M, Willer EA, Rothenhöfer M, Heilmann J, Fürst R, Jürgenliemk G. Spirostanol saponins and esculin from Rusci rhizoma reduce the thrombin-induced hyperpermeability of endothelial cells. Phytochemistry. 2013 Jun;90:106-13.
  221. Sadarmin PP, Timperley J. An unusual case of Butcher’s Broom precipitating diabetic ketoacidosis. J Emerg Med. 2013 Sep;45(3):e63-5.
  222. Tamayo C, et al. The chemistry and biological activity of herbs used in Flor-essence herbal tonic and Essiac. Phytotherapy Res 2000;14:1-14.
  223. Fetrow CW, et al. Professional’s Handbook of Complementary and Alternative Medicines. Philadelphia: Springhouse; 1999.
  224. Newall CA, et al. Herbal medicines: a guide for health-care professionals. Pharmaceutical Press. London. 1996.
  225. Chu DT, Wong WL, Mavligit GM. Immunotherapy with Chinese medicinal herbs. II. Reversal of cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivoJ Clin Lab Immunol 1988;25:125-9.
  226. Taixiang W, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004540.
  227. McCulloch M, See C, Shu XJ, et al. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trialsJ Clin Oncol. 2006 Jan 20;24(3):419-30.
  228. Cui R, He J, Wang B, et al. Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemother Pharmacol. 2003 Jan;51(1):75-80.
  229. Cho WC, Leung KN. In vitro and in vivo anti-tumor effects of Astragalus membranaceus.Cancer Lett. Jul 8 2007;252(1):43-54.
  230. Yu L, Lu Y, Li J, Wang H. Identification of a gene associated with astragalus and angelica’s renal protective effects by silver staining mRNA differential display. Chin Med J (Engl) 2002;115:923-7.
  231. Ahmed MS, Hou SH, Battaglia MC, et al. Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus. Am J Kidney Dis. Dec 2007;50(6):1028-1032.
  232. Ai P, Yong G, Dingkun G, et al. Aqueous extract of Astragali Radix induces human natriuresis through enhancement of renal response to atrial natriuretic peptide. J Ethnopharmacol. Mar 28 2008;116(3):413-421.
  233. Shen HH, Wang K, Li W, et al. Astragalus Membranaceus prevents airway hyperreactivity in mice related to Th2 response inhibition.J Ethnopharmacol. Mar 5 2008;116(2):363-369.
  234. Chen KT, Su CH, Hsin LH, et al. Reducing fatigue of athletes following oral administration of huangqi jianzhong tang. Acta Pharmacol Sin. 2002 Aug;23(8):757-61.
  235. Shi R, He L, Hu Y, et al. The regulatory action of radix astragali on M-cholinergic receptor of the brain of senile ratsJ Tradit Chin Med 2001;21:232-5.
  236. Tang W, et al. Chinese Drugs of Plant Origin. Berlin: Springer-Verlag; 1992.
  237. Qun L, Luo Q, Zhang ZY, et al. Effects of astragalus on IL-2/IL-2R system in patients with maintained hemodialysis. Clin Nephrol. 1999 Nov;52(5):333-4.
  238. Chu DT, Lepe-Zuniga J, Wong WL, et al. Fractionated extract of Astragalus, a Chinese medicinal herb, potentiates LAK cell cytotoxicity generated by a low dose of recombinant interleukin-2J Clin Lab Immunol 1988;26:183-7.
  239. Upton R. Astragalus root: analytical, quality control and therapeutic monograph. American Herbal Pharmacopoeia. 1999;1:1-25.
  240. Wu P, Dugoua JJ, Eyawo O, Mills EJ. Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis. J Exp Clin Cancer Res.2009 Aug 12;28(1):112.
  241. Lu MC, Yao CH, Wang SH, et al. Effect of Astragalus membranaceus in rats on peripheral nerve regeneration: in vitro and in vivo studies. J Trauma. 2010 Feb;68(2):434-40.
  242. Wojcikowski K, Wohlmuth H, Johnson DW, Gobe G. Effect of Astragalus membranaceus and Angelica sinensis combined with Enalapril in rats with obstructive uropathy. Phytother Res. 2010 Jun;24(6):875-84.
  243. Auyeung KK, Woo PK, Law PC, Ko JK. Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells. J Ethnopharmacol. 2011 Aug 12.
  244. Guo L, Bai SP, Zhao L, Wang XH. Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival. Med Oncol. 2011 Sep 18.
  245. Zhang WJ, Wojta J, Binder BR. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression. J Vasc Res. 1997 Jul-Aug;34(4):273-80.
  246. Chen HW, Lin IH, Chen YJ,  et al. A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: a phase II double-blind, randomized placebo-controlled study.Clin Invest Med. 2012 Feb 1;35(1):E1-11.
  247. Zhang CZ, Wang SX, Zhang Y, Chen JP, Liang XM. In vitro estrogenic activities of Chinese medicinal plants traditionally used for the management of menopausal symptoms. J Ethnopharmacol. 2005 Apr 26;98(3):295-300.
  248. Fu J, Wang Z, Huang L, et al. Review of the Botanical Characteristics, Phytochemistry, and Pharmacology of Astragalus membranaceus (Huangqi). Phytother Res. 2014 Sep;28(9):1275-83.
  249. Xu X, Li F, Zhang X, et al. In vitro synergistic antioxidant activity and identification of antioxidant components from Astragalus membranaceus and Paeonia lactiflora. PLoS One. 2014 May 9;9(5):e96780. doi: 10.1371/journal.pone.0096780. eCollection 2014.
  250. Ji L, Chen X, Zhong X, et al. Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy. BMC Complement Altern Med.2014 Jun 18;14:195. doi: 10.1186/1472-6882-14-
  251. Anasuya Ray, Smreti Vasudevan, Suparna Sengupta, 6-Shogaol Inhibits Breast Cancer Cells and Stem Cell-Like Spheroids by Modulation of Notch Signaling Pathway and Induction of Autophagic Cell Death.  Published: September 10, 2015. DOI: 10.1371/journal.pone.0137614
  252. 195.http://www.theguardian.com/world/2013/aug/03/uruguay-cannabis-
  253. lawhttp://www.presstv.ir/detail/2013/08/01/316632/uruguay-passes-bill-on-
  254. marijuana/http://www.ctvnews.ca/business/uruguay-taking-steps-to-become-first-nation-with-legal-marijuana-industry-1.1393211
  255. http://news.yahoo.com/uruguays-house-oks-legal-marijuana-market-plan-024441970.html(1)
  256. http://edrv.endojournals.org/content/27/1/73.fullhttp://rstb.royalsocietypublishing.org/content/367/1607/3326.abstract?sid=20cf2c23-e4fd-49e3-9398-ec8be2e00226.
  257. A.  JOHNS, Psychiatric effects of cannabis. SUBSTANCE MISUSE PAPERS, 
  258. IBID.
  259. Abrams DI, Jay CA, Shade SB, et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007;68(7):515-521.
  260. Ahmedzai S, Carlyle DL, Calder IT, Moran F. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy. Br J Cancer. 1983;48(5):657-663.
  261. American College of Physicians. Supporting research into the therapeutic role of marijuana. (Position paper, 2008.) Accessed at http://www.acponline.org/advocacy/where_we_stand/other_issues/medmarijuana.pdf on March 4, 2015.
  262. Bhattacharyya S, Crippa JA, Allen P, et al. Induction of psychosis by {delta}9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry. 2012;69(1):27-36.
  263. Beal JE, Olson R, Laubenstein L, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage. 1995;10(2):89-97.
  264. Beal JE, Olson R, Lefkowitz L, et al. Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Manage. 1997;14(1):7-14.
  265. Cannabis-In-Cachexia-Study-Group, Strasser F, Luftner D, Possinger K, et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Onc. 2006;24:3394-3400.
  266. Ellis RJ, Toperoff W, Vaida F, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology. 2009;34(3):672-680.
  267. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203.
  268. Haney M, Rabkin J, Gunderson E, Foltin RW. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology. (Berl). 2005;181:170-178.
  269. Haney M, Gunderson EW, Rabkin J, et al. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood,and sleep. J Acquir Immune Defic Syndr. 2007;45(5):545-554.
  270. Herman TS, Einhorn LH, Jones SE, et al. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med. 1979;300(23):1295-1297.
  271. Jatoi A, Windschitl HE, Loprinzi CL, et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol. 2002;20(2):567-573.
  272. Johnson JR, Burnell-Nugent M, Lossignol D, et al. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010;39(2):167-179.
  273. Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manage. 2013;46(2):207-218.
  274. Karst M, Salim K, Burstein S, et al. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA. 2003;290:1757-1762.
  275. Koppel BS, Brust JC, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82(17):1556-1563.
  276. Kramer JL. Medical marijuana for cancer. CA Cancer J Clin. 2014 Dec 10.
  277. Meiri E, Jhangiani H, Vredenburgh JJ, et al. Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Curr Med Res Opin. 2007;23(3):533-543.
  278. Musty RE, Rossi R. Effects of Smoked Cannabis and Oral Δ9-Tetrahydrocannabinol on Nausea and Emesis After Cancer Chemotherapy: A Review of State Clinical Trials. Journal of Cannabis Therapeutics. 2001; 1(1): 29-56.
  279. National Cancer Institute. Cannabis and Cannabinoids (PDQ®) Health Professional Version, updated 12/17/14. Accessed at http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional on March 4, 2015.
  280. Portenoy RK, Ganae-Motan ED, Allende S, et al. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain. 2012;13(5):438-449.
  281. Radwan MM, Elsohly MA, Slade D, et al. Biologically active cannabinoids from high-potency Cannabis sativa. J Nat Prod. 2009;72(5):906-911.
  282. Rog DJ, Nurmikko TJ, Young CA. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin Ther. 2007;29(9):2068-2079.
  283. Ross SA, ElSohly MA, Sultana GN, et al. Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L. Phytochem Anal. 2005;16(1):45-48.
  284. Smith PF. New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids. Ther Clin Risk Manag. 2010;6:59-63.
  285. Tramér MR, Carroll D, Campbell FA, et al. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ. 2001;323:16-21.
  286. Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 2010;182(14):E694-701.
  287. Wilsey B, Marcotte T, Deutsch R, et al. Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain. 2013;14(2):136-148.
  288. Woolridge E, Barton S, Samuel J, et al. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage. 2005;29:358-367.
  289. M Guzmán, M J Duarte, C Blázquez, J Ravina, M C Rosa, I Galve-Roperh, C Sánchez, G Velasco and L González-Feria, A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme, British Journal of Cancer (2006) 95, 197–203. doi:10.1038/sj.bjc.6603236 www.bjcancer.com Published online 27 June 2006.
  290.  M. van der SteltW. B. VeldhuisP. R. BärG. A. VeldinkJ. F. G. Vliegenthart, and K. Nicolay, Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity.  The Journal of Neuroscience, 1 September 2001, 21(17): 6475-6479.
  291. Paola MassiAngelo VaccaniStefania CerutiArianna ColomboMaria P. Abbracchio and Daniela ParolaroAntitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines.  JPET March 2004 vol. 308 no. 3 838-845.
  292. Sofía TorresMar Lorente1Fátima Rodríguez-Fornés1Sonia Hernández-Tiedra1María Salazar1,2, A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma.  doi: 10.1158/1535-7163.MCT-10-0688Mol Cancer Therapy, January 2011 10; 90.
  293. McAllister SDMurase RChristian RTLau DZielinski AJAllison JAlmanza CPakdel ALee JLimbad CLiu YDebs RJMoore DHDesprez PY,  Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.  Breast Cancer Res Treat. 2011 Aug;129(1):37-47. doi: 10.1007/s10549-010-1177-4. Epub 2010 Sep 22.
  294. Alessia Ligresti, Aniello Schiano Moriello, Katarzyna Starowicz, Isabel Matias, Simona Pisanti, Luciano De Petrocellis, Chiara Laezza, Giuseppe Portella, Maurizio Bifulco and Vincenzo Di Marzo,  Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.   Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, CNR Pozzuoli, Italy (AL, ASM, KS, IM, VDM); Istituto di Cibernetica, CNR Pozzuoli, Italy (ASM, LDP); Dipartimento di Biologia e Patologia Cellulare e Molecolare “L.Califano”, Università di Napoli “Federico II”(SP, CL, GP, MB) and Dipartimento di Scienze Farmaceutiche, Università degli Studi di Salerno, Fisciano, Italy (SP, MB).
  295. María M CaffarelClara AndradasEmilia MiraEduardo Pérez-GómezCamilla CeruttiGema Moreno-BuenoJuana M FloresIsabel García-RealJosé PalaciosSantos MañesManuel Guzmán and Cristina Sánchez, Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition, Molecular Cancer20109:196, 22 July 2010.
  296. LUCIANO DE PETROCELLIS, DOMINIQUE MELCK, ANTONELLA PALMISANO§, TIZIANA BISOGNO, CHIARA LAEZZA, MAURIZIO BIFULCO, AND VINCENZO DI MARZO, The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.  Proc. Natl. Acad. Sci. USA, Vol. 95, pp. 8375–8380, July 1998 Pharmacology.
  297. A Preet, R K Ganju, J E Groopman,  Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.  Oncogene (2008) 27, 339–346; doi:10.1038/sj.onc.1210641; published online 9 July 2007
  298. Ramer R1, Bublitz KFreimuth NMerkord JRohde HHaustein MBorchert PSchmuhl ELinnebacher MHinz B.,  Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J. 2012 Apr;26(4):1535-48. doi: 10.1096/fj.11-198184. Epub 2011 Dec 23.
  299.  Preet AQamri ZNasser MWPrasad AShilo KZou XGroopman JEGanju RK, Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Cancer Prev Res (Phila). 2011 Jan;4(1):65-75. doi: 10.1158/1940-6207.CAPR-10-0181. Epub 2010 Nov 19.
  300. Mimeault MPommery NWattez NBailly CHénichart JP.  Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production.  Prostate. 2003 Jun 15;56(1):1-12.
  301. Juan A. Ramos and  Fernando J. Bianco, The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications.  Indian J Urol. 2012 Jan-Mar; 28(1): 9–14.
  302. De Petrocellis LLigresti ASchiano Moriello AIappelli MVerde RStott CGCristino LOrlando PDi Marzo V, Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. Br J Pharmacol. 2013 Jan;168(1):79-102. doi: 10.1111/j.1476-5381.2012.02027.
  303.  Kristin GustafssonBirger ChristenssonBirgitta Sander and Jenny FlygareCannabinoid Receptor-Mediated Apoptosis Induced by R(+)-Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma.  Molecular PharmacologyNovember 2006 vol. 70 no. 5 1612-1620.
  304. Kristin Gustafsson, Xiao Wang1, Denise Severa1, Maeve Eriksson1, Eva Kimby2, Mats Merup2, Birger Christensson1, Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation. International Journal of Cancer, Volume 123,  Issue 5pages 1025–10331 September 2008.
  305. Jia WHegde VLSingh NPSisco DGrant SNagarkatti MNagarkatti PS, Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. Mol Cancer Res. 2006 Aug;4(8):549-62.
  306.  Whyte DAAl-Hammadi SBalhaj GBrown OMPenefsky HSSouid AK.  Cannabinoids inhibit cellular respiration of human oral cancer cells. Pharmacology. 2010;85(6):328-35. doi: 10.1159/000312686. Epub 2010 Jun 2.
  307. Vara DSalazar MOlea-Herrero NGuzmán MVelasco GDíaz-Laviada, Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ. 2011 Jul;18(7):1099-111. doi: 10.1038/cdd.2011.32. Epub 2011, April 8.
  308. A. Carracedo, M. Gironella, M. Lorente, S. Garcia, M. Guzam, F. Velasco, J. Lovanna, Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress–Related Genes. Cancer Research, The American Association of Cancer Research, 2006, May 5.
  309. Morgan G1, Ward RBarton M.The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies.  Clin Oncol (R Coll Radiol). 2004 Dec;16(8):549-60.

– See more at: www.phoreveryoung.com

The Cure for Cancer? That’s an easy question to answer! The Cure for Cancer is Found in its Prevention NOT in its Treatment! – Dr. Robert O. Young

Do you know what rotten apples, grapefruit or bananas look like? If you do then you know what cancer cells look like. Cancer cells are nothing more that healthy cells that are spoiling because of a compromised environment! Look at the picture below and you will see colorized cancerous body cells rotting in their toxic acidic environment.

What compromises the internal environment of a human body that causes body cells to begin spoiling and rotting? The answer is simple! The body’s build-up of acidic metabolic and dietary waste that has not been properly eliminated through the four channels of elimination – urination, defecation, respiration and perspiration!

Cancer is not a noun but an adjective that describes what is happening to body cells in an acidic environment due to an acidic lifestyle and diet. www.phoreveryoung.com
To learn more about Dr. Robert O. Young go to: https://www.linkedin.com/in/drrobertoyoung

The Future for Cancer Prevention and Treatment Here Today – The pH Miracle for Cancer!

images-5

Cancer Metastasis Rev. 2014 Dec;33(4):1095-108. doi: 10.1007/s10555-014-9531-3.

Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy.

Fais S 1, Venturi GGatenby B.

Author information:

  • 1Department of Therapeutic Research and Medicines Evaluation, Unit of Antitumor Drugs, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome, Italy, stefano.fais@iss.it.

Abstract

Much effort is currently devoted to developing patient-specific cancer therapy based on molecular characterization of tumors. In particular, this approach seeks to identify driver mutations that can be blocked through small molecular inhibitors. However, this approach is limited by extensive intratumoral genetic heterogeneity, and, not surprisingly, even dramatic initial responses are typically of limited duration as resistant tumor clones rapidly emerge and proliferate. We propose an alternative approach based on observations that while tumor evolution produces genetic divergence, it is also associated with striking phenotypic convergence that loosely correspond to the well-known cancer “hallmarks”. These convergent properties can be described as driver phenotypes and may be more consistently and robustly expressed than genetic targets. To this purpose, it is necessary to identify strategies that are critical for cancer progression and metastases, and it is likely that these driver phenotypes will be closely related to cancer “hallmarks”. It appears that an antiacidic approach, by targetting a driver phenotype in tumors, may be thought as a future strategy against tumors in either preventing the occurrence of cancer or treating tumor patients with multiple aims, including the improvement of efficacy of existing therapies, possibly reducing their systemic side effects, and controlling tumor growth, progression, and metastasis. This may be achieved with existing molecules such as proton pump inhibitors (PPIs) and buffers such as sodium bicarbonate, citrate, or TRIS.

To learn more about the prevention and non-invasive treatment for Cancer  read the following introduction to the pH Miracle for Cancer  by Dr. Robert O. Young:

 The pH Miracle for Cancer is coming out next week. I thought you might enjoy a preview by reading the introduction – I am very, very grateful to be able to share with you my cancer research I call the New Biology(R). I also refer to my research as the pH Miracle – a new way of living, a new way of eating, a new way of thinking. Some of the questions I will be covering in the pH Miracle for Cancer include:

What is Cancer?
What is the cause of all cancers? (Is cancer a mutant cell, a virus, a mold? Or is cancer an acidic liquid?) Is cancer a noun or is it actually an adjective that explains what’s happening to the body cells? Are tumors bad or good? What role does the lymphatic system play in preventing and reversing a cancerous condition? The focus for preventing and reversing cancer must be on the alkaline pH of the body fluids as a systemic acidic condition. The key to preventing and/or reversing cancer is to obtain the necessary sustainable energy for optimal body function and the elimination of toxic acidic waste products from diet, metabolism, respiration and the environment that all contribute to the cause of a cancerous condition.

Most of the last 30 years of my cancer research has been focused on what is happening to the cells as it pertains specifically to the environment around those cells. I love this quote by Ralph Waldo Emerson: “What lies behind us and what lies before us are tiny matters compared to what lies within us.” The focus of my cancer research has been specifically on what lies within us and, more specifically, how the internal fluids of the body affect the health, energy, and vitality of the human cell, tissues, organs and glands. Dr Benjamin Rush, eminent physician and signer of the Declaration of Independence, said: “Unless we put medical freedom into the Constitution, the time will come when medicine will organize into an underground dictatorship. To restrict the art of healing to one class of men and deny equal privileges to others will constitute the Bastille of medical science. All such laws are un-American and despotic.”

As I think about my vision, the relative purpose of medicine I believe medicine must include not just the treatment but also the prevention of illness and the promotion of health and fitness, rather than just focusing all of our attention on a specific diagnosis or even the treatment of the disease. Because disease is an illusion! In reality, disease is the body trying to prevent over-acidification or fermentation or breakdown of the body cells, tissues, organs or glands.

Disease is the body in preservation mode trying to maintain the homeostasis of the internal fluids of the body, which are all alkaline.

I believe that the ultimate purpose of medicine is to help people discover something fundamental within themselves. And that is an awareness of the true source of wellbeing, the true source of joy, the true source of contentment that we all seek which lies in one’s mind and in one’s heart – which are the emotions and the spirit. And this is important so that you and I can all begin to be free from the process of grasping for happiness in a physical world.
To support this approach, this theory, I believe we must begin to embrace a more spiritual vision of ourselves and of humanity as a whole, while at the right time providing great love, care, and attention to the physical body. Then, and only then, will medicine (or the treatments that medicine is current performing) help people discover this non-physical, spiritual dimension of themselves. And when this happens I believe that we can live and work with less fear.

Rather than working in fear you can work in its opposite – you can work in faith. You are going to have less stress grasping to preserve the physical body at all costs, then I believe you can truly be happy, energetic, and free from ALL sickness and disease, especially cancer.

Several years ago Shelley and I had the opportunity to have a wonderful experience with Dr. Lawrence Carter who is the caretaker of the estate of Martin Luther King, at Morehouse College and also the protégé of M. L. King, and there he honored. The most important thing that I learned about Dr. Carter was his openness to not just thinking outside the box, because we talk a lot about thinking outside the box, but making our box of knowledge bigger. I would like to suggest rather than thinking outside the box as you contemplate my theories on the prevention and treatment of cancer but making your box bigger to include all truth. I would also suggest as you read this book that you do not have to think outside the box, you just need to make your box of knowledge bigger to allow for new technology, new biology, and new protocols that are effectively making the difference, specifically in the prevention and treatment of cancer.

I truly believe in the words of Gandhi when he said, “you must be the change you want to see.”

If you are looking for the cure for cancer, I believe you must be change you want to see. You’ll have to look at cancer differently, not outside the box but inside the box making it bigger. Expanding your views and your perspective as it relates to prevention and the true cause of cancer.

Now, before you start exploring the pH Miracle for Cancer, I must start by defining a ‘pH miracle’. I would suggest that a ‘pH miracle’ is a natural phenomenon, that is not currently understood by medical researchers, specifically in the cause and effect relationship. What is the cause? Is cancer a cause for disease? I say NO! Cancer is the body perfectly attempting to maintain alkaline homeostasis. Cancer is the body in perfect preservation mode trying to maintain its natural healthy alkaline design. So first, you must understand that cancer is unequivocally not a disease, but a symptom or better yet an effect of gastrointestinal, respiratory, environmental and metabolic acids that build up in the blood and then thrown off into the tissues poisoning and suppressing our immune system making it increasingly difficult to maintain the alkaline pH of the internal fluids of the body. Metabolic, respiratory, environmental and dietary acids also destroy the white cells’ ability to remove toxins and the cells which they spoil or degenerate.

What I’m simply suggesting is that cancer is not a cell, but an acidic toxic liquid that spoils and degenerated the body cells that make up our tissues, organs and glands. This happens when toxic acidic waste products are not properly eliminated through the four channels of elimination, which are urination, perspiration, respiration and defecation.

Let’s now look at the current medical definition of cancer. What is it? Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal body cells. If the spread is not controlled it can result in death. Cancer is caused by both external factors, some of which are known and are common in our society such as tobacco, chemicals, radiation (from our cellular phones) and internal factors: hormone imbalances, immune deficiency and gene mutations – which is what they’re suggesting. These factors may act together in a sequence to promote what is called carcinogenesis. This is the classical definition of cancer, taken directly from the American Cancer Society.

What is being suggested by current medical science is that the cancer is some mutating cell – a transmutation of the genes – triggered by internal or external factors. This is true but what is not understood is these internal or external factors are the acidic waste products of diet, metabolism, respiration and the environment. When you are dealing with any symptom or an effect, you need to look at the cause. Whether externally or internally, the focus traditionally has been to look at the matter or cells that make up your tissues, organs and glands rather than looking at the internal environment around the matter. And, to understand the cause of cancer is very simple just like the treatment. The New Biology® explains the cause and effect of all sickness and disease and specifically cancer as well as how to improve the quality and quantity of life without chemical therapy, radiation or surgery. The pH Miracle for Cancer is a drug-free protocol to a cure for cancer!

Let me give you an example. Enervation (ie, lack of energy), muscle weakness, you’ve probably seen the commercials on television, it’s a new disease they call restless legs syndrome (RLS) for which there are drugs that supposedly treat the syndrome. Current medical researchers want to put everything in a disease modality – a nice little box – that has a specific treatment. Yet restless legs syndrome is weakness or loss of electrical power to the muscles. It’s not a disease. But, by causing a flagging of the toxic elimination from the tissue, the blood becomes charged with these metabolic toxic acids and when it’s charged with these metabolic toxic acids the blood has to purify itself by throwing these metabolic toxic acids into the tissues to maintain its delicate pH balance of 7.365. This is what I call the body in preservation mode, which leads to what I refer to as latent tissue acidosis or acid build-up in the connective and fatty tissues. Acid is poison in the blood, and if that poison is not eliminated through urination, defecation, respiration or perspiration the body has to purify itself so it eliminates this acidic poison into the connective and fatty tissues. This is the disease, or is it? Not even skin challenges when the acids accumulate beyond the toleration point, a crisis takes place, which means that the acidic poison is being eliminated through the pores of the skin.

Looking at the 2012 statistics for cancer, this coming year in America we’re looking at 1,400,000 new cases of cancer. By the way, this statistic doesn’t even include skin cancer, which is actually bigger than lung cancer, breast cancer or prostate cancer combined. And, prostate cancer is known to be the leading cause of death in men while lung cancer being the leading cause of death in women. And yet when we look at cancer, the new incidents of cancer and the new diagnoses are skin cancers because the skin is the third kidney – the largest acid elimination organ for removing acidic toxic waste products. And if acids are not properly eliminated through normal elimination channels, then those acids are thrown out into the tissues and this is what’s not currently recognized or understood by medical science.

This is the way the blood maintains its delicate alkaline pH and purity by either eliminating acid through urination or defecation or throwing it into the connective or fatty tissues which leads to this crisis, this poisoning, this elimination through the pores of the skin, again the third kidney! And this is not a disease! The only disease is systemic, because acids flow out through your whole body. They are the waste products of metabolism, diet, respiration and the external toxic environment.

Your body is like a car. You are constantly on 24/7 and you require energy and when energy is being used, a waste product like carbon dioxide or carbon monoxide or lactic acid or uric acid is being created. So acid is constantly being created by the body cells, which has to be eliminated or it will cause cancer!
When energy is being used to think, to move, to breathe, at the same time an acidic waste product is being created and this acidic waste product needs to be eliminated. If the acid is not eliminated, it is pushed out into the connective tissue. It is your connective tissue that becomes the ‘acid catcher’ in order to maintain the purity and alkalinity of the blood. The blood has to maintain its purity and alkalinity and this is why the blood has a constant pH of 7.365. If it varies even just one-tenth of one point you can have ill effects. The proper healthy pH balance of the blood is 7.365. If the blood pH starts dropping or if it starts going up, the body will do whatever it can to maintain its delicate pH. This is very significant in order to understand the cause and treatment of cancer and why it’s not a cell but the spoiling of the cells by dietary and/or metabolic acids, which have not been properly eliminated through normal elimination. When you are enervated or fatigued you do not have the energy to move the acidic waste products out of the body to maintain the purity of the blood. When this happens the blood pushes these acidic waste products out into the connective and fatty tissues.

For example, when acidic waste elimination takes place through the mucus membrane of the nose, it is called a cold – catarrh of the nose. And when this crisis is repeated for years the mucus membrane thickens and ulcerates, and the bones enlarge, closing the passages. At this stage hay fever, then asthma develops. When the tonsils or any other respiratory passages become the seat of the crisis of acidity (because the acids were not properly eliminated through urination or defecation or respiration or perspiration) then we have tonsillitis, laryngitis, bronchitis, asthma, pneumonia, and finally cancer. You see, it’s progressive. It’s the same disease at different levels of acidity. All of these symptoms are happening in different progressions from the same thing – just different levels of states of acidosis.

When acid is located in the cranial cavity we have dementia, Alzheimer’s, Parkinson’s, muddle thinking, and/or forgetfulness. If the acids accumulate in the digestive area, we end up with irritable bowel syndrome, gastro intestinal problems, stenosis, and colitis. And, when the acids locate in the pelvic tissue, or in the breasts, we end up with micro-calcifications and finally cancerous breast and reproductive organs. When the body is in the preservation mode, it is using alkaline buffers such as calcium, potassium, magnesium and sodium to neutralize or solidify the acidic liquid waste.

This is why I first see, using Ultrasound imaging, micro-calcifications in the pelvic area and in the breast tissue prior to the cancerous breast condition. The buffering of toxic acidic waste, forming micro-calcifications always precedes the cancerous condition of the tissue, organ or gland. Even in prostate cancer.

Hence all cancerous conditions are the expulsion of acids from the blood and then the tissues, organs and glands at different points and are essentially the same character evolving from the same cause, namely systemic acidosis – a crisis of toxemia. The description can be extended to every organ of the body: the lung, the liver, the pancreas, the bowels, the brain, including the largest organs which have the highest incidents, the skin. Any organ that is enervated or fatigued below the average standard (from stress of habit, from overstressed at work, from worry, anxiety, fear, injury, etc.) may become the location of the crisis of systemic latent tissue acidosis. The symptoms are presented differently depending upon which organ is being affected. Which is what makes it appear as if every symptom complex is a separate and distinct disease. You need to begin thinking inside the box and make your box bigger.

I give thanks to this new light and knowledge shed upon nomen culture naming disease by the philosophy of The New Biology(R), every symptom complex goes back to the one and only cause of all so-called cancers, namely systemic latent tissue acidosis. To find the cause of all symptomologies – lung cancer, breast cancer, brain cancer, bowel cancer, pancreatic cancer, thyroid cancer, and prostate cancer – you start with colds and catarrh, and watch the pathology as is it travels from irritation to catarrh to inflammation to induration to ulceration and finally to degeneration or cancer – Nothing more than rotting degenerating tissues, organs or glands. And what is causing this transformation or the degeneration of the cell(s), including the gene transmutation? It is simply the spoiling of the cell(s) due to the build-up of dietary, respiratory, environmental and/or metabolic acids, which have not been properly eliminated through urination, defecation, respiration or perspiration!

10422569_694599750666114_7788723169049035777_n

Have you ever opened a refrigerator and smelt the spoiling of food at the back? What you are smelling is the acidic wastes from spoiling food! It’s not some germ, it’s not some virus, it’s not some mold that’s breaking the food down, it’s the acidic waste products that are breaking the tissue down and giving rise to the symptomatology. Mold is like a smoking gun, the bullet being the acid. And yet it’s not the bullet or the acid that kills, and surely not the smoke or some gene mutation, or some bacteria or virus, but it is the person himself or herself that is pulling the acidic lifestyle and dietary trigger which then releases the acids that then tenderizes or spoils or rots the cells that make up your tissues, organs and glands. And, a cancerous condition always expresses itself first in the weakest parts of the body.

Nature’s order is interfered with by innovating acidic lifestyle and dietary habits until acidosis is established.

A vaccination as evidenced by the Spanish flu epidemic or an infection, in truth is literally an out-fection from the same source causing the most vulnerable organ, specifically the bowels, to take on organic or anatomical changes. The organ however has nothing to do with the cause, and directing treatment to the organ is actually compounding the problem. You cannot treat disease when in reality disease is the body in preservation mode trying to re-establish alkaline homeostasis when in a state of systemic acidosis that is affecting the weakest parts of the body, first!

When you realize that breast cancer is the second leading cause of death in women and these fatty tissues (breast areas) are being used by the body to bind or collect acidic waste products in order to protect the organs that sustain life. And, by the way, when one does a mammogram and sees these micro-calcification in the breast tissue, this is an indication of a state of tissue acidosis – the body’s defensive mechanism to relieve or remove or neutralize and solidify acidity that has not been properly eliminated though urination, defecation, respiration or perspiration.

If you are dealing with a cancerous prostate, you are dealing with localized acidity. If you are dealing with lung cancer, you are dealing with localized acidity that has been caused by external or internal forces even though a cancerous condition begins from within. As you take in tobacco smoke, there are acids or toxins or poisons – one being sugar which breaks down to acetaldehyde, which tenderizes and rots the lung tissues. Tobacco smoking is not an addiction of nicotine alone. It is an addiction of sugar, which causes excess acidity in the lung causing lung cancer. The cause is always constant, ever-present, always the same, only the effects change. To illustrate, a catarrh of the stomach presents first irritation, then inflammation, then ulceration, induration and finally degeneration or a cancerous stomach. Cancer is not at the first, it’s the culmination of deteriorating or broken tissue spoiled by an over-acidic stomach from an over-acidic lifestyle and diet.

Most people in the world are challenged with the symptomatology of indigestion, which can include acid reflux, bloating, heartburn, burping, diarrhea, or even constipation. The proper way to study a disease is to study health in every aspect. Disease is perverted health. Cancer is perverted health – any influence that lowers energy becomes disease-producing.

There’s an important question now to answer. Why do I crave sugar? It’s interesting when doing an MRI or a CAT scan. What is used but radioactive sugar that is taken up by the acidic cancerous cells – not cancer cells because we don’t have cancer cells, we have acidic cells or cancerous cells – cells that have been spoiled by the environment in which they live. So sugar cravings are the body’s need for sustainable energy. And energy can only be transported through a matrix of salt. Therefore sugar cravings are the body’s needs for salt, not sugar. I would suggest that sugar is an acid of cellular transformation – a waste product – not a product of energy, but a by-product of what the body truly uses which is electrical potential in the form of electrons.

The body doesn’t use carbohydrates, the body uses electrons to run. The body is electrical. And sugar is nothing more than an acidic waste product of cellular breakdown and transformation. Isn’t that what happens to the banana? As the banana moves from irritation to inflammation to induration and then to cancer, going from green to yellow to brown, getting its “liver spots” the same way you get liver spots, through excess fermentation and rotting. You do not say the banana has cancer, you say the banana is spoiling. In the same way you shouldn’t say that the lung has cancer but rather that the lung is spoiling – it is cancerous. Cancer is not a noun but an adjective expressing the process of cellular transformation. Again, sugar is the waste product. In fact, that’s why a banana gets sweeter and sweeter as it ferments. Consistently in my cancer research I see that we have a release of sugar from the breakdown of tissues, organs or glands. And to overcome sugar cravings you don’t have to eat sugar, you need to eat more salt. The secondary metabolites of this primary acid or sugar are acetaldehyde and ethanol alcohol. So sugar cravings are the body’s signal that the body needs more sustainable energy. You need energy to remove the acids of diet and metabolism – the body utilizing electrons for energy purposes. Food, water, sun, minerals, vitamins, drugs… are common choices made by us to achieve sustainable energy, but yet what you are looking for are the electrons from these sources. And your choices will determine whether or not your cravings will lead to true sustainable energy which maintains the alkaline integrity of the fluids of body and therefore the integrity of the tissues, organs and glands, or gives you false energy which creates this over-acidic state that leads to latent tissue acidosis which begins the process of spoiling of the tissues, organs and glands and finally a degenerative or cancerous condition.

Sugar stimulates and gives the body a deceptive quick-fix – it’s illusionary – whereas salt provides the matrix of life and gives your body the rise in sustainable energy, over a longer period of time, without the high and extreme lows that come from eating an acid – whether it be sugar or any other acidic foods or drinks.

It is the skin that suffers most, because if the body can’t eliminate the acids that are created through energy use, it throws the acidic wastes out into the connective and fatty tissues and into the lymphatic system. This is why the lymphatic system is so critical in the prevention of cancer and in the treatment of cancer, because it is the lymphatic system that is the vacuum cleaner of the acids that are in the interstitial fluids of the body, pulling these poisonous acids out in order to maintain the integrity of the tissue through diaphramic breathing and perspiration (that is if you are perspiring, which is one of the most important things you need to do on a daily basis to remove cancer causing acids). If you cannot eliminate your acidic wastes completely through urination, respiration or defecation then your body urinates through the skin – which is why there is over a million cases of skin cancer a year in the United States alone. It’s not talked about. Why? Because the etiology of skin cancer is not understood. It is unknown. Scientists don’t know what causes basal cell carcinoma, melanoma, they do not understand it because they don’t understand latent tissue acidosis and the importance of the lymphatic system as the vacuum cleaner to remove poisonous acidic wastes out via the kidneys and through perspiration. But people are not exercising, and this is why obesity and a lack of exercise have been associated with cancer. Yet when you are moving your body you are moving the acidic wastes out of the connective and fatty tissues, organs and glands. The lymphatic system, unlike the circulatory system, does not have a pump (the heart), it actually flows through movement. It is the diaphragm muscle that acts as a pump for the lymphatic system that moves acidic wastes through the system – out through perspiration or back into general circulation to be eliminated through urination.

And if you have a cancerous condition you have to pee your way to health. Because cancer is not a cell, but a poisonous acidic liquid. A cancer cell is a cell that has been spoiled or poisoned by the metabolic, respiratory, environmental and/or gastrointestinal acids that are produced internally, or may be taken in via the lungs or skin. That’s when the body will go into the preservation mode by forming fibrous materials, which cross-link to encapsulate the spoiled cancerous cells and thus forming the protective tumor. Hence, the tumor is the body’s protective mechanism to encapsulate spoiled or poisoned acidic cells from excess acidic wastes which have not been properly eliminated through urination, defecation, respiration and/or perspiration. The tumor is the body’s solution to protect healthy cells that make up tissues, organs and glands of the body. So, the tumor is not the problem. Let the tumor go. Let it do its job. The focus must be placed not on the tumor but on the internal environment around the tumor, which is full of acidic cells. One of the common acids which is in higher concentration around all tumors is lactic acid. Lactic acid is a by-product of metabolism when you are in a state of oxygen deprivation. Think of any cancerous condition as a systemic acidic condition that affects first the weakest parts of the body, not a local problem that metastasizes. You see metastasis is localized acids that spoil other cells much like a rotten apple placed in the center of a bushel of healthy apples will spoil the whole bushel. I call this the ‘domino effect’ where one acidic cell spoils another healthy cell causing a chain reaction. The body stops the ‘domino effect’ by forming the tumor around the cancerous or acidic body cells.

Therefore, there is no such thing as a cancer cell. A cancer cell in reality is a cancerous cell. Cancer is an adjective expressing the spoiling body cells that are rotting in an over-acidic environment. A cancerous cell was once a healthy cell that has been spoiled from an over-acidic lifestyle and diet and the body’s inability to remove these acids through the proper channels of elimination.
The only solution to the acidic toxic liquids that poison our body cells causing the effect that medical doctors call cancer, is to change the environment. It has to be a contextual approach. You must restore and maintain the alkaline design of the human body if you want to prevent or reverse a cancerous condition. This has been my great discovery of the 21st century – that the human organism is alkaline by design and acidic by function. Every part of the body that makes up every anatomical element, that makes up your genetic material, that makes up your body cells, every single part has to be bathed in an alkaline fluid which needs to be purified every 24 hours to remain healthy.

Early in the 19th century, beginning on January 17, 1912, a famous French physiologist of the Rockefeller Institute and Nobel Prize winner, Dr. Alexis Carrel, removed a very small piece of heart muscle from an un-hatched chicken embryo—still warm and living—and placed it in fresh nutrient solution in a glass flask of his own design. He transferred the tissue every forty-eight hours, during which time it doubled in size and had to be trimmed before being moved to its new flask. Every time he moved the heart he would put it into an alkaline saline solution with the appropriate alkalizing minerals. Twenty years later the heart tissue was still growing. Keep in mind that the average chicken lives for 5 – 7 years. So, after getting bored of singing “Happy Birthday” to the chicken heart for over twenty years he decided to pull the plug and not change the fluids every 48 hours and the heart finally died.

This is a very important discovery, which very few people know about. Why? Because it answers the question about why cells live and why cells die. You see, the life expectancy of the human cell is infinite. The body cells become compromised by their environment. Once you understand that matter cannot be created nor can it be destroyed it can only change its form or function, then you will realize that the environment is everything, the terrain is everything, and the cell is subservient to that.

The secret to Dr. Carrel’s chicken heart surviving for twenty years lies in this knowledge, this New Biology, this new way of living and thinking as we expand the box rather than thinking outside the box, that the cell is only as healthy as the alkaline fluids it is bathed in. The heart is only as healthy as the cells and the fluids they are bathed in. If you have any cancerous condition, this cancerous condition is the expression of your internal environment. The human cell will only breakdown in an acidic environment and become cancerous.

Carrel’s experiment brought me to the modern New Biology, the new understanding, the new expansion, the new medicine and the new definition of cancer – that the composition of our body fluids that bath the outside of our cells must be controlled very carefully from moment to moment and day-to-day with no single important constituent varying more than a one percent. This condition of health can be controlled and you can do it yourself!

In 1932 Otto Warburg received his Nobel Prize in medicine for discovering the cause of cancer. He described it as a cell changing its mode of respiration, its mode of metabolism – from respiration to fermentation. He suggested that cancer was the result of acidic environment, a state of oxygen deprivation. Warburg also wrote a paper entitled, “The Prime Cause and Prevention of Cancer.” He states: “There is no disease whose prime cause is better known – over acidity.”

When you understand this you realize that all conditions of cancer potentially can be reversed if the treatments are focused on the fluids and not the cells of the body. Therefore it doesn’t matter what the cancerous condition is, because cancer is not the cause but the effect of an over-acidic lifestyle and diet which is the cause of cancer. It’s you pulling the acidic lifestyle and dietary trigger that causes cancer. You do NOT get CANCER – You DO CANCER with your daily lifestyle and dietary choices!

After 30 years of doing blood research, after looking at thousands and thousands of cancerous patients, I’ve never seen healthy blood or an alkaline internal environment – whether testing the pH of the saliva, or the urine, or the blood, or the sweat, or the tears – they are all acidic in an over-acidic internal environment. I have come to understand that the human organism is alkaline by design and acidic by function, and if you maintain this alkaline design of your body through an alkaline lifestyle and diet you WiLL prevent all cancerous conditions. For the cure of cancer is not found in its treatment, because a cancerous condition is the body in preservation mode trying to restore its alkalinity. The cure for a cancerous condition will not be found in its treatment of the tissues but in maintaining the alkaline design of the body fluids.

As Thomas Edison said: “The doctor of the future will give no medicine, but will involve the patient in the proper use of food, fresh air and exercise.

The future is here and NOW and is found in the following chapters of pH Miracle for Cancer.

My hope is The pH Miracle for Cancer will expand your box of truth and knowledge to protect you from the acidic condition medical science calls Cancer.

To pre-order The pH Miracle for Cancer go to: http://www.phoreveryoung.com

The digital version of The pH Miracle for Cancer is NOW Available just order on line at: http://www.phoreveryoung.com

.@wsjhealth,.@foxnews,.@cnn,.@cbsnews,.@abcnews,.@nbcnews,.@msnbc,.@usatoday,.@bbc,.@time,.@newsweek

References

1. Hanna G, Fontanella A, Palmer G, Shan S, Radiloff DR, Zhao Y, Irwin D, Hamilton K, Boico A, Piantadosi CA, Blueschke G, Dewhirst M, McMahon T, Schroeder T. Automated measurement of blood flow velocity and direction and hemoglobin oxygen saturation in the rat lung using intravital microscopy. American Journal of Physiology. Lung Cellular and Molecular Physiology. 2013;304(2):L86–L91.[PubMed]

2. Yang, K.R., Mooney, S., Zarif, J.C., Coffey, D.S., Taichman, R.S. & Pienta, K.J. (2014). Niche inheritance: a cooperative pathway to enhance cancer cell fitness through ecosystem engineering. Journal of Cellular Biochemistry. [PMC free article]  [PubMed]

3. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nature reviews. Cancer. 2004;4(11):891–899.  [PubMed]

4. Lee WY, Huang SC, Hsu KF, Tzeng CC, Shen WL. Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence. Gynecologic Oncology. 2008;108(2):377–384.  [PubMed]

5. Ibrahim-Hashim A, Cornnell HH, Abrahams D, Lloyd M, Bui M, Gillies RJ, Gatenby RA. Systemic buffers inhibit carcinogenesis in TRAMP mice. The Journal of Urology. 2012;188(2):624–631.[PMC free article]  [PubMed]

6. Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, Johnson J, Gatenby RA, Gillies RJ. Acidity generated by the tumor microenvironment drives local invasion. Cancer Research. 2013;73(5):1524–1535.[PMC free article]  [PubMed]

7. Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Research. 2009;69(6):2260–2268. [PMC free article]  [PubMed]

8. Warburg O. On the origin of cancer cells. Science (New York, N.Y.) 1956;123(3191):309–314.[PubMed]

9. Zu XL, Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochemical and Biophysical Research Communications. 2004;313(3):459–465.  [PubMed]

10. Kroemer G. Mitochondria in cancer. Oncogene. 2006;25(34):4630–4632.  [PubMed]

11. Hume DA, Weidemann MJ. Role and regulation of glucose metabolism in proliferating cells. Journal of the National Cancer Institute. 1979;62(1):3–8.  [PubMed]

12. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (New York, N.Y.) 2009;324(5930):1029–1033.[PMC free article]  [PubMed]

13. DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(49):19345–19350. [PMC free article]  [PubMed]

14. Lemons JM, Feng XJ, Bennett BD, Legesse-Miller A, Johnson EL, Raitman I, Pollina EA, Rabitz HA, Rabinowitz JD, Coller HA. Quiescent fibroblasts exhibit high metabolic activity. PLoS Biology. 2010;8(10):e1000514. [PMC free article]  [PubMed]

15. Gillies RJ, Robey I, Gatenby RA. Causes and consequences of increased glucose metabolism of cancers. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 2008;49(Suppl 2):24S–42S.  [PubMed]

16. Gatenby RA. The potential role of transformation-induced metabolic changes in tumor-host interaction. Cancer Research. 1995;55(18):4151–4156.  [PubMed]

17. Gillies RJ, Martinez-Zaguilan R, Martinez GM, Serrano R, Perona R. Tumorigenic 3T3 cells maintain an alkaline intracellular pH under physiological conditions. Proceedings of the National Academy of Sciences of the United States of America. 1990;87(19):7414–74

18. [PMC free article]  [PubMed]18. Gatenby RA, Gillies RJ. A microenvironmental model of carcinogenesis. Nature Reviews. Cancer. 2008;8(1):56–61.  [PubMed]

19. Garcia SB, Novelli M, Wright NA. The clonal origin and clonal evolution of epithelial tumours. International Journal of Experimental Pathology. 2000;81(2):89–116. [PMC free article]  [PubMed]

20. Nowell PC. The clonal evolution of tumor cell populations. Science (New York, N.Y.) 1976;194(4260):23–28.  [PubMed]

21. Ilyas M, Straub J, Tomlinson IP, Bodmer WF. Genetic pathways in colorectal and other cancers. European Journal of Cancer (Oxford, England: 1990) 1999;35(3):335–351.  [PubMed]

22. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759–767.[PubMed]

23. Silva AS, Gatenby RA, Gillies RJ, Yunes JA. A quantitative theoretical model for the development of malignancy in ductal carcinoma in situJournal of Theoretical Biology. 2010;262(4):601–613.  [PubMed]

24. Gatenby RA, Smallbone K, Maini PK, Rose F, Averill J, Nagle RB, Worrall L, Gillies RJ. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. British Journal of Cancer. 2007;97(5):646–653. [PMC free article]  [PubMed]

25. Smallbone K, Gatenby RA, Gillies RJ, Maini PK, Gavaghan DJ. Metabolic changes during carcinogenesis: potential impact on invasiveness. Journal of Theoretical Biology. 2007;244(4):703–713.[PubMed]

26. Wykoff CC, Beasley N, Watson PH, Campo L, Chia SK, English R, Pastorek J, Sly WS, Ratcliffe P, Harris AL. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. The American Journal of Pathology. 2001;158(3):1011–1019.[PMC free article]  [PubMed]

27. Huber V, De Milito A, Harguindey S, Reshkin SJ, Wahl ML, Rauch C, Chiesi A, Pouyssegur J, Gatenby RA, Rivoltini L, Fais S. Proton dynamics in cancer. Journal of Translational Medicine. 2010;8:57.[PMC free article]  [PubMed]

28. Webb BA, Chimenti M, Jacobson MP, Barber DL. Dysregulated pH: a perfect storm for cancer progression. Nature Reviews. Cancer. 2011;11(9):671–677.  [PubMed]

29. Rich IN, Worthington-White D, Garden OA, Musk P. Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na(+)/H(+) exchanger. Blood. 2000;95(4):1427–1434.  [PubMed]

30. Che XF, Zheng CL, Akiyama S, Tomoda A. 2-Aminophenoxazine-3-one and 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one cause cellular apoptosis by reducing higher intracellular pH in cancer cells. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 2011;87(4):199–213. [PMC free article]  [PubMed]

31. Nagata H, Che XF, Miyazawa K, Tomoda A, Konishi M, Ubukata H, Tabuchi T. Rapid decrease of intracellular pH associated with inhibition of Na+/H+ exchanger precedes apoptotic events in the MNK45 and MNK74 gastric cancer cell lines treated with 2-aminophenoxazine-3-one. Oncology Reports. 2011;25(2):341–346.  [PubMed]

32. Di Sario A, Bendia E, Omenetti A, De Minicis S, Marzioni M, Kleemann HW, Candelaresi C, Saccomanno S, Alpini G, Benedetti A. Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2007;39(1):60–69.  [PubMed]

33. Roepe PD. Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein. Biochemistry. 1992;31(50):12555–12564.  [PubMed]

34. Murakami T, Shibuya I, Ise T, Chen ZS, Akiyama S, Nakagawa M, Izumi H, Nakamura T, Matsuo K, Yamada Y, Kohno K. Elevated expression of vacuolar proton pump genes and cellular PH in cisplatin resistance. International Journal of Cancer. Journal International Du Cancer. 2001;93(6):869–874.[PubMed]

35. Martinez-Zaguilan R, Raghunand N, Lynch RM, Bellamy W, Martinez GM, Rojas B, Smith D, Dalton WS, Gillies RJ. pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines. Biochemical Pharmacology. 1999;57(9):1037–1046.[PubMed]

36. Keizer HG, Joenje H. Increased cytosolic pH in multidrug-resistant human lung tumor cells: effect of verapamil. Journal of the National Cancer Institute. 1989;81(9):706–709.  [PubMed]

37. Altan N, Chen Y, Schindler M, Simon SM. Defective acidification in human breast tumor cells and implications for chemotherapy. The Journal of Experimental Medicine. 1998;187(10):1583–1598.[PMC free article]  [PubMed]

38. Belhoussine R, Morjani H, Sharonov S, Ploton D, Manfait M. Characterization of intracellular pH gradients in human multidrug-resistant tumor cells by means of scanning microspectrofluorometry and dual-emission-ratio probes. International Journal of Cancer. Journal International Du Cancer. 1999;81(1):81–89.  [PubMed]

39. Becelli R, Renzi G, Morello R, Altieri F. Intracellular and extracellular tumor pH measurement in a series of patients with oral cancer. The Journal of Craniofacial Surgery. 2007;18(5):1051–1054.  [PubMed]

40. Raghunand N, Mahoney B, van Sluis R, Baggett B, Gillies RJ. Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone. Neoplasia (New York, N.Y.) 2001;3(3):227–235. [PMC free article]  [PubMed]

41. Simon S, Roy D, Schindler M. Intracellular pH and the control of multidrug resistance. Proceedings of the National Academy of Sciences of the United States of America. 1994;91(3):1128–1132.[PMC free article]  [PubMed]

42. Ouar Z, Bens M, Vignes C, Paulais M, Pringel C, Fleury J, Cluzeaud F, Lacave R, Vandewalle A. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells. The Biochemical Journal. 2003;370(Pt 1):185–193. [PMC free article]  [PubMed]

43. Federici C, Petrucci F, Caimi S, Cesolini A, Logozzi M, Borghi M, D’Ilio S, Lugini L, Violante N, Azzarito T, Majorani C, Brambilla D, Fais S. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PloS One. 2014;9(2):e88193. [PMC free article][PubMed]

44. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, Coscia C, Iessi E, Logozzi M, Molinari A, Colone M, Tatti M, Sargiacomo M, Fais S. Microenvironmental pH is a key factor for exosome traffic in tumor cells. The Journal of Biological Chemistry. 2009;284(49):34211–34222.[PMC free article]  [PubMed]

45. Fais S. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism. Journal of Internal Medicine. 2010;267(5):515–525.  [PubMed]

46. Nishi T, Forgac M. The vacuolar (H+)-ATPases—nature’s most versatile proton pumps. Nature Reviews. Molecular Cell Biology. 2002;3(2):94–103.  [PubMed]

47. Sennoune SR, Martinez-Zaguilan R. Plasmalemmal vacuolar H+-ATPases in angiogenesis, diabetes and cancer. Journal of Bioenergetics and Biomembranes. 2007;39(5–6):427–433.  [PubMed]

48. Chung C, Mader CC, Schmitz JC, Atladottir J, Fitchev P, Cornwell ML, Koleske AJ, Crawford SE, Gorelick F. The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer. Laboratory Investigation; A Journal of technical Methods and Pathology. 2011;91(5):732–743.[PMC free article]  [PubMed]

49. Sennoune SR, Bakunts K, Martinez GM, Chua-Tuan JL, Kebir Y, Attaya MN, Martinez-Zaguilan R. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. American Journal of Physiology. Cell Physiology. 2004;286(6):C1443–C1452.[PubMed]

50. Martinez-Zaguilan R, Lynch RM, Martinez GM, Gillies RJ. Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. The American Journal of Physiology. 1993;265(4 Pt 1):C1015–C1029.  [PubMed]

51. Xu J, Xie R, Liu X, Wen G, Jin H, Yu Z, Jiang Y, Zhao Z, Yang Y, Ji B, Dong H, Tuo B. Expression and functional role of vacuolar H(+)-ATPase in human hepatocellular carcinoma. Carcinogenesis. 2012;33(12):2432–2440.  [PubMed]

52. Avnet S, Di Pompo G, Lemma S, Salerno M, Perut F, Bonuccelli G, Granchi D, Zini N, Baldini N. V-ATPase is a candidate therapeutic target for Ewing sarcoma. Biochimica et Biophysica Acta. 2013;1832(8):1105–1116.  [PubMed]

53. Philippe JM, Dubois JM, Rouzaire-Dubois B, Cartron PF, Vallette F, Morel N. Functional expression of V-ATPases in the plasma membrane of glial cells. Glia. 2002;37(4):365–373.  [PubMed]

54. Hinton A, Sennoune SR, Bond S, Fang M, Reuveni M, Sahagian GG, Jay D, Martinez-Zaguilan R, Forgac M. Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells. The Journal of Biological Chemistry. 2009;284(24):16400–16408. [PMC free article]  [PubMed]

55. Lu Q, Lu S, Huang L, Wang T, Wan Y, Zhou CX, Zhang C, Zhang Z, Li X. The expression of V-ATPase is associated with drug resistance and pathology of non-small cell lung cancer. Diagnostic Pathology. 2013;8:145. [PMC free article]  [PubMed]

56. Michel V, Licon-Munoz Y, Trujillo K, Bisoffi M, Parra KJ. Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion. International Journal of Cancer. Journal International Du Cancer. 2013;132(2):E1–E10. [PMC free article][PubMed]

57. Nishisho T, Hata K, Nakanishi M, Morita Y, Sun-Wada GH, Wada Y, Yasui N, Yoneda T. The a3 isoform vacuolar type H(+)-ATPase promotes distant metastasis in the mouse B16 melanoma cells. Molecular Cancer Research: MCR. 2011;9(7):845–855.  [PubMed]

58. Luciani F, Spada M, De Milito A, Molinari A, Rivoltini L, Montinaro A, Marra M, Lugini L, Logozzi M, Lozupone F, Federici C, Iessi E, Parmiani G, Arancia G, Belardelli F, Fais S. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. Journal of the National Cancer Institute. 2004;96(22):1702–1713.  [PubMed]

59. De Milito A, Marino ML, Fais S. A rationale for the use of proton pump inhibitors as antineoplastic agents. Current Pharmaceutical Design. 2012;18(10):1395–1406.  [PubMed]

60. Xu K, Mao X, Mehta M, Cui J, Zhang C, Mao F, Xu Y. Elucidation of how cancer cells avoid acidosis through comparative transcriptomic data analysis. PloS One. 2013;8(8):e71177. [PMC free article][PubMed]

61. Katara, G.K., Jaiswal, M.K., Kulshrestha, A., Kolli, B., Gilman-Sachs, A. & Beaman, K.D. (2013). Tumor-associated vacuolar ATPase subunit promotes tumorigenic characteristics in macrophages. Oncogene.  [PubMed]

62. Huang L, Lu Q, Han Y, Li Z, Zhang Z, Li X. ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells. Diagnostic Pathology. 2012;7:180.[PMC free article]  [PubMed]

63. Garcia-Garcia A, Perez-Sayans Garcia M, Rodriguez MJ, Antunez-Lopez J, Barros-Angueira F, Somoza-Martin M, Gandara-Rey JM, Aguirre-Urizar JM. Immunohistochemical localization of C1 subunit of V-ATPase (ATPase C1) in oral squamous cell cancer and normal oral mucosa. Biotechnic & Histochemistry: Official Publication of the Biological Stain Commission. 2012;87(2):133–139.  [PubMed]

64. Ohta T, Numata M, Yagishita H, Futagami F, Tsukioka Y, Kitagawa H, Kayahara M, Nagakawa T, Miyazaki I, Yamamoto M, Iseki S, Ohkuma S. Expression of 16 kDa proteolipid of vacuolar-type H(+)-ATPase in human pancreatic cancer. British Journal of Cancer. 1996;73(12):1511–1517. [PMC free article][PubMed]

65. De Milito A, Canese R, Marino ML, Borghi M, Iero M, Villa A, Venturi G, Lozupone F, Iessi E, Logozzi M, Della Mina P, Santinami M, Rodolfo M, Podo F, Rivoltini L, Fais S. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. International Journal of Cancer. Journal International Du Cancer. 2010;127(1):207–219.  [PubMed]

66. Malo ME, Fliegel L. Physiological role and regulation of the Na+/H+ exchanger. Canadian Journal of Physiology and Pharmacology. 2006;84(11):1081–1095.  [PubMed]

67. Daniel C, Bell C, Burton C, Harguindey S, Reshkin SJ, Rauch C. The role of proton dynamics in the development and maintenance of multidrug resistance in cancer. Biochimica et Biophysica Acta. 2013;1832(5):606–617.  [PubMed]

68. Harguindey S, Arranz JL, Polo Orozco JD, Rauch C, Fais S, Cardone RA, Reshkin SJ. Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs–an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research. Journal of Translational Medicine. 2013;11:282. [PMC free article]  [PubMed]

69. Amith SR, Fliegel L. Regulation of the Na+/H+ exchanger (NHE1) in breast cancer metastasis. Cancer Research. 2013;73(4):1259–1264.  [PubMed]

70. Magalhaes MA, Larson DR, Mader CC, Bravo-Cordero JJ, Gil-Henn H, Oser M, Chen X, Koleske AJ, Condeelis J. Cortactin phosphorylation regulates cell invasion through a pH-dependent pathway. The Journal of Cell Biology. 2011;195(5):903–920. [PMC free article]  [PubMed]

71. Bourguignon LY, Singleton PA, Diedrich F, Stern R, Gilad E. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. The Journal of Biological Chemistry. 2004;279(26):26991–27007.  [PubMed]

72. Halestrap AP. The monocarboxylate transporter family—structure and functional characterization. IUBMB Life. 2012;64(1):1–9.  [PubMed]

73. Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacology & Therapeutics. 2009;121(1):29–40.  [PubMed]

74. Pinheiro C, Reis RM, Ricardo S, Longatto-Filho A, Schmitt F, Baltazar F. Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. Journal of Biomedicine & Biotechnology. 2010;2010:427694. [PMC free article]  [PubMed]

75. Miranda-Goncalves V, Honavar M, Pinheiro C, Martinho O, Pires MM, Pinheiro C, Cordeiro M, Bebiano G, Costa P, Palmeirim I, Reis RM, Baltazar F. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. Neuro-Oncology. 2013;15(2):172–188.[PMC free article]  [PubMed]

76. Wahl ML, Owen JA, Burd R, Herlands RA, Nogami SS, Rodeck U, Berd D, Leeper DB, Owen CS. Regulation of intracellular pH in human melanoma: potential therapeutic implications. Molecular Cancer Therapeutics. 2002;1(8):617–628.  [PubMed]

77. Fang J, Quinones QJ, Holman TL, Morowitz MJ, Wang Q, Zhao H, Sivo F, Maris JM, Wahl ML. The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. Molecular Pharmacology. 2006;70(6):2108–2115.  [PubMed]

78. Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. The Journal of Clinical Investigation. 2008;118(12):3930–3942. [PMC free article]  [PubMed]

79. Swietach P, Hulikova A, Vaughan-Jones RD, Harris AL. New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation. Oncogene. 2010;29(50):6509–6521.  [PubMed]

80. Swietach P, Vaughan-Jones RD, Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Reviews. 2007;26(2):299–310.  [PubMed]

81. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Research. 2000;60(24):7075–7083.  [PubMed]

82. Pastorek J, Pastorekova S, Callebaut I, Mornon JP, Zelnik V, Opavsky R, Zat’ovicova M, Liao S, Portetelle D, Stanbridge EJ. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene. 1994;9(10):2877–2888.  [PubMed]

83. De Simone G, Supuran CT. Carbonic anhydrase IX: biochemical and crystallographic characterization of a novel antitumor target. Biochimica et Biophysica Acta. 2010;1804(2):404–409.  [PubMed]

84. Pastorekova S, Parkkila S, Parkkila AK, Opavsky R, Zelnik V, Saarnio J, Pastorek J. Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology. 1997;112(2):398–408.  [PubMed]

85. Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2001;19(16):3660–3668.  [PubMed]

86. Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, Harris AL. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Research. 2001;61(21):7992–7998.  [PubMed]

87. Generali D, Fox SB, Berruti A, Brizzi MP, Campo L, Bonardi S, Wigfield SM, Bruzzi P, Bersiga A, Allevi G, Milani M, Aguggini S, Dogliotti L, Bottini A, Harris AL. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer. Endocrine-Related Cancer. 2006;13(3):921–930.  [PubMed]

88. Roos A, Boron WF. Intracellular pH. Physiological Reviews. 1981;61(2):296–434.  [PubMed]

89. Cardone RA, Casavola V, Reshkin SJ. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nature Reviews. Cancer. 2005;5(10):786–795.  [PubMed]

90. Harguindey S, Orive G, Luis Pedraz J, Paradiso A, Reshkin SJ. The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin–one single nature. Biochimica et Biophysica Acta. 2005;1756(1):1–24.  [PubMed]

91. Reshkin SJ, Cardone RA, Harguindey S. Na+-H+ exchanger, pH regulation and cancer. Recent Patents on Anti-Cancer Drug Discovery. 2013;8(1):85–99.  [PubMed]

92. Harguindey S, Arranz JL, Wahl ML, Orive G, Reshkin SJ. Proton transport inhibitors as potentially selective anticancer drugs. Anticancer Research. 2009;29(6):2127–2136.  [PubMed]

93. Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Rey JM, Garcia-Garcia A. V-ATPase inhibitors and implication in cancer treatment. Cancer Treatment Reviews. 2009;35(8):707–713.  [PubMed]

94. Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Diz PG, Rey JM, Garcia-Garcia A. Multidrug resistance in oral squamous cell carcinoma: the role of vacuolar ATPases. Cancer Letters. 2010;295(2):135–143.  [PubMed]

95. Bowman EJ, Siebers A, Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proceedings of the National Academy of Sciences of the United States of America. 1988;85(21):7972–7976. [PMC free article]  [PubMed]

96. Boyd MR, Farina C, Belfiore P, Gagliardi S, Kim JW, Hayakawa Y, Beutler JA, McKee TC, Bowman BJ, Bowman EJ. Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases. The Journal of Pharmacology and Experimental Therapeutics. 2001;297(1):114–120.  [PubMed]

97. Beutler JA, McKee TC. Novel marine and microbial natural product inhibitors of vacuolar ATPase. Current Medicinal Chemistry. 2003;10(9):787–796.  [PubMed]

98. Lu X, Qin W, Li J, Tan N, Pan D, Zhang H, Xie L, Yao G, Shu H, Yao M, Wan D, Gu J, Yang S. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Research. 2005;65(15):6843–6849.  [PubMed]

99. You H, Jin J, Shu H, Yu B, De Milito A, Lozupone F, Deng Y, Tang N, Yao G, Fais S, Gu J, Qin W. Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells. Cancer Letters. 2009;280(1):110–119.  [PubMed]

100. Capecci J, Forgac M. The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells. The Journal of Biological Chemistry. 2013;288(45):32731–32741. [PMC free article]  [PubMed]

101. Mullin JM, Gabello M, Murray LJ, Farrell CP, Bellows J, Wolov KR, Kearney KR, Rudolph D, Thornton JJ. Proton pump inhibitors: actions and reactions. Drug Discovery Today. 2009;14(13–14):647–660.  [PubMed]

102. Olbe L, Carlsson E, Lindberg P. A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. Nature Reviews. Drug Discovery. 2003;2(2):132–139.  [PubMed]

103. Ferrari S, Perut F, Fagioli F, Brach Del Prever A, Meazza C, Parafioriti A, Picci P, Gambarotti M, Avnet S, Baldini N, Fais S. Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed. Journal of Translational Medicine. 2013;11:268. [PMC free article]  [PubMed]

104. Chen M, Zou X, Luo H, Cao J, Zhang X, Zhang B, Liu W. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells. Cell Biology International. 2009;33(9):1008–1019.  [PubMed]

105. Chen M, Huang SL, Zhang XQ, Zhang B, Zhu H, Yang VW, Zou XP. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1alpha/P-gp and MRP1 signaling pathway in vitro and in vivoJournal of Cellular Biochemistry. 2012;113(7):2474–2487. [PMC free article]  [PubMed]

106. Udelnow A, Kreyes A, Ellinger S, Landfester K, Walther P, Klapperstueck T, Wohlrab J, Henne-Bruns D, Knippschild U, Wurl P. Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. PloS One. 2011;6(5):e20143. [PMC free article]  [PubMed]

107. Spugnini EP, Baldi A, Buglioni S, Carocci F, de Bazzichini GM, Betti G, Pantaleo I, Menicagli F, Citro G, Fais S. Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors. Journal of Translational Medicine. 2011;9:221.[PMC free article]  [PubMed]

108. De Milito A, Iessi E, Logozzi M, Lozupone F, Spada M, Marino ML, Federici C, Perdicchio M, Matarrese P, Lugini L, Nilsson A, Fais S. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Research. 2007;67(11):5408–5417.  [PubMed]

109. Marino ML, Fais S, Djavaheri-Mergny M, Villa A, Meschini S, Lozupone F, Venturi G, Della Mina P, Pattingre S, Rivoltini L, Codogno P, De Milito A. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death & Disease. 2010;1:e87.[PMC free article]  [PubMed]

110. Yeo M, Kim DK, Kim YB, Oh TY, Lee JE, Cho SW, Kim HC, Hahm KB. Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 2004;10(24):8687–8696.  [PubMed]

111. Shen W, Zou X, Chen M, Shen Y, Huang S, Guo H, Zhang L, Liu P. Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phosphoLRP6 expression in Wnt/beta-catenin signaling. Oncology Reports. 2013;30(2):851–855.  [PubMed]

112. Perut F, Avnet S, Fotia C, Baglio SR, Salerno M, Hosogi S, Kusuzaki K, Baldini N. V-ATPase as an effective therapeutic target for sarcomas. Experimental Cell Research. 2014;320(1):21–32.  [PubMed]

113. Bellone M, Calcinotto A, Filipazzi P, De Milito A, Fais S, Rivoltini L. The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors. Oncoimmunology. 2013;2(1):e22058. [PMC free article]  [PubMed]

114. Calcinotto A, Filipazzi P, Grioni M, Iero M, De Milito A, Ricupito A, Cova A, Canese R, Jachetti E, Rossetti M, Huber V, Parmiani G, Generoso L, Santinami M, Borghi M, Fais S, Bellone M, Rivoltini L. Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Research. 2012;72(11):2746–2756.  [PubMed]

115. Vishvakarma NK, Singh SM. Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: Implication in antitumor activation of tumor-associated macrophages. Immunology Letters. 2010;134(1):83–92.  [PubMed]

116. Singh, S., Garg, S.K., Singh, P.P., Iyer, P.G. & El-Serag, H.B. (2013). Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett’s oesophagus: a systematic review and meta-analysis. Gut. [PMC free article]  [PubMed]

117. Kastelein F, Spaander MC, Steyerberg EW, Biermann K, Valkhoff VE, Kuipers EJ, Bruno MJ, ProBar Study Group Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett’s esophagus. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association. 2013;11(4):382–388.  [PubMed]

118. Harley W, Floyd C, Dunn T, Zhang XD, Chen TY, Hegde M, Palandoken H, Nantz MH, Leon L, Carraway KL, 3rd, Lyeth B, Gorin FA. Dual inhibition of sodium-mediated proton and calcium efflux triggers non-apoptotic cell death in malignant gliomas. Brain Research. 2010;1363:159–169.[PMC free article]  [PubMed]

119. Yang X, Wang D, Dong W, Song Z, Dou K. Inhibition of Na(+)/H(+) exchanger 1 by 5-(N-ethyl-N-isopropyl) amiloride reduces hypoxia-induced hepatocellular carcinoma invasion and motility. Cancer Letters. 2010;295(2):198–204.  [PubMed]

120. Wong P, Kleemann HW, Tannock IF. Cytostatic potential of novel agents that inhibit the regulation of intracellular pH. British Journal of Cancer. 2002;87(2):238–245. [PMC free article]  [PubMed]

121. Chang WH, Liu TC, Yang WK, Lee CC, Lin YH, Chen TY, Chang JG. Amiloride modulates alternative splicing in leukemic cells and resensitizes Bcr-AblT315I mutant cells to imatinib. Cancer Research. 2011;71(2):383–392.  [PubMed]

122. Miraglia E, Viarisio D, Riganti C, Costamagna C, Ghigo D, Bosia A. Na+/H+ exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin. International Journal of Cancer. Journal International Du Cancer. 2005;115(6):924–929.  [PubMed]

123. Lauritzen G, Jensen MB, Boedtkjer E, Dybboe R, Aalkjaer C, Nylandsted J, Pedersen SF. NBCn1 and NHE1 expression and activity in DeltaNErbB2 receptor-expressing MCF-7 breast cancer cells: contributions to pHi regulation and chemotherapy resistance. Experimental Cell Research. 2010;316(15):2538–2553.  [PubMed]

124. Kellen JA, Mirakian A, Kolin A. Antimetastatic effect of amiloride in an animal tumour model. Anticancer Research. 1988;8(6):1373–1376.  [PubMed]

125. Matthews H, Ranson M, Kelso MJ. Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty? International Journal of Cancer. Journal International Du Cancer. 2011;129(9):2051–2061.  [PubMed]

126. Reshkin SJ, Bellizzi A, Cardone RA, Tommasino M, Casavola V, Paradiso A. Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 2003;9(6):2366–2373.  [PubMed]

127. Pacchiano F, Carta F, McDonald PC, Lou Y, Vullo D, Scozzafava A, Dedhar S, Supuran CT. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. Journal of Medicinal Chemistry. 2011;54(6):1896–1902.  [PubMed]

128. Touisni N, Maresca A, McDonald PC, Lou Y, Scozzafava A, Dedhar S, Winum JY, Supuran CT. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. Journal of Medicinal Chemistry. 2011;54(24):8271–8277.  [PubMed]

129. Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, Kyle A, Auf dem Keller U, Leung S, Huntsman D, Clarke B, Sutherland BW, Waterhouse D, Bally M, Roskelley C, Overall CM, Minchinton A, Pacchiano F, Carta F, Scozzafava A, Touisni N, Winum JY, Supuran CT, Dedhar S. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Research. 2011;71(9):3364–3376.  [PubMed]

130. Dubois L, Peeters S, Lieuwes NG, Geusens N, Thiry A, Wigfield S, Carta F, McIntyre A, Scozzafava A, Dogne JM, Supuran CT, Harris AL, Masereel B, Lambin P. Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology. 2011;99(3):424–431.  [PubMed]

131. Halestrap AP, Price NT. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. The Biochemical Journal. 1999;343(Pt 2):281–299. [PMC free article]  [PubMed]

132. Colen CB, Shen Y, Ghoddoussi F, Yu P, Francis TB, Koch BJ, Monterey MD, Galloway MP, Sloan AE, Mathupala SP. Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study. Neoplasia (New York, N.Y.) 2011;13(7):620–632. [PMC free article][PubMed]

133. Matsubara T, Kusuzaki K, Matsumine A, Shintani K, Satonaka H, Uchida A. Acridine orange used for photodynamic therapy accumulates in malignant musculoskeletal tumors depending on pH gradient. Anticancer Research. 2006;26(1A):187–193.  [PubMed]

134. Hashiguchi S, Kusuzaki K, Murata H, Takeshita H, Hashiba M, Nishimura T, Ashihara T, Hirasawa Y. Acridine orange excited by low-dose radiation has a strong cytocidal effect on mouse osteosarcoma. Oncology. 2002;62(1):85–93.  [PubMed]

135. Kusuzaki K, Aomori K, Suginoshita T, Minami G, Takeshita H, Murata H, Hashiguchi S, Ashihara T, Hirasawa Y. Total tumor cell elimination with minimum damage to normal tissues in musculoskeletal sarcomas following photodynamic therapy with acridine orange. Oncology. 2000;59(2):174–180.[PubMed]

136. Kusuzaki K, Hosogi S, Ashihara E, Matsubara T, Satonaka H, Nakamura T, Matsumine A, Sudo A, Uchida A, Murata H, Baldini N, Fais S, Marunaka Y. Translational research of photodynamic therapy with acridine orange which targets cancer acidity. Current Pharmaceutical Design. 2012;18(10):1414–1420.[PubMed]

137. Kusuzaki K, Murata H, Matsubara T, Miyazaki S, Shintani K, Seto M, Matsumine A, Hosoi H, Sugimoto T, Uchida A. Clinical outcome of a novel photodynamic therapy technique using acridine orange for synovial sarcomas. Photochemistry and Photobiology. 2005;81(3):705–709.  [PubMed]

138. Kusuzaki K, Murata H, Matsubara T, Miyazaki S, Okamura A, Seto M, Matsumine A, Hosoi H, Sugimoto T, Uchida A. Clinical trial of photodynamic therapy using acridine orange with/without low dose radiation as new limb salvage modality in musculoskeletal sarcomas. Anticancer Research. 2005;25(2B):1225–1235.  [PubMed]

139. Matsubara T, Kusuzaki K, Matsumine A, Murata H, Nakamura T, Uchida A, Sudo A. Clinical outcomes of minimally invasive surgery using acridine orange for musculoskeletal sarcomas around the forearm, compared with conventional limb salvage surgery after wide resection. Journal of Surgical Oncology. 2010;102(3):271–275.  [PubMed]

140. Liu, J., Huang, Y., Kumar, A., Tan, A., Jin, S., Mozhi, A. & Liang, X.J. (2013). pH-Sensitive nano-systems for drug delivery in cancer therapy. Biotechnology Advances.  [PubMed]

141. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.[PubMed]

GcMAF INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF

GcMAF

INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF

(NaturalNews) The history of the suppression of medical science in America is a long one, filled with true accounts of pioneering doctors and clinicians being threatened, intimidated and even assassinated in order to bury emerging cures and keep the “sick care” industry in control. (The American Medical Association, for example, has been found guilty by the U.S. federal courts of a conspiracy to destroy the chiropractic industry, by the way.)

Over the last few days, we’ve learned that before being found shot in the chest and floating in the river, pioneering medical researcher Dr. Bradstreet was working with a little-known molecule that occurs naturally in the human body. Called, “GcMAF”, this molecule has the potential to be a universal cancer cure for many people. It has also been shown to reverse signs of autism in the vast majority of patients receiving the treatment.

While GcMAF is perfectly legal as a treatment in dozens of advanced nations around the world, the U.S. Food and Drug Administration has outlawed it, calling it an “unapproved drug.” It is with this designation — an effort to suppress the forward progress of medical science — that the U.S. government conducted a raid on Dr. Bradstreet’s clinic, specifically seeking to confiscate GcMAF in order to shut down his research and halt his treatment of patients. Meanwhile, Big Pharma gets special permission to unleash untested, experimental drugs on the public as long as those drugs earn sufficient profits (http://www.naturalnews.com/044197_FDA-approved_drugs_Big_Pharma_scientific_evidence.html).

In this article, I summarize the videos, articles and documents covering GcMAF and the mysterious death of Dr. Bradstreet. An exhaustive investigation needs to be pursued on this matter, possibly involving private investigators. The timing and manner of Dr. Bradstreet’s death seems highly suspicious, especially in light of the many other holistic doctors who have recently been found dead under mysterious circumstances. (Dr. Nicholas Gonzalez died just days ago…)

Motive to murder medical researchers and suppress a promising cancer treatment breakthrough

Is there a motive for the murder of pioneering cancer researchers working on a possible universal cancer cure? Of course there is… it’s the most common motive in the world: MONEY.

A universal cancer cure would destroy the profitability of the highly lucrative cancer industry and collapse the American Cancer Society, hospitals, oncology clinics and pharmaceutical companies that depend on chemotherapy revenues to stay profitable. Key to their profitability is the inescapable fact that conventional cancer treatments simply don’t work most of the time (http://www.naturalnews.com/033847_chemotherapy_cancer_treatments.html), creating a reliable profit stream of repeat business from patients who are never cured (by design).

Would the cancer industry murder doctors to protect its profits? Of course it would. The industry kills patients as a routine part of its business operations! For example, an oncologist named Farid Fata was recently sentenced to 56 years in prison for falsely diagnosing patients with cancer so that he could sell them chemotherapy treatments they didn’t need. See the article Cancer doctors ‘fess up to making false diagnoses just to make more money.

Click here to search for “cancer false diagnosis” at GoodGopher.com, the search engine for truth seekers.

INVESTIGATION: Here’s what we know so far

Multiple hat tips to all the outstanding citizen journalists, video creators and bloggers who have created the items cited below:

U.S. govt. search warrant document served against Dr. Jeffrey Bradstreet to confiscate GcMAF from his research facility (http://www.naturalnews.com/files/GCMAF-Bradstreet-Search-Warrant.pdf).

Video that connects the dots between Dr. Bradstreet, GcMAF, cancer cures and the suppression of medical science by the U.S. government.

Video detailing the Dr. Bradstreet search warrant, served June 30 (https://www.youtube.com/watch?v=0v3IA2Hj1TA), during which the U.S. government seized GcMAF from Dr. Bradstreet’s research clinic:

HealthNutNews story that covers the apparent series of murders of holistic doctors, many of whom are working on advanced treatment protocols that render high-profit sectors of conventional medicine OBSOLETE:

Yet another doctor was just found murdered inside his home here on the East Coast of Florida. This makes six doctors to be found dead in the last month just from this region of the country alone. Four out of the six were found dead here in Florida. We lost the holistic Dr. Teresa Sievers, MD, who was found murdered in her Florida home just weeks ago. We’ve also lost the alternative Dr. Jeff Bradstreet, MD, who was found in a river with a gunshot to his chest. He’d recently moved to Georgia from Florida. We’ve also lost the Osteopath. Dr. Riley, who was found in Georgia at her home; just a few hours from the Florida border. She was found with a gunshot wound to her head.

Now we’ve lost Dr. Schwartz MD, who was found murdered in his home, on Sunday, July 19th, 2015. This was four weeks to the day after the death of the first physician: (Dr. Bradstreet MD) who I broke the story on a month ago. His family is still seeking answers as to what happened to him and they’re some of the kindest people I know. The latest MD, Dr. Schwartz, in the picture above, lived just north of the fit, healthy, holistic Dr. Hedendal; who was the second doctor to be found dead this past Father’s Day, in Boca Raton. This was the same day that Dr. Holt died at the age of 33. Both were fathers; and again, both men died here in Florida on June 21st, 2015.

SCIENCE.NaturalNews.com entry describing the extraordinary benefits of GcMAF in a published study (http://science.naturalnews.com/2008/4030259_Immunotherapy_of_metastatic_breast_cancer_patients_with_vitamin_D_binding.html):

Stepwise incubation of purified Gc protein with immobilized beta-galactosidase and sialidase generated probably the most potent macrophage activating factor (termed GcMAF) ever discovered, which produces no adverse effect in humans…

After about 16-22 administrations (approximately 3.5-5 months) of GcMAF, these patients had insignificantly low serum enzyme levels equivalent to healthy control enzyme levels, ranging from 0.38 to 0.63 nmole/min/mg protein, indicating eradication of the tumors. This therapeutic procedure resulted in no recurrence for more than 4 years.

In other words, the administration of GcMAF eradicated tumors and left patients cancer-free for 4+ years with no additional treatment!

Both U.S. and UK governments desperately seizing all supply, shutting down clinics, even as millions die from cancer every decade…

UK govt. admission that GcMAF was on track to being commercialized as a pioneering cancer treatment (http://www.gov.uk/government/news/regulator-warns-against-gcmaf-made-in-unlicensed-facility-in-cambridgeshire), so they had to confiscate it!

GcMAF (Globulin component Macrophage Activating Factor), a blood product, claims to treat a range of conditions including cancer, HIV and autism…

More than 10,000 vials were seized at this site and production of this unlicensed medicine has now ceased. These products were sold through various European websites and UK patients may have bought it from one of these websites. We are working with colleagues in other countries to alert them to the potential risks. Our investigations are ongoing and we have received no reports to date of side effects caused by this product.

That same page lists some of the websites where GcMAF had been available for purchase:

www.GcMAF.eu
www.immunobiotech.eu
www.immunocentre.eu
www.petgcmaf.com
www.firstimmune.fr
www.firstimmune.de
www.firstimmune.it
www.gcmaf.gr
www.gcmaf.se
www.gcmaf.es
www.gcmaf.ru
www.gcmaf.pl

GcMAF is readily available as a medical treatment in Japan (http://www.saisei-mirai.or.jp/gan/index_eng.html). This site explains:

GcMAF (Gc Protein derived Macrophage Activating Factor) – Gc MAF treatment is a highly effective macrophage activating therapy, used to stimulate the immune system and activate macrophages so that they can destroy cancer cells and other abnormal cells in the body.

From the FAQ page of the treatment clinic (http://www.saisei-mirai.or.jp/gan/macrophage_gcmaf_faq_eng.html):

What exactly is Second Generation GcMAF?
High Dose Second Generation Gc-MAF is produced using our new Patent Pending process which was developed here in Japan by Saisei Mirai in collaboration with Dr Hitoshi Hori and Dr Yoshihiro Uto at the University of Tokushima who have been studying GcMAF for over 20 years. Studies on GcMAF began at the University of Tokushima in 1992, after they were introduced to Dr Nobuto Yamamoto’s work and a collaboration began…

Second Generation GcMAF is made using a new and improved 2nd generation method of Gc-MAF production which is 10-20 times more concentrated and is more active and stable than other GcMAF that is currently available. Importantly, this much higher concentration GcMAF has been clinically demonstrated to be largely free of any side effects in the great majority of patients and is much more stable because it is resistant to oxidation.

That same site describes Oral GcMAF as follows: “Oral GcMAF is a form of GcMAF produced from bovine colostrum by Saisei Mirai which was developed in collaboration with Tokushima University.”

It also lists the following health conditions as being treatable with GcMAF, potentially a “universal cancer cure” substance:

Gc-MAF and/or oral Colostrum MAF macrophage activation therapy is indicated in the treatment of any diseases where there is immune dysfunction or where the immune system is compromised, such as:

Cancer
Autoimmune diseases
Epstein-Barr Virus (EBV)
Hepatitis B virus (HBV)
Herpes Simplex virus (HSV)
Cystitis
Hepatitis C virus (HCV)
Multiple sclerosis (MS)
Urinary tract infection (UTI)
Autism Spectrum Disorders (ASD)
Rheumatoid arthritis (RA)
Endometriosis
Chronic Fatigue Syndrome (CFS)
Lyme disease (Lyme borreliosis)
IgA deficiency disorder
Myalgic Encephalomyelitis (ME)
Mycobacteria infections
Parkinson’s disease
Tuberculosis
Fibromyalgia
Human papillomavirus (HPV)
Lupus (Systemic lupus erythematosus, SLE)
HIV AIDS
Dengue fever
Pneumonia infection
Warts caused by viral infection
Norovirus
Malaria Influenza virus (flu)
Herpes simplex virus (HSV)
Q fever (Coxiella burnetii)
Polycystic ovary syndrome (PCOS)
Chicken pox (varicella zoster virus)
Psoriasis
Respiratory tract infections
Ulcerative colitis, Crohn’s disease
Type 1 diabetes (T1DM), insulin-dependent diabetes (IDDM)
Type 1.5 diabetes, Latent autoimmune diabetes of adults (LADA)

Do you see yet why the medical establishment must SUPPRESS GcMAF and destroy all knowledge of its clinical applications? This one substance holds the potential to render numerous vaccines and pharmaceuticals utterly obsolete.

GcMAF protein described at NaturalHealth365.com:

Researchers and practitioners have demonstrated that GcMAF can reverse diseases that attack the immune system such as: chronic inflammation, bacterial and viral infections, chronic herpes, chronic acne, Lyme disease, fibromyalgia osteoporosis, Hodgkin’s, Lupus, MS, Parkinson’s and remarkably – autism.

A clinical study out of Italy on 94 children with autism showed that 83 of them made considerable progress while on GcMAF. The most common reported improvements involve:

• Cognitive abilities including attention and focus, learning and understanding, receptiveness and awareness of the environment and both receptive and expressive language gains.

• Social Skills including willingness to interact and communicate with peers.

• Behavior including less hyperactivity, less stereotypical behaviors and improved cooperation and compliance.

In another study of 1500 children with autism, 85% had high levels of viruses and a compromised immune system. All 1500 received weekly GcMAF injections and 70% of the children responded to the treatment with reduced symptoms and another 15% made full recoveries. The other 15% did not respond.

It was stated that the reduction of autistic symptoms is permanent provided that GcMAF has been taken long enough for the body to produce its own GcMAF which typically takes 24 weeks.

The systematic suppression of medical science to protect the lucrative cancer treatment industry (chemotherapy, oncology, radiotherapy, etc.)

ANH-EUROPE.org covers the systematic suppression of advanced cancer treatments and cures (http://anh-europe.org/news/how-maverick-cancer-treatments-are-suppressed-by-the-mainstream):

Back in 1993, Nobuto Yamamoto, then working at Temple University School of Medicine in Philadelphia, PA, USA, first described a remarkable molecule. His paper reported the conversion of vitamin D3 binding protein (DBP, known in humans as Gc) into a potent macrophage-activating factor (MAF), known as Gc-MAF. Macrophages are a key part of the human immune system with two roles: to engulf and destroy pathogens and cellular debris, and to recruit other immune cells to respond to the pathogen.

Gc-MAF hasn’t had the benefit of a single patent owner – as a natural molecule, it cannot be patented without being modified – with the will and resources to push it under the noses of the public and health authorities. Dr Yamamoto has run small human trials in breast, prostate and colorectal cancers, with promising results.

David Noakes might just be the person to bring Gc-MAF into the mainstream. He’s the CEO of Immuno Biotech Ltd. and spokesperson for First Immune Gc-MAF, a project he describes as, “PhD and BSc biochemists and biomedical scientists… with external doctors, oncologists and scientists who kindly provide advice, committed to bringing some of the increasing number of published but relatively unused medical cures to as many people as we can.” At the moment, Noakes and his colleagues are supplying Gc-MAF to 30 countries where it is legal, via a network of “around 300” doctors. Their Gc-MAF is made to extremely high standards, and is being used in ongoing clinical research by Noakes’ collaborators and others. Their ultimate goal is to, “Build the case that GcMAF is effective for various illnesses, which will help to make it available to the public”.

GcMAF suppliers fighting for survival against a global medical monopoly that profits from disease

MUST-SEE website: http://gcmaf.se/

From the site:

The medical laws have been changed over the last 40 years so that all the brilliant breakthroughs in cancer are denied to the British public. Lord Maurice Saatchi had to watch his wife die, while his doctor told him the only thing he was allowed to prescribe her was chemotherapy, which would shorten her life. He hopes to bring the Medical Innovation Bill to Parliament, so instead of obeying a destructive government law, a doctor will be able to prescribe whatever treatment is best for the patient…

Bad law kills, and Britain has the worst medical laws in Europe. The 1939 Cancer Act makes it illegal to discuss the possibility cancer can be cured, which is partly why 160,000 people die unnecessarily of cancer in Britain every year. Science and treatments are decades ahead of where the medical industry is today. The MHRA’s job is to get life saving treatments like GcMAF out to people as quickly as possible. Instead they block them to protect billion dollar Big Pharma monopolies, who also fund the MHRA. Over a hundred thousand lives could be saved every year if the 1939 Cancer Act were repealed, and the MHRA were closed down.

There are 142 eminent scientists who have published GcMAF research papers on the US National Library of Medicine alone.

From the how GcMAF works page(https://gcmaf.se/gcmaf-science/how-gcmaf-works/):

Your GcMAF empowers your body to cure itself. In a healthy person your own GcMAF has 11 actions discovered so far, including two on cells, three excellent effects on the brain, and 6 on cancer. Amongst these it acts as a “director” of your immune system. But viruses and malignant cells like cancer send out an enzyme called Nagalase that prevents production of your GcMAF: that stops its 11 beneficial effects, and neutralises your immune system. So diseases become chronic, and cancer cells grow unchecked.

Minutes after a receiving a dose, 10 of the body’s actions restart. In three weeks of two GcMAF 0.25ml doses a week, your immune system is rebuilt to above normal strength. You need two doses a week for typically 24 weeks for many diseases and early cancers, up to seven one ml doses a week and a year for stage 4 cancers. Your body then takes the disease down without side effects, and successfully in 80% of cases -depending upon how well you follow the protocol under “Treatment Protocol” on this website.

What is GcMAF?
It is a human protein. One week’s GcMAF looks like a small raindrop. If properly produced it is perfectly sterile, and a most ethical course for doctors.

GcMAF is therefore a replacement therapy for those who can’t make their own. Taking GcMAF replaces the missing part of the immune system, and also acts as the body’s own internal medicine.

GcMAF is extracted and isolated; its a 24 step process, and at the end it must have tests to prove its sterility and activity. (If it does not come with published tests, its probably not GcMAF.) One GcMAF has been tested in universities, laboratories and clinics, where, as a result of the testing, consistent activity and sterility have always been found, and been the subject of 40 scientific research papers.

What does GcMAF do?
The GcMAF Conference 2013 showed GcMAF is a far more powerful molecule than thought, both in terms of the science, and doctors’ results. In stage 4 cancer, some doctors who use the full protocol, listed on “Treatment Strategies,” are saving every patient (if they have not had chemotherapy.) Success can be achieved with all tumour cancers including breast, lung, prostate, pancreatic and melanoma.

GcMAF can eradicate chronic inflammation and viral infections. It is better than antibiotics in many areas, and 25% successful with Autism, 50% or more with Chronic Herpes, Chronic Acne, Chronic cirrhosis of the liver, Chronic kidney disease, Chronic depression, Colitis, Crohn’s, Fibromyalgia, Hepatitis, Herpes, LMBBS, ME/CFS, Osteoporosis, Periodontal disease, Psoriasis and various types of Immune dysfunction including allergies. Research shows GcMAF can halt deterioration in Parkinsons, multiple sclerosis (MS), dementia and ALS, and in its role of immune system regulator, can reverse diseases that attack the immune system like Lupus and Arthritis. And is effective with wound healing. Its successful with tumour cancers, and some others.

In addition to rebuilding a depressed immune system, GcMAF:
Inhibits angiogenesis – stops blood supply to tumours
Activates macrophages – phagocytosis and destruction of cancer cells
Apoptosis – suicide of cancer cells
Reverts the cancer cell phenotype to normal (Turns cancer cells into healthy cells)
Reduces the metastatic potential of human cancer cells in culture.
Increases energy production at the mitochondrial level – ME/CFS
Improves human neuronal metabolic activity through cAMP signaling – autism, ME/CFS, MS, ALS
Counters toxic effects including cadmium – ME/CFS

It abolishes neuropathic pain due to neuro-oxidative stress (stress due to the anti-cancer drug oxaliplatin) in the lab. (neurodegenerative diseases and autism that have oxidative stress as a pathogenetic mechanism)
It increases neuronal connectivity by promoting differentiation and the formation of dendrites and neuritis (autism and ME/CFS, where there is a lack of connectivity between neurons).

See the 31 research papers published, particularly Brescia, and the 60 published by others listed under “The science”.

80% of terminal stage four tumour cancers cases can be saved (40% if they’ve had chemo), but usually when they are closely monitored, which is why residential Treatment Centres are being run in Switzerland. If they have three months to live and have not had chemo, almost no one needs to be lost.

The 180 scientists who have published papers on trials of GcMAF selected those in the early stages of cancer and HIV, and reported nearly 100 percent success, with no recurrence after many years. They did not attempt trials on people with large tumours.

Our trials are quite different: many people are over 50, some over 80, with advanced or terminal cancers, with significant tumour mass. Most come to us when their doctors tell them they can do no more.

The life of GcMAF is only six days – you have to keep taking it until your disease has gone (ie your nagalase is under 0.65 nmol/min/mg) then a further 8 weeks, or the immune system gets shut down again.

How long should you take GcMAF for?
8 weeks for chronic herpes/acne, fibromyalgia, inflammation.
Allow 24 weeks plus of GcMAF for: Autism (85% improve, 25% eradication), CFS (70% eradication), HIV, Lyme (8% respond, most appear to have the VDR gene blocked and the viruses conceal themselves with biofilms) and stage 1 to 2 cancer, (80% respond).
Late stage cancer, if you follow “Treatment Protocol” again has 80% responders, but it takes a year to 18 months to become cancer free.
Cirrhosis of the liver: 16 months

Remember everyone responds differently. We can’t say how you will respond.

The more minor the disease, the easier it is for GcMAF to eradicate. GcMAF needs normal levels of vitamin D to function strongly (take 10,000iu a day). in low responders, larger doses are required.

We have probably proved GcMAF can work for people up to age 90, and can destroy large tumour mass. See “Participants experiences”.

If you have your blood taken for monocyte counts, relevant markers and vitamin D levels, and again for a nagalase test at the beginning, you should see on your next test after three weeks that your immune system is back to full strength, and after 8 weeks significantly falling nagalase will indicate the disease is losing its grip. Don’t stop the GcMAF until your nagalase gets below 0.65 nmol/min/mg, when it loses the ability to prevent your body producing your own GcMAF, and then you no longer need ours. Even better, get scans.

Autism children can improve at five weeks with substantial improvements at 8 weeks. See “Participants experiences.” But everyone is different.

The beauty of using your own immune system to attack disease or cancer is that it remembers how to defeat it for the rest of your life: it doesn’t come back. And unlike chemotherapy, the side effects are trivial.

The only way you can tell if GcMAF is genuine and active is to test with living cells in a laboratory. See “Quality and Tests of our GcMAF.” To recap:

We put live macrophages cells and MCF7 breast cancer cells together; nothing happens. Then we add GcMAF; in 72 hours the macrophages eat all the MCF7 cancer cells. We then put only GcMAF and MCF7 together, and the GcMAF turns the cancer cells back into healthy cells.

We have GcMAF available for preclinical trials. See “Buy GcMAF”.

You must read at least all of “Buy GcMAF” and “Treatment strategies” on the left if you want to take this further. And you must be prepared to give us feedback.

Patent document on GcMAF

See the Yamamoto patent involving GcMAF (http://www.google.com/patents/US5620846):

Cancerous cells and HIV-infected cells secrete -N-acetylgalactosaminidase into the blood stream, resulting in deglycosylation of serum Gc protein. This inactivates the MAF precursor activity of Gc protein, leading to immunosuppression… When peripheral blood monocytes/macrophages of 175 cancer patients bearing various types of cancer were treated in vitro with 100 pg GcMAF/ml, monocytes/macrophages (phagocytes) of all cancer patients were activated for phagocytic and superoxide generating capacity. This observation indicates that patient phagocytes are capable of being activated… 

Also see BetterHealthGuy.com coverage on GcMAF:

first heard about GcMAF almost a year ago. At the same time, I had first learned about “nagalase”, a blood test that is used to in part determine whether or not one might be a candidate for GcMAF therapy. Nagalase is an enzyme that prevents Vitamin D receptors (VDR) from being activated on the surface of the macrophage. As a result, macrophages are not “activated” and our immune systems are not able to properly respond to invaders.

Here are some points that I have learned thus far on GcMAF:

– GcMAF has reportedly been tested more for safety, purity, etc. than other human blood products.
– Macrophages are cultured, destroyed, and the GcMAF receptors are purified.
– Treatment is via injection 1x/week for 8-20 weeks. Dose is titrated initially to avoid exacerbation or Herx responses as much as possible.
– A commonly used dose is .25ml once weekly (a 2.2 ml vial should last 8 injections).
– The primary test used in looking at whether or not GcMAF may be a reasonable intervention is nagalase.
– Nagalase inactivates macrophages.
– I personally would NEVER consider this option without having a baseline nagalase test. Normal is < 0.95. Mine was 2.9.

The practitioner I worked with suggested that 2.9 was in the range of someone with HIV or cancer in terms of the impact on the immune system. I’d like to hear from others in the Lyme community as you get test results as well to see if there is a pattern of elevated nagalase in those with Lyme disease. Whether or not Lyme itself has anything to do with nagalase elevation is something I have not been able to find anything on. We certainly all have underlying viral co-factors that are likely in play as well, but I suspect that Borrelia may also play a role in nagalase elevation.

– In healthy college students, a nagalase 0.4 is not uncommon (the lower the better).

– At 2.9, my practitioner was surprised that I did not have more cognitive deficits such as memory loss and other cognitive issues.

– It has been suggested that ongoing antimicrobial therapy without a working immune system is like leaving the house with the door wide open inviting burglars in. By using GcMAF to activate macrophages, nagalase drops, and one may regain a functional immune system. The door is then closed to further invaders and we may no longer serve as a microbe hotel.

– Maintenance therapy should not be needed once the immune system is once again properly functioning.

– Activated macrophages only remain active for 7 days so any negative responses are generally short-lived. That said, some people do have strong inflammatory responses that are not believed to be typical die-off reactions.

– It has been indicated that in some cases, other medications may be needed in order to manage the inflammatory response. This is another reason that one needs to be working closely with a knowledgeable practitioner before considering GcMAF in my opinion. In the CFS and GcMAF world, this more severe form of a die-off reaction is called IRIS.

– VDR genetics do not seem to play a role in predicting response as earlier thought according to one practitioner that I have spoken with. That said, Vitamin D levels do correlate with the positive response rate of GcMAF. Thus, Vitamin D supplementation may be required in order to optimize outcome.

– Other than die-off reactions or activation of symptoms (inflammation), no other side effects are generally expected.

– Nagalase should be monitored every 1-2 months while on treatment to determine the required duration of the therapy. Target nagalase after treatment would be 0.4 to 0.6.

– Elevated nagalase has a profound detrimental effect on the immune system. Elevated nagalase is often presumed to be related to microbes of viral origin or cancer. Viruses that are nagalase producers open the door to chronic infections.

– Hemagglutinin contains nagalase and is also found in flagella of some bacteria so it could also be the case that some bacteria may produce nagalase.

– Parents with ASD children also often have elevated nagalase.

– A practitioner I spoke with likened Lyme disease to a “peat moss fire” burning below the surface. Activating macrophages should help to deal with the fire.

– GcMAF should be helpful in dealing with other infections that are not of viral origin; for example, Borrelia, Bartonella, and other infections commonly associated with Tick-Borne Infections (TBIs). GcMAF is active against many cancers and many different kinds of microbes.

– Neopterin is another test that is sometimes used as an indicator of immune suppression. As macrophages become activated, neopterin may rise and later fall. If one is in the normal range for neopterin and has an immune-related illness, this could be an indication that the immune system is suppressed and not responding appropriately.

– People with autoimmune conditions can generally use GcMAF. However, GcMAF may be contraindicated in people with Multiple Sclerosis.

– Reduction in nagalase is generally seen early in the course of treatment; within the first 3-6 weeks. In some studies, nagalase dropped by over 50% in less than six weeks.

– Cancer patients may initially feel as bad on GcMAF as they do on chemotherapy, but often feel much better after the first month.

– Anti-inflammatories may limited the effect of GcMAF.

– Enzymes and biofilm-reducing supplements may have a negative impact on GcMAF therapy and may be best avoided. It is still too early to know what the impact may be, but one practitioner I spoke with feels that it is best to avoid these.

– One should not be on any immune-suppressing agents while on GcMAF as the immune system must be partially functional in order to respond appropriately to the treatment.

– A common pattern is to see elevated lymphocytes, high nagalase, and low NK cells. Once nagalase drops, it may be the case that NK cell function could be positively impacted. CD57 is a type of NK cell. It is too early to know if this proves to be true, but it is one of the things I’m quite interested in.

Watch this video presentation on GcMAF therapy to learn more.

http://cfspatientadvocate.blogspot.com/2011/11/mt-sinai-mecfs-conference-de-meirleir.html

Read about GcMAF from Alternative-Health-Group.org.
http://cfspatientadvocate.blogspot.com/2011/11/mt-sinai-mecfs-conference-de-meirleir.html

Read The GcMAF Book at this link.
http://gcmaf.timsmithmd.com/book/chapter/44/

Open the “Stop Fighting Cancer” PDF document (http://www.stopfightingcancer.com/stop-fighting-cancer.pdf) and search it for “GcMAF” to read some intriguing passages:

Researchers testing GcMAF stated it, “works 100% of the time to eradicate cancer completely, and cancer does not recur even years later.” (This was stated based on the tested group of patients -nothing works 100% for everyone) The weekly injection GcMAF, a harmless glyco-protein activates the human immune system which then can kill the growing cancer. Studies among breast cancer and colon cancer patients produced complete remissions lasting 4 and 7 years respectively. This glyco-protein ‘cure’ is totally without side effect but currently goes unused and completely ignored by cancer doctors. Why? Maybe it is because there is little money to be made in selling it. For less than $2000USD a cancer patient can obtain an adequate amount of GcMAC.

See the National Library of Medicine page Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2510818/):

When human macrophages were treated in vitro with 100 pg GcMAF/ml for 3 hours and a prostate cancer cell line LNCaP was added with an effector/target ratio of 1.5, approximately 51% and 82% of LNCaP cells were killed by 4 and 18 hours of incubation, respectively [14,15]. This in vitro tumoricidal capacity of macrophages activated by GcMAF led us to investigate the therapeutic efficacy of GcMAF for prostate cancer. GcMAF therapy as a single remedy modality can eradicate metastatic breast and colorectal cancers most effectively

Click here to search for “GcMAF” on GoodGopher.com, the new search engine for truth seekers.

Read this article from The Telegraph on how scientists are being assassinated because of what they know.

http://www.telegraph.co.uk/news/earth/environment/globalwarming/11762680/Three-scientists-investigating-melting-Arctic-ice-may-have-been-assassinated-professor-claims.html

Alkalizing Nutritional Therapy For Any Cancerous Condition: How It Works

51978-william170

 Abstract

Due to the evident ineffectiveness of conventional cancer treatments (e.g. chemotherapy and radiation), more efficient alternatives are needed.  The potential of Alkaline Nutritional Infusion (ANI) as a legitimate alternative to chemotherapy and radiation is examined.  While largely ignored in conventional oncology, the pH of the interstitial fluids is suggested as paramount in identifying a pre-cancerous and cancerous condition. It is further suggested that cancer is an over-acidic condition of the body that can be reversed and prevented with alkalizing treatments such as ANI.  Full Body Bio-Electro Scan (FBBES), Full Body Thermography (FBT) and Full Body Ultrasound (FBU) is presented as a noninvasive and nonradioactive means to examine body pH and the presence of pre-cancerous or cancerous condition.  In contrast to the acidosis caused by conventional cancer treatments, ANI methods such as Intravenous Nutritional Infusion (INI) and Rectal Nutritional Infusion (RNI) provide an alkalizing approach to cancer prevention and treatment.Introduction

While largely ignored in conventional oncology for decades, intravenous  and rectal nutritional infusion therapy plays a major key in recovering from and reversing any metabolic, environmental, or dietary caused dis-ease. But when you visit your conventional doctor for any condition or dis-ease, he or she will never address the patient’s lifestyle or diet, besides sometimes shrugging and saying, “Eat better and get more exercise.”  This is generally stated to the patient without giving any specific recommendations of what to eat, what to drink or how to exercise.

This general mindset stems from medical schools where a physician may receive only a few hours of nutritional, dietary or physical training in their nutritional, biochemistry or physiology courses on the importance of nutrition, diet and exercise. Then all training, including residency and fellowship is completely pharmaceutical-drug focused. Only a select few take the time to be trained and mentored by traditional, integrative or naturopathic physicians that specialize in the prevention and treatment of cancer or other dis-ease conditions.

Powerful Insights to Non-Invasive Cancer Treatment

Alkalizing nutrition, diet and exercise is key in prevention, treatment and recovery, especially with a cancerous condition, because chemotherapy and radiation treatments deplete the nutrients and electron energy right out of the body. This is why patients undergoing chemo lose their hair, lose weight and look so gaunt or ill – their bodies are literally starving for electron-rich alkalizing nutrition, food and water while simultaneously loading-up with an acid-rich and toxic diet combined with their associated metabolic waste, such as lactic, uric or acetic acid.  In addition, it is important to understand when dietary and metabolic acids are NOT eliminated through the four channels of elimination via urination, defecation, perspiration and respiration, these toxins will eventually buildup in the connective tissues leading to inflammation and ultimately degenerative disease, namely cancer. [1,2,3,4]

Every person has unique dietary and metabolic needs, meaning that telling a patient to open wide and then administer some minerals and vitamins orally will not always do the trick. Some people need more sodium or potassium and some may need extra vitamin A or E in their diet, while others may need less. Some patients need more magnesium and others have iron deficiencies due to the poor health in the crypts of the small intestines where stem cells are made for differentiation into new and healthy red blood cells.[5]

Even though oncology as a whole has ignored intravenous and/or rectal alkalizing nutritional infusions, fearing that alkalizing nutrients will adversely impact chemotherapy or radiation, they really detour patients from these kinds of supportive and non-invasive treatments. This is in spite of 280 peer-reviewed studies, including 50 human studies involving 8,521 patients that have emerged since the 1970’s. 5081 subjects that were give nutrients have shown that supplementing  nutrients do not interfere with conventional therapeutic modalities for cancer. [6]

So what are we left with? The fact is, every cancer patient needs a complete, personalized physiological, anatomical, functional, hematological and nutritional profile if he or she really wants the edge in preventing and removing the acids that cause the inflammation that leads to a cancerous condition. [1,2,3,4] Let’s explore what this all means and how it can make the difference in a patients survival and improving the quality and quantity of  life.

In The Beginning . . .

Life on earth depends on appropriate pH levels in and around living organisms and cells. Human life requires a tightly controlled pH level in the serum of about 7.365 (a slightly alkaline range of 7.35 to 7.45) to survive [7].

As a comparison, in the past 100 years with increasing industrialization, the pH or acid/base balance of the ocean has dropped from 8.2 to 8.1 because of increasing CO2 or carbon monoxide deposition. This has a negative impact on life in the ocean [8, 9] and may lead to the collapse of the coral reefs.  Why”  Because the ocean is using the calcium in the coral to maintain its alkalinity much like the body uses the calcium from the bones to maintain the alkalinity of the intracellular fluids, interstitial fluids and blood fluids. [7]. Even the pH of the soil in which plants are grown can have considerable influence on the mineral content of the food we eat (as minerals are used as buffers to maintain pH). The ideal pH of soil for the best overall availability of essential nutrients is between 6 and 7. Acidic soils below pH of 6 may have reduced calcium and magnesium, and soil above pH 7 may result in chemically unavailable iron, manganese, copper and zinc. Adding dolomite and manure are ways of raising pH in an acidic soil environment when the pH is below 6. [10]

When it comes to the pH and net acid load in the human diet, there has been considerable change from the hunter gather civilization to the present. [11]  With the agricultural revolution (last 10,000 years) and even more recently with industrialization (last 200 years), there has been an decrease in potassium (K) compared to sodium (Na) and an increase in chloride compared to bicarbonate found in the diet. [12]  The ratio of potassium to sodium has reversed, K/Na previously was 10 to 1 whereas the modern diet has a ratio of 1 to 3. [13] It is generally accepted that agricultural humans today have a diet poor in magnesium and potassium as well as fiber and rich in saturated fat, simple sugars, processed sodium containing aluminum, and processed chloride as compared to the preagricultural period. [14]  This results in a diet that may induces dietary acidosis which is mismatched to the genetically determined alkaline nutritional requirements. [15]  With aging, there is a gradual loss of renal acid-base regulatory function and a resultant increase in diet-induced metabolic acidosis while ingesting the modern or Standard American Diet. [16]

A low-carbohydrate high-protein diet with its increased acid or proton/hydrogen load results in very little change in blood chemistry, and pH, but results in many changes in interstitial and urinary pH chemistry. Urinary and interstitial fluid sodium and magnesium levels, urinary citrate and pH are decreased, urinary calcium,  potassium, undissociated uric acid, and phosphates are increased. All of these result in an increased risk for metabolic tissue acidosis, bone loss and an increase in blood, breast, brain, liver, gallbladder, pancreas, prostate, uterus and kidney stones. [16]  The reason for the increase in stones throughout the body is to buffer the increase of dietary and metabolic acids found throughout the fluids of the body.  The increase of stones is the direct result of an increase of the dietary and/or metabolic acid-load which if not corrected will lead to a cancerous condition in those specific areas. [16]

Alkalinity and Chemotherapy in the Treatment of Cancer

The effectiveness of chemotherapeutic agents is markedly influenced by the pH or the acid/base chemistry of the body.  Numerous agents such as epirubicin and adriamycin require an alkaline media to be more effective. Others, such as cisplatin, mitomycin C, and thiotepa, are more cytotoxic in an acid media [17]. Cell death correlates with acidosis and intracellular pH shifts higher (more alkaline) after chemotherapy may reflect response to chemotherapy [18]. I have noted with many of my patients that inducing metabolic alkalosis may be useful in enhancing some treatment regimes by using alkalizing intravenous or rectal mineral and vitamin infusion therapy of sodium bicarbonate, carbicab, and furosemide [19]. In addition, extracellular alkalinization by using mineral salts such as sodium and potassium bicarbonate may result in improvements in the effectiveness of chemotherapy. [20]

Alkalizing Nutrition, the Immune System and How Together They Fight Cancer

cancer1_2130923b

 

Briefly, let’s review: cancer is an adjective not a noun.  Cancer is what happens to cells in a toxic acidic environment.  Simply put cancer is an acidic metabolic or dietary waste that spoils healthy cells. Healthy cells are affected by their environment which can activate protective genes. [21]  If the acidic internal environment of the body is not returned to its alkaline design this will cause mutations or fermentation of the cell and the acids from these spoiling cells will spoil other cells, just like one domino tipping-over another domino leading to a cancerous condition. [61, 62]

The reason the body can have such trouble fighting cancer varies – in part, it has do with protecting the alkaline design of the body fluids, the health of the white blood cells and the body’s ability to neutralize metabolic and/or dietary acidic waste that has NOT been properly removed via the four channels of elimination – urination, defection, perspiration and respiration.

Poor circulation, elimination and alkaline nutrition leads to a build-up of acidic waste and poor immune defense (the janitors of the blood and interstitial fluids), which can increase the number of cancerous cells, as one spoiled or rotting cell spoils another, much like one rotten apple will spoil a bushel of healthy apples creating an acidic microenvironment that creates more and more rotten apples or cancerous cells  that would be resistant to any conventional acidic treatment.

Now, the most commonly accepted forms of cancer treatment are chemotherapy and radiation therapy. These acidic drugs and ionizing radiation will systemically destroy already acidic cancerous cells, but they will also turn healthy blood and body cells into cancerous cells.  This will create an immediate response from the body to produce and release alkaline compounds, such as sodium bicarbonate to buffer the increased amounts of acidic waste draining the body of essential nutrients and critically paralyzing the white blood cells making them inactive and ineffective in buffering and removing cellular waste. During these acidic conventional treatments, the immune system is essentially obliterated, which can lead to metastasis while not even affecting the original cancerous condition.  According to a medical researcher, Steve Gullans, Ph.D, only 30% of  ALL people respond to chemotherapy or radiation, leaving 70% unresponsive. [22]  In addition, the data is clear that after initial chemotherapy fails, as many as 95% of cancer patients will not respond to the next suggested chemotherapy drug recommended by conventional methods.[23 ]  It is also important to understand that conventional treatments for cancer are NOT a cure for cancer.[24]

Truly, the alkaline buffering system (the stomach is the main alkalizing organ and responsible to maintain alkalinity of the blood, tissues and organs by producing sodium bicarbonate) which releases antioxidants to buffer increased acidic toxic waste build-up is the first and last defense against a cancerous condition. [25] If poor alkalizing nutrition is ignored, as it has been by conventional oncology for decades, how can a full recovery or at least a satisfactory quality of life be expected? In my clinical experience it’s difficult. Some oncology groups have improved by offering in house nutritionists, but oral supplementation is nowhere near sufficient in reversing a cancerous condition.

The best analogy is that it’s like trying to take out a forest fire with a squirt gun.  Or another analogy would be treating a fish in a polluted pond without changing or cleaning the water.  In other words if the fish is sick what would you do?  Treat the fish or change the water? (63,64)  Unfortunately, most groups that advertise integrative, alternative or naturopathic medicine for reversing a cancerous condition lack proper testing, a targeted method of administration or proper combination with personalized alkalizing treatments. That’s the difference that lengthens the quality and quantity of life, in my 30 plus years of clinical research experience.

Nutritional Deficiencies and Their Negative Health Effects

Below are some common alkalizing nutrients, their purpose and symptoms, as well as how frequent these deficiencies are seen in the general public in pre-cancerous and cancerous conditions.

Sodium (extremely common)

Purpose: Maintains alkalinity of the blood, interstitial and intracellular fluids, and provides the matrix for the transport of electrons for the energy of body cells.

Common Sources: Sea salt, celery, green fruit and vegetables, sprouted seeds and grasses.

Symptoms of Deficit: Low sodium bicarbonate levels, acid reflux,  excess stomach acid, headache, nausea, compensated, decompensated and latent tissue acidosis, low energy, low interstitial and intracellular pH, hypertension, heart disease, diabetes, all cancers and death. [26]

Potassium (extremely common)

Purpose: Low potassium bicarbonate, maintains alkalinity of the blood, interstitial and intracellular fluids. Major alkalizing element in the body to maintain the alkaline design of all body fluids.  The major alkaline buffer in neutralizing metabolic, dietary, respiratory and environmental acids.

Common Sources: Avocado, almond, green fruit and vegetables, sprouted seeds. nuts and grasses.

Symptoms of Deficit: Compensated, decompensated and latent tissue acidosis, low energy, low interstitial and intracellular pH, hypertension, heart disease, diabetes, and all cancers. [27]

Calcium (extremely common)

Purpose: Builds bones, teeth, assists the heart, nerves and muscles.

Common Sources: Green fruit and vegetables, sprouted seeds, nuts and grains, brazil nuts, broccoli, cabbage, dark leafy greens, hazelnuts, and salmon.

Symptoms of Deficit: Osteoporosis, osteomalacia, osteoarthritis, muscle cramps, irritability, acute anxiety and increased colon cancer risk.[28]

Magnesium (very common)

Purpose: More than 300 biochemical reactions, including muscle and nerve function, heart rhythm, immune system, strong bones, regulates calcium, copper, zinc, potassium, vitamin D.

Common Sources: Green fruit and vegetables, sprouted beans, peas, nuts, seeds, whole unprocessed alkalizing grains.

Symptoms of Deficit: Appetite, nausea, vomiting, fatigue cramps, numbness, tingling, seizures, heart spasms, personality changes, heart rhythm and colon cancer. [29]

Zinc (extremely common)

Purpose: Supports alkalizing, immune system, wound healing, taste and smell, DNA synthesis, normal growth and development during pregnancy, childhood and adolescence.

Common Sources: Found in green fruit and vegetables, sprouted seeds, grains and beans, nuts, whole grains.

Symptoms of Deficit: Growth retardation, hair loss, diarrhea, impotence, eye and skin lesions, loss of appetite, taste, weight loss, mental lethargy. [30]

Vitamin E (very common)

Purpose: This antioxidant regulates oxidation reactions, stabilizes cell membranes, immune function, protects against cardiovascular disease, cataracts and macular degeneration. [31]

Common Sources: Found in  green fruit and vegetables, sprouted seeds and grains, wheat germ, nuts, seeds, dark leafy greens, avocados, asparagus and certain cold-pressed vegetable oils, like hemp oil. [32]

Symptoms of Deficit: Anemia, rupturing of red blood cells, bruising, PMS, hot flashes, eczema, psoriasis, cataracts, wound healing, muscle weakness, sterility. [31,32,33]

Vitamin B1 (very common)

Purpose: Carbohydrate conversion, breaks down fats and protein, assists digestion, the nervous system, skin, hair, eyes, mouth, liver, immune system.

Common Sources: Green fruit and vegetables, sprouted seeds and grains, brown rice, wheat germ, and bran.

Symptoms of Deficit: Age-related cognitive decline, heart problems, Alzheimer’s and fatigue. [34]

Vitamin B2 (very common)

Purpose: Like Vitamin B1, works in carbohydrate conversion, breaks down fats and proteins, assists digestion, the nervous system, skin, hair, eyes, mouth, liver and also metabolism.

Common Sources: Green fruit and vegetables, almonds, sprouted seeds and grains, wheat germ, sprouts of all kinds, including soy sprouts.

Symptoms of Deficit: Anemia, decreased free radical protection, cataracts, poor thyroid function, B6 deficiency, fatigue, elevated homocysteine. [35, 36, 37, 38, 39, 40]

Vitamin B3 (less common)

Purpose: Helps with energy, digestion, nervous system, skin, hair, eyes, liver, eliminates harmful toxins, assists sex and stress hormones and improves circulation.

Common Sources: Green fruit and vegetables, beets, sprouted seeds, nuts and grains.

Symptoms of Deficit: Cracking, scaling skin, digestive problems, confusion, anxiety, fatigue. [41]

Vitamin B6 (common)

Purpose: Assists with buffering metabolic acids, protein metabolism, RBC production, reduces homocysteine, helps nerve and muscle cells, DNA/RNA, B12 absorption, and immune function.

Common Sources: Green fruit and vegetables, especially avocado, and sprouted seeds, nuts and grains.

Symptoms of Deficit: Depression, sleep and skin problems, confusion, anxiety and fatigue. [42, 43]

Vitamin C (common)

Purpose: Aids in alkaline buffering activation, second messenger roles (transmitting hormonal information), blood clotting, cell and cell organelle membrane function, nerve impulse transmission and muscular contraction, tone and irritability. (Not to be confused with High Dose Vitamin C that acts as an oxidative therapy)

Common Sources: Supplements, broccoli, Brussels sprouts, avocado, and all green fruit and vegetables.

Symptoms of Deficit: Muscular and nervous irritability, muscle spasms, muscle cramps and tetany, tooth decay, periodontal disease, depression and possibly hypertension. [44, 45, 46]

Vitamin D (very common)

Purpose: Calcium and phosphorus levels, calcium absorption, bone mineralization.

Common Sources: Sunlight, green fruit and vegetables, sprouted seeds, nuts and beans and fish.

Symptoms of Deficit: Osteoporosis, calcium absorption and thyroid issues, cardiovascular risks and 15 cancer risks.[47]

Folate (very common)

Purpose: Mental health, infant DNA and RNA, adolescence and pregnancy, works with vitamin B12 to regulate red blood cell production, iron function and reduce homocysteine.

Common Sources: Supplements, sprouted grains, tomato, green vegetables and fruit, avocado, black-eyed peas, sported lentils and beans.

Symptoms of Deficit: Anemia, poor immune function, fatigue, insomnia, loss of hair, high homocysteine, colon cancer, and cardiovascular disease.[48]

N-aetyl-Cysteine (very common)

Purpose: Powerful antioxidant or anti-acid, normalizes the alkaline interstitial fluid pH, urinary tract infections, neutralizes metabolic and dietary alcohol poisoning, protects lungs against toxins from air pollution and tobacco smoke.

Common Sources: Supplements, sprouted grains, sulfur-rich vegetables such as garlic, onions, parsley and cruciferous vegetables are particularly helpful in addition to avocados, squash and tomatoes.

Symptoms of Deficit: Anemia, poor immune function, fatigue, insomnia, loss of hair, high homocysteine, urinary tract infections,  lung cancer, gastric cancers, colon cancer, ovarian cancer. .[49, 50, 51, 52, 53, 54, 55, 56, 57, 58]

Glutathione (very common)

Purpose: Potent antioxidant or anti-acid, protects endothelium from dietary and metabolic acids, protects against chemotherapy toxicity, inhibits platelets formation, buffers aflatoxins, infections of the lung, used in cases of Malaria and AIDS, supports immune system, as an alkaline effect on the body fluids.

Common Sources: Supplements, sprouted grains, sulfur-rich vegetables such as garlic, onions, parsley and cruciferous vegetables are particularly helpful in addition to avocados, squash and tomatoes.

Symptoms of Deficit: Anemia, poor immune function, fatigue, insomnia, loss of hair, infections, high homocysteine, lung congestion and cancer, gastric cancer, colon cancer, reproductive cancers in men and women, neurological and cardiovascular disease. [59, 60, 61, 62]

Consider that, if these shortages are found in a healthy population, what I see in patients with a cancerous condition is far worse, due to their high acidity and metabolic demands. Though an alkaline lifestyle and diet is important, it’s the amount and quality of care received at therapeutic intravenous, oral, rectal and respiratory levels that is vital.

Alkalizing Non-Invasive Rectal Nutrient Infusions

One important point concerning the infusion of alkalizing nutrients!  For those who do not want an invasive intravenous infusion of alkaline minerals, salts, vitamins, chlorophyll, antioxidants such as glutathione, and/or long-chain polyunsaturated oils you can elect a non-invasive rectal infusion or nebulize your nutrients, which I believe is just as effective.  When these supportive nutrients are infused via the anus into the rectum, the hemorrdoidal vein absorbs these alkalizing nutrients into the blood.  The blood has a very narrow pH range so these highly alkalizing nutrients are pushed-out into the interstitial fluids to the body cells.  This becomes a very important therapy in reducing the metabolic acids that surround the cell and cause the fermentation and break-down of cell leading to a cancerous condition.

How Supplementation Can Kick-Start Your Recovery from a Cancerous Condition

As you can see, nutritional deficiencies can lead to a serious amount of health issues. These problems can become exponential in a patient with a cancerous condition because of the severe strain placed on the patient, especially when chemotherapy and/or ionizing radiation is involved.

To make matters worse, absorption of salts, minerals, and vitamins is impaired. This means, eating a alkaline diet and swallowing a few minerals and vitamins is not sufficient to support the nutritional needs of the patient. These changes are essential for long-term health, but in the wake of a cancerous condition, it’s hardly enough.

What needs to be done is intravenous and/or rectal nutritional infusion therapy. When nutrients are channeled directly into the bloodstream and then to the interstitial fluids, the results are immediate, targeted and dramatic. Keep in mind, this methodology isn’t a treatment in-and-of itself. Intravenous and rectal nutritional therapy must be combined with other forms of treatment to be truly effective. But once it is combined with the correct, personalized alkalizing therapy, alkalizing diet, exercise, and proper alkalizing water, then a revolutionary pH Miracle can begin. [63, 64]

Using 3-D Bio-Electro Functionality Scanning to Determine the Best Possible Strategy for Preventing and/or Reversing Any Cancerous Condition [65]

In modern day oncology, surgeons biopsy the lymph nodes to determine how cancer is spreading or provide staging. Lymphocytes, a type of white blood cell that is found in these lymph nodes which are catch-basins for acidic waste and cancerous cells are responsible for breaking-down and removing cellular acidic waste and cancerous cells. Impaired lymphocytes and/or congested lymph nodes are at least one major factor in the many areas I test for functionality.

The lymphatic system, the lymph nodes and the lymphocytes themselves must be functional in preventing and reversing any cancerous condition.

Using electrodes attached to the head, hands and feet I am able to test the functionality of the lymphatic system, circulatory system, muscular system, skeletal system, endocrine system, neurological system, reproductive system, vascular system, digestive system,  and respiratory system.  interstitial chemistry, interstitial pH for metabolic acidosis and the electro-conductivity of the cells to determine the state of health of ALL organs, glands and tissues in the prevention and reversal of any cancerous condition.[65]

3-D

10915125_777454528969810_207832653051135622_o

I also test for nutritional deficiencies and metabolic alkalosis or acidosis by measuring the  interstitial chemistry, interstitial pH and the electro-conductivity.  Measuring the pH of the interstitial fluids is more revealing of a cancerous condition since the blood is always trying to maintain its delicate alkaline pH of 7.365 and does not vary much.  Based upon my theory that cancer is a compromised acidic environment of the interstitial fluids which then negatively affects the state of health of ALL body cells which make up the organs, glands and tissues.  It is significantly more important to measure interstitial and intracellular fluids than blood fluids in order to obtain a correct chemistry and pH when making nutritional recommendations in the prevention and treatment of a cancerous condition. [63, 64, 65,66,67]

The following are quantitative measurements in healthy patients, without cancer, comparing Blood fluids with Intracellular and Interstitial fluids of the body compartments as a benchmark which I use to determine deficiencies in alkalizing minerals, protein and whether or not the patient is in metabolic acidosis or a pre-cancerous or cancerous condition (Note: all cancer patients are in interstitial metabolic acidosis, low in interstitial sodium and high in interstitial calcium and potassium): [66,67]

1) Sodium: Na+ mEq/l

Venous blood: 130, Arterial blood: 137, Capillary blood: 135, Intracellular fluid: 10 and Interstitial fluid: 135

2) Potassium: K+ mEq/l

Venous blood: 3.2, Arterial blood: 3.5, Capillary blood: 4, Intracellular fluid: 140 and Interstitial fluid: 3.17

3) Calcium: Ca++ mEq/l

Venous blood: 2.5, Arterial blood: 2.2, Capillary blood: 2.3, Intracellular fluid: 0.0001 and Interstitial fluid: 1.55

4) Magnesium: Mg mEq/l

Venous blood: 0.64, Arterial blood: 0.62, Capillary blood: 0.60, Intracellular fluid: 58 and Interstitial fluid: 0.50

5) Chloride: Cl- mEq/l

Venous blood: 104, Arterial blood: 101, Capillary blood: 103, Intracellular fluid: 4 and Interstitial fluid: 106

6) Bicarbonate: HCO3 mEq/l

Venous blood: 22, Arterial blood: 24, Capillary blood: 23, Intracellular fluid: 10 and Interstitial fluid: 24

7) Phosphorus: P mE/l

Venous blood: 2.5, Arterial blood: 2.3, Capillary blood: 2, Intracellular fluid: 75 and Interstitial fluid: 0.70

8) Sulfate: SO4 mEq/l

Venous blood: 0.8, Arterial blood: 0.6, Capillary blood: 0.5, Intracellular fluid: 2 and Interstitial fluid: 0

9) Glycemia mg/dl

Venous blood: 1, Arterial blood: 1, Capillary blood: 1.01, Intracellular fluid: 0.20 and Interstitial fluid: 0.90

10) Cholesterol mg/dl

Venous blood: 0.66, Arterial blood: 0.630, Capillary blood: 0.676, Intracellular fluid: 0.2 and Interstitial fluid: 0.188

11) Partial Pressure of Oxygen or PO2 mmHg

Venous blood: 80, Arterial blood: 90, Capillary blood: 89, Intracellular fluid: 20 and Interstitial fluid: 87.2

12) Carbon Dioxide Or PCO2

Venous blood: 46, Arterial blood: 40, Capillary blood: 42, Intracellular fluid: 50 and Interstitial fluid: 46

13) pH or potential of hydrogen

Venous blood: 7.36, Arterial blood: 7.4, Capillary blood: 7.38, Intracellular fluid: 7.2 and Interstitial fluid: 7.36

14) Protein g/dl

Venous blood: 72, Arterial blood: 74, Capillary blood: 73.7, Intracellular fluid: 68 and Interstitial fluid: 20.6

As I correct the deficiencies in the intracellular and interstitial fluids targeted with key alkalizing nutritional treatments, patients see the difference through follow-up tests using quantitative non-invasive 3-D Full Body Bio-Electro scanning.  They also feel the difference physiologically and functionally.[65,66,67]

This is how I know proper alkalizing nutritional support in any cancerous condition is important in the prevention and treatment of cancer, the  metastasis of cancer and the shrinking of a cancerous cyst or mass without chemotherapy and/or radiation. The best part about these alkalizing nutritional treatments is they are helpful in most, if not in all cancerous conditions.[61, 64,65]

The following case study with one of my patients was diagnosed by biopsy with inflammatory ductal cell carcinoma who reversed her cancerous condition without chemotherapy, radiotherapy, and surgery.[65]

Using breast thermography and tumor location and size measured by breast ultrasound you can see the week by week reduction of a 14.2cm tumor in the left breast reduce to less than 2cm in 7 weeks of treatment using an alkaline lifestyle and dietary protocol as outlined in Chapter 11 of the pH Miracle revised and updated book. (63,64,65)

10431696_1430260873907495_2483446741826247915_n

Summary

The safest, painless, non-invasive, affordable full body screening tests are a combination of a Medical Diagnostic Ultrasound and Thermography, which may give the Physician about 95% accuracy in detecting breast cancer.[65]

Thermography is a physiological, non-invasive screening procedure that detects and records infrared heat emissions from the pre-cancerous or cancerous area, which can aid in the early detection of abnormal changes in body tissues, organs and glands. Thermography offers information that no other procedure can provide. The procedure is based on the principle that chemical and blood vessel activity in both pre-cancerous or cancerous tissue and the area surrounding a developing cancer is almost always higher in temperature than in the normal tissue.

Since pre-cancerous and cancerous masses are highly metabolic tissues, they need an abundant supply of nutrients to maintain their growth. The cells release substances that stimulate the formation of new blood vessels (neoangiogenesis). This process results in an increase in surface temperatures of the affected tissue, organ or gland.

The most promising aspect of medical diagnostic thermography is its ability to spot abnormalities years before the tumor is seen on any anatomical test. Since thermal imaging detects changes at the cellular level, this test can detect activity 8 to 10 years before any other test. This makes it unique in that it affords the physician the opportunity to view changes before the actual formation of the cancerous tumor.

Studies have shown that by the time a tumor has grown to sufficient size to be detectable by physical examination or mammography, it has in fact been growing for about seven years achieving more than 25 doublings of the malignant cell colony. At 90 days there are two cells, at one year there are 16 cells, and at five years there are 1,048,576 cells–an amount that is still undetectable by a mammogram. Thermography has the ability to provide the patient with future risk assessment. If discovered, certain thermographic risk markers can warn the patient that she/he needs to work closely with their physician with regular checkups to monitor her  health.


Full-Body Ultrasound [FBU} is an anatomical non-invasive, painless screening test without ionized radiation. Ultrasound, also known as sonography, uses sound waves to outline a part of the body. For this test, a small instrument called a transducer is placed on the skin (which is often first lubricated with ultrasound gel) and emits sound waves off body tissues. The echoes are converted by a computer into an image that is displayed on a computer screen.

Full Body Ultrasound imaging is “real-time,” meaning that it can show exactly what’s happening in the tissue, organ or gland at that moment, help to distinguish between cysts (fluid-filled sacs) and solid masses, detect increased vascularity around or within the mass, see the shape, exact size and location of the mass, cyst, calcification or dilated mammary ducts.

These safe medical diagnostic tests can be done on early bases for a regular check up, or more often if the problem was detected, to monitor a noninvasive alkalizing nutritional treatment progress.

Early detection, which includes self examination and safe, painless, non-invasive medical diagnostic Full Body Bio-electro Scan(FBBES) Full Body Thermography (FBT) and Full Body Ultrasound (FBU) screenings with no ionizing radiation coupled with a supportive alkalizing nutritional diet and ANI whether or not the patient is receiving chemotherapy and/or radiation, I have found that this approach a precancerous or cancerous condition will saves lives!

If you have questions concerning any specific acidic cancerous condition or to learn more about ANI and a alkalizing nutritional dietary and lifestyle protocol in the prevention and reversal of any precancerous or cancerous condition, please read The pH Miracle revised and update, Reverse Cancer NOW and The pH Miracle for Cancer. [63, 64] http://www.phoreveryoung.com  You can also email: phmiraclelife@gmail.com

AAEAAQAAAAAAAAU-AAAAJGQyNmQ5M2FjLTJjNWUtNDJiNi1iODRhLTNkNmE4ODEzMmI5Mg

References

[1] Immunity, Inflammation, and Cancer http://www.sciencedirect.com/science/article/pii/S0092867410000607

[2] Inflammation: Gearing the journey to cancer –http://www.uccs.edu/Documents/rmelamed/kundu_surh_2008_18485806.pdf

[3] Researchers examine how BRD4 contributes to sustained presence of NF-kappa B in cancer cells – http://www.news-medical.net/news/20130520/Researchers-examine-how-BRD4-contributes-to-sustained-presence-of-NF-kappa-B-in-cancer-cells.aspx

[4] The Epidermal Growth Factor Receptor: A Link Between Inflammation and Liver Cancer – http://ebm.sagepub.com/content/234/7/713.abstract#target-1 – See more at: http://envita.com/cancer/chronic-inflammation#sthash.1KCydZeZ.dpuf

[5]  Nick Barker1, Johan H. van Es1, Jeroen Kuipers1, Pekka Kujala2, Maaike van den Born1, Miranda Cozijnsen1, Andrea Haegebarth1, Jeroen Korving1, Harry Begthel1, Peter J. Peters2 & Hans Clevers1,  “Identification of stem cells in small intestine and colon by marker gene Lgr5,” Nature 449, 1003-1007 (25 October 2007) | :10.1038/nature06196; Received 21 June 2007; Accepted 24 August 2007; Published online 14 October 2007.

  1. Hubrecht Institute, Uppsalalaan 8, 3584CT Utrecht, The Netherlands
  2. The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands

[6] (Charles B Simone MD, NicoleL. Simone MD) “Antioxidants and other Nutrients Do Not Interfere With Chemotherapy or Radiation Therapy and Increase Kill and Survival.”

[7] Waugh A, Grant A. Anatomy and Physiology in Health and Illness. 10th edition. Philadelphia, Pa, USA: Churchill Livingstone Elsevier; 2007.

[8] University, Birmingham oAa. Oceans reveal further impacts of climate change. ScienceDaily, 2010.

[9] Hoegh-Guldberg O, Mumby PJ, Hooten AJ, et al. Coral reefs under rapid climate change and ocean acidification. Science. 2007;318(5857):1737–1742. [PubMed]

[10] Dam-ampai SO J, Nilnond C. Effect of cattle manure and dolomite on soil properties and plant growth in acid upland soils. Songklanakarin Journal of Science and Technologh. 2005;27(supplement 3):727–737.

[11] Ströhle A, Hahn A, Sebastian A. Estimation of the diet-dependent net acid load in 229 worldwide historically studied hunter-gatherer societies. American Journal of Clinical Nutrition. 2010;91(2):406–412. [PubMed]

[12] Sebastian A, Frassetto LA, Sellmeyer DE, Merriam RL, Morris RC., Jr. Estimation of the net acid load of the diet of ancestral preagricultural Homo sapiens and their hominid ancestors. American Journal of Clinical Nutrition. 2002;76(6):1308–1316. [PubMed]

[13] Frassetto L, Morris, Jr. R.C. RC, Jr., Sellmeyer DE, Todd K, Sebastian A. Diet, evolution and aging—the pathophysiologic effects of the post-agricultural inversion of the potassium-to-sodium and base-to-chloride ratios in the human diet. European Journal of Nutrition. 2001;40(5):200–213. [PubMed]

[14] Konner M, Boyd Eaton S. Paleolithic nutrition: twenty-five years later. Nutrition in Clinical Practice. 2010;25(6):594–602. [PubMed]

[15] Lindeman RD, Goldman R. Anatomic and physiologic age changes in the kidney. Experimental Gerontology. 1986;21(4-5):379–406. [PubMed]

[16] Reddy ST, Wang CY, Sakhaee K, Brinkley L, Pak CY. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. American Journal of Kidney Diseases. 2002;40(2):265–274. [PubMed]

[17] Groos E, Walker L, Masters JR. Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity. Cancer. 1986;58(6):1199–1203.  [PubMed]

[18] Smith SR, Martin PA, Edwards RHT. Tumour pH and response to chemotherapy: an in vivo 31P magnetic resonance spectroscopy study in non-Hodgkin’s lymphoma. British Journal of Radiology. 1991;64(766):923–928.  [PubMed]

[19] Raghunand N, Gillies RJ. pH and chemotherapy. Novartis Foundation Symposium. 2001;240:199–211.  [PubMed]

[20] Raghunand N, He X, Van Sluis R, et al. Enhancement of chemotherapy by manipulation of tumour pH. British Journal of Cancer. 1999;80(7):1005–1011. [PMC free article]  [PubMed]

[21]  “Distinct E-cadherin-based complexes regulate cell behaviour through miRNA processing or Src and p120 catenin activity.” Nature Cell Biology 17, 1145–1157  doi:10.1038/ncb3227

[22] (Medscape article) “One Size Fits All Drug Dosing Give Suboptimal Results”

[23]  Holly G. Prigerson, PhD1,2; Yuhua Bao, PhD3; Manish A. Shah, MD4; M. Elizabeth Paulk, MD6; Thomas W. LeBlanc, MD, MA5; Bryan J. Schneider, MD7; Melissa M. Garrido, PhD8,9; M. Carrington Reid, MD, PhD2; David A. Berlin, MD10; Kerin B. Adelson, MD13; Alfred I. Neugut, MD, PhD11,12; Paul K. Maciejewski, PhD1,14[+] Author Affiliations, “Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.” JAMA Oncol. 2015;1(6):778-784. doi:10.1001/jamaoncol.2015.2378.

[24] Cancer Treatment & Survivorship, Facts & Figures, Estimated Numbers of Cancer Survivors by State as of January 1, 2014.

http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-042801.pdf

American Cancer Society Inc. 250 Williams Street, NW, Atlanta, GA 30303-1002, 404-320-3333

[25] Scand J Gastroenterol. 1992 Oct;27(10):829-36, “Measurement of gastric bicarbonate secretion in the human stomach: different methods produce discordant results.” Odes HS1, Hogan DLSteinbach JHBallesteros MAKoss MAIsenberg JI

[26] Campling BG, Sarda IR, Baer KA, Pang SC, Baker HM, Lofters WS, Flynn TG. Secretion of atrial natriuretic peptide and vasopressin by small cell lung cancer. Cancer. 1995;75:2442-51

[27] Rethinking Cancer – http://www.rethinkingcancer.org/resources/magazine-articles/18_7-8/potassium.php

[28] “Calcium supplementation may attenuate the hyprproliferation and hyperplasia induced in the mouse colon by a Western-stye diet.”

Click here to read the entire abstract

Pubmed Data : Carcinogenesis. 1995 Nov;16(11):2685-9. PMID: 7586187Article Published Date : Nov 01, 1995Study Type : Animal Study

Additional Links

Substances : Calcium : CK(232) : AC(35)Diseases : Colon Cancer : CK(895) : AC(233)Western-Style Diet Induced Toxicity : CK(6) : AC(3)Pharmacological Actions : Antiproliferative : CK(1061) : AC(775)

[29] “Magnesium intake and colorectal tumor risk: a case-control study and meta-analysis.” Petra A WarkRosa LauTeresa Norat, and Ellen KampmanThe American Journal of Clinical Nutrition September 2012

[30]  L C Costello1, P Feng1, B Milon1, M Tan2 and R B Franklin1Prostate Cancer and Prostatic Diseases (2004) 7, 111–117. doi:10.1038/sj.pcan.4500712, “Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve.”

  1. 1Department of Biomedical Sciences, Dental School, University of Maryland, Baltimore, Maryland, USA
  2. 2Division of Biostatistics, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, USA

Correspondence: LC Costello, Department of Biomedical Sciences, Dental School/University of Maryland, 666 West Baltimore Street, Baltimore, MD 21201, USA. E-mail: lcc@dental.umaryland.edu

Received 17 December 2003; Revised 22 January 2004; Accepted 2 February 2004.

[31] Bjelakovic G, Nikolova D, Gluud LL, et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane.Database.Syst.Rev. 2012;3:CD007176. – See more at: http://ww5.komen.org/BreastCancer/VitaminE.html#sthash.cTdPRkTA.dpuf

[32] Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am.J.Gastroenterol. 2012;107(6):811-826. – See more at: http://ww5.komen.org/BreastCancer/VitaminE.html#sthash.cTdPRkTA.dpuf

[33] Cortes-Jofre M, Rueda JR, Corsini-Munoz G, et al. Drugs for preventing lung cancer in healthy people. Cochrane.Database.Syst.Rev. 2012;10:CD002141. – See more at: http://ww5.komen.org/BreastCancer/VitaminE.html#sthash.cTdPRkTA.dpuf

[34] Cancer Chemother Pharmacol. 2014 Mar;73(3):585-94. doi: 10.1007/s00280-014-2386-z. Epub 2014 Jan 23., “High-dose vitamin B1 reduces proliferation in cancer cell lines analogous to dichloroacetate.” Hanberry BS1, Berger RZastre JA.

[35]  Bareford L M, Avaritt B R, Ghandehari H, Nan A, Swaan P W (2013), “Riboflavin-targeted polymer conjugates for breast tumor delivery.” Pharm Res, 30, 1799-812.

[36] Ainiwaer J, Tuerhong A, Hasim A, et al (2013), “Association of the plasma riboflavin levels and riboflavin transporter (C20orf54) gene statuses in Kazak esophageal squamous cell carcinoma patients.” Mol Biol Rep 40, 3769-75.

[37] Bassett J K, Severi G, Hodge A M, et al (2013), “Dietary intake of B vitamins and methionine and colorectal cancer risk.” Nutr Cancer, 65, 659-67.

[38] Powers HJ (2003). Riboflavin (vitamin B-2) and health. Am J Clin Nutr, 77, 1352-60

[39] Chaves Neto A H, Pelizzaro-Rocha K J, Fernandes M N, Ferreira- Halder C V (2014). Antitumor activity of irradiated riboflavin on human renal carcinoma cell line 786-O. Tumour Biol.

[40] Powers HJ (2005). Interaction among folate riboflavin genotype and cancer with reference to colorectal and cervical cancer. J Nutr, 135, 2960-66

[41] Nutr Cancer. 2003;46(2):110-8, “Niacin and carcinogenesis.” Kirkland JB1.

[42]  Zhang SM, Moore SC, Lin J, et al (2006), “Folate vitamin B6 multivitamin supplements and colorectal cancer risk in women.” Am J Epidemiol, 163, 108-115

[43] Ma E, Iwasaki M, Kobayashi M, et al (2009), “Dietary intake of folate vitamin B2 vitamin B6 vitamin B12 genetic polymorphism of related enzymes and risk of breast cancer: a case-control study in Japan.” Nutr Cancer, 61, 447-456.

[44] Nutr Cancer. 2003;46(2):110-8, “Niacin and carcinogenesis.” Kirkland JB1.

[45) Cameron E, Pauling L (October 1976). “Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer”PNAS 73 (10): 3685–3689. Bibcode:1976PNAS…73.3685Cdoi:10.1073/pnas.73.10.3685PMC 431183PMID 1068480.

[46] Cabanillas, F (2010). “Vitamin C and cancer: what can we conclude–1,609 patients and 33 years later?”. Puerto Rico health sciences journal 29 (3): 215–7. PMID 20799507edit

[47] Review: there is a consistently strong inverse correlations with solar UVB for 15 types of cancers, Anticancer Res. 2012 Jan ;32(1):223-36. PMID: 22213311Substances : Vitamin D : CK(1682) : AC(238)Diseases : Bladder Cancer : CK(186) : AC(60)Breast Cancer : CK(2372) : AC(660)Cervical Cancer : CK(378) : AC(69)Colon Cancer : CK(895) : AC(233)Colorectal Cancer : CK(877) : AC(321),Endometrial Cancer : CK(269) : AC(45)Esophageal Cancer : CK(328) : AC(55)Hodgkin Lymphoma : CK(53) : AC(7)Lung Cancer : CK(496) : AC(198)Non-Hodgkin Lymphoma : CK(525) : AC(67),Ovarian Cancer : CK(154) : AC(58)Pancreatic Cancer : CK(530) : AC(168)Renal Cancer : CK(25) : AC(4)Vulvar Cancer : CK(52) : AC(4)Therapeutic Actions : Sunlight exposure : CK(432) : AC(39)Pharmacological Actions : Chemopreventive : CK(1528) : AC(382)

[48] “High dose folic acid supplementation is associated with a significant reduction in the recurrence of colon cancers” World J Gastroenterol. 2008 Jul 28;14(28):4492-8. PMID: 18680228

[49} Guan D, Xu Y, Yang M, Wang H, Wang X, Shen Z. N-acetyl cysteine and penicillamine induce apoptosis via the ER stress response-signaling pathway. Mol Carcinog. 2010 Jan;49(1):68-74.

[59] Li J, Tu HJ, Dai G, et al. N-acetyl cysteine inhibits human signet ring cell gastric cancer cell line (SJ-89) cell growth by inducing apoptosis and DNA synthesis arrest. Eur J Gastroenterol Hepatol. 2007 Sep;19(9):769-74.

[51] Yang J, Su Y, Richmond A. Antioxidants tiron and N-acetyl-L-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-kappaB pathway. Free Radic Biol Med. 2007 May 1;42(9):1369-80.

[52] Krasnowska EK, Pittaluga E, Brunati AM, et al. N-acetyl-l-cysteine fosters inactivation and transfer to endolysosomes of c-Src. Free Radic Biol Med. 2008 Dec 1;45(11):1566-72.

[53] Reliene R, Pollard JM, Sobol Z, Trouiller B, Gatti RA, Schiestl RH. N-acetyl cysteine protects against ionizing radiation-induced DNA damage but not against cell killing in yeast and mammals. Mutat Res. 2009 Jun 1;665(1-2):37-43.

[54] Balansky R, Ganchev G, Iltcheva M, Steele VE, De Flora S. Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetyl cysteine. Int J Cancer. 2010 Mar 1;126(5):1047-54.

[55] Nishikawa-Ogawa M, Wanibuchi H, Morimura K, et al. N-acetyl cysteine and S-methylcysteine inhibit MeIQx rat hepatocarcinogenesis in the post-initiation stage. Carcinogenesis. 2006 May;27(5):982-8.

[56] Van Schooten FJ, Besaratinia A, De Flora S, et al. Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers. Cancer Epidemiol Biomarkers Prev. 2002 Feb;11(2):167-75.

[57] Ponz de Leon M, Roncucci L. Chemoprevention of colorectal tumors: role of lactulose and of other agents. Scand J Gastroenterol Suppl. 1997;222:72-5.

[58] Estensen RD, Levy M, Klopp SJ, et al. N-acetyl cysteine suppression of the proliferative index in the colon of patients with previous adenomatous colonic polyps. Cancer Lett. 1999 Dec 1;147(1-2):109-14.

[59] Cascinu S, Cordella L, Del Ferro E, et al., “Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled study.” J Clin Oncol. 1995; 13:26-32.

[60] Hercbergs A, Brok-Simoni F, Holtzman F, et al., “Erythrocyte glutathione and tumor response to chemotherapy.”  Lancet. 1992; 339:1074-1076.

[61] Schmidinger M, Budinsky AC, Wenzel C, et al., “Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized
pilot trial in patients with head and neck cancer and non small cell lung cancer.” Wien Klin Wochenschr. 2000; 112:617-623.

[62] Smyth JF, Bowman A, Perren T, et al., “Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomized trial.” Ann Oncol. 1997; 8:569-573.

[63] (Robert O. Young, Ph.D., D.Sc., ND and Shelley Redford Young, LMT) “The pH Miracle revised and updated,”Hachett Publishing, Boston, USA, June, 2010.

[64] Robert O. Young, Ph.D., D.Sc., ND and Shelley Redford Young, LMT, The pH Miracle for Cancer,” Hikari Omni Publishing, Valley Center, California, September, 2015.

[65] Galina Migalko, MD, ND, Universal Medical Imaging Group, Valley Village, California, http://www.universalmedicalimaging,com

[66] Reference Studies: Niels Fough-Anderson, Burton M, Attura, BElla T. Attura, Ole Siggard-Andersen, Clinical Chemistry, 41/10, 1522-1525, (1995)

[67] Gilariyi M., Bcriyi C., Fekete J, Ikreriyi K., Kovach AGB, “Ion Concentration in Subcutaneous Interstitial Fluid Measured versus Expected Values.” AMJ of Physiololgy 1988.

– See more at: www.phoreveryoung.com

The Cure for Cancer? That’s an easy question to answer! The Cure for Cancer is Found in its Prevention NOT in its Treatment! – Dr. Robert O. Young

Do you know what rotten apples, grapefruit or bananas look like? If you do then you know what cancer cells look like. Cancer cells are nothing more that healthy cells that are spoiling because of a compromised environment! Look at the picture below and you will see colorized cancerous body cells rotting in their toxic acidic environment.

What compromises the internal environment of a human body that causes body cells to begin spoiling and rotting? The answer is simple! The body’s build-up of acidic metabolic and dietary waste that has not been properly eliminated through the four channels of elimination – urination, defecation, respiration and perspiration! 

Cancer is not a noun but an adjective that describes what is happening to body cells in an acidic environment due to an acidic lifestyle and diet. www.phoreveryoung.com
To learn more about Dr. Robert O. Young go to: https://www.linkedin.com/in/drrobertoyoung
To read more of Dr. Young’s articles go to: www.phoreveryoung.wordpress.com
To join Dr. Young on Twitter go to: @drrobertyoung
To watch more videos on YouTube go to: https://www.youtube.com/user/pHMiracleCenter
Join Dr. Young on Facebook at: The PH Miracle Medical Association or The pH Miracle
To purchase Dr. Young’s books or nutritional productts go to: www.phoreveryoung.com or www.phmiracle.com

Descubre los alimentos más beneficiosos para ayudar a prevenir el cáncer

cabecera_alimentos_cancer

Nota: compartimos con vosotros esta interesante información publicada en el portal web Medicinas Naturales, un espacio en el que tratan distintas patologías con remedios y curas naturales, basadas en una buena alimentación y un estilo de vida saludable.


Ahora mismo, en nuestro cuerpo no sólo tenemos células cancerosas, también tenemos la enzimas, proteínas y la predisposición genética para matar las células cancerosas.

Nuestro sistema inmunológico trabaja constantemente para eliminar las células cancerosas de nuestros cuerpos cada día.

La mejor manera en la que podemos evitar que las células cancerosas se desarrollen es prestar atención a lo que ponemos en nuestros cuerpos. Las proteínas que combaten el cáncer específico en los órganos no funcionarán si  ha habido daños en el ADN de la célula o si las toxinas dañan el sistema inmunológico del cuerpo. En la siguiente lista encontraréis los alimentos más funcionales que ayudan a prevenir el cáncer:

1. Cáñamo

La magia en el aceite de cáñamo es su capacidad para aumentar los niveles de melatonina en el cuerpo en miles de veces más alto de lo que normalmente sería. La melatonina reduce la velocidad o detiene el crecimiento del tumor, y siempre sirve para tratar algunas formas de cáncer. El cáñamo es también una de las formas más concentradas de obtener la proteína de la planta y una de las más altas concentraciones de aminoácidos que existe en la naturaleza.Aceite Omega 3-6-9

En Alkaline Care conocemos las propiedades beneficiosas del cáñamo para nuestro organismo, por eso comercializamos el Aceite Omega 3-6-9 dentro de los productos Young pHorever, un aceite compuesto de la combinación única de lino orgánico, borraja y cáñamo, conteniendo un ratio ideal (2:1:1) de aceites esenciales omega 3, 6 y 9.

2. El ajo

La alicina, que da al ajo su aroma y sabor, es en realidad el  más potente antioxidante del mundo. El proceso en el que la mayoría de ajo es preparado comercialmente destruye la mayor parte de la alicina, así que lo mejor es utilizar el ajo fresco siempre que sea posible. El ajo se ha utilizado en la medicina tradicional china desde hace miles de años y los científicos sugieren que los compuestos de sulfuro de dialilo en el ajo son la clave para que los poderes de prevención del cáncer.

3. Tomates

El consumo regular de jugo de tomate se ha relacionado con un menor riesgo de varios tipos de cáncer y enfermedades coronarias. Los carotenoides en los tomates, así como el licopeno, se están investigando como las principales razones de las habilidades del tomate para prevenir enfermedades.

4. Té verde

El té verde contiene un grupo de plantas flavonoides llamadas catequinas, específicamente epigalocatequina-3-O-galato (EGCG), que se está investigando en  todo el mundo. En Corea del Sur, los científicos están estudiando los efectos del EGCG sobre el factor de necrosis tumoral en los tejidos musculares del sistema vascular. La capacidad del EGCG para interrumpir elementos inflamatorios en el cuerpo podría recorrer un largo camino para prevenir el cáncer en general.

5. Uvas

Las Uvas Rojas tienen un compuesto antioxidante muy poderoso conocido como resveratrol. El resveratrol también reduce la muerte celular como resultado de la oxidación y evita los procesos naturales en el cuerpo que pueden conducir a daños en el hígado. El zumo de fruta de la uva roja natural contiene los más altos niveles de resveratrol, que si se consumen diariamente, tiene un gran efecto  para la prevención de tumores.

6alga marina (wakame). Las verduras del mar (algas marinas)

Alimentos como el nori, hijiki, wakame, arame, kombu y otras algas marinas son sólo unos pocos vegetales marinos que ayudan a estimular la protección natural contra el cáncer en nuestro cuerpo. Los vegetales marinos se sabe que contienen compuestos muy potentes anti-inflamatorios y anti-oxidantes, así como minerales, incluyendo magnesio, calcio, hierro y yodo. Se cree que los niveles de antioxidantes en las verduras del mar son lo que los hace tan eficaces en la lucha contra las células cancerosas.

7. La cúrcuma

La cúrcuma contiene un compuesto natural conocido como curcumina, que es un antioxidante muy potente. Además de una larga lista de otros beneficios para la salud, la curcumina ha demostrado que detiene el crecimiento de las metástasis(tumores que se originaron en otro órgano y se difundieron).

8. Las zanahorias

La zanahoria es un alimento que dentro de sus múltiples vitaminas y como fuente de fibra, ácido fólico, manganeso, hierro, potasio y cobre, posee un alto contenido en falcarinol, un compuesto natural que estimula los mecanismos del cuerpo para luchar contra el cáncer. Estudios recientes de investigadores de la Escuela de Agricultura, Alimentación y Desarrollo Rural de la Universidad de Newcastle, encabezados por la Dra. Kirsten Brandt, descubrieron que las zanahorias cocidas enteras contenían un 25% más de falcarinol que las que se hervían trozadas. El falcarinol protege a las zanahorias contra diversos hongos que atacan sus raíces. Existen los casos de dos mujeres que tomando zumos de zanahoria durante unos meses después de estar diagnosticadas de cáncer se curaron por completo de dicha enfermedad, ya que en un principio vieron como se reducían poco a poco los tumores y dejaban de expandirse hasta quedar eliminados del organismo.

9. Nueces

Comer nueces puede reducir la tasa de enfermedades del corazón y el cáncer e incluso alargar la esperanza de vida de acuerdo a muchos estudios. En estudios recientes, se observo la influencia en la salud de los cacahuetes, pistachos, almendras, nueces y otros frutos secos. En el estudio, 119 mil hombres y mujeres que comían frutos secos todos los días tenían un 20% menos de probabilidades de morir durante el período del estudio que los que nunca consumían frutos secos.

Un nuevo estudio realizado por investigadores del Health Science Center de la Universidad de Texas (EE.UU.) muestra que consumir dos raciones de nueces diarias, unos 60 gramos díarios, podría proteger contra el desarrollo y evolución del cáncer de próstata. Los hechos muestran que al ser alimentados con determinados frutos de cáscara como las nueces, son capaces de suprimir el crecimiento de células de cáncer de mama en placas de Petri. Otros estudios sugieren que las nueces tienen mucha influencia en el bloqueo de los cánceres colorrectales.

nueces

Introducing Dr. Robert O. Young and the “pH Miracle for Cancer”

DOC_ROY_G_2_035bw copy

Introducing Dr. Robert O. Young and the “pH Miracle for Cancer”

I am very excited to introduce you to the work of the leading nutritional microbiologist in the world today — Dr. Robert O. Young.

Over the past two and a half decades, Dr. Robert O. Young has been widely recognized as one of the top research scientists in the world. Throughout his career, his research has been focused at the cellular level. Having a specialty in cellular nutrition, Dr. Young has devoted his life to researching the true causes of “disease,” subsequently developing The New Biology™ to help people balance their life.

THE NEW BIOLOGY 

Dr. Young’s scientific findings have led him to a new science he calls The New BiologyTM.

In contrast, the ‘old’ biology (based on the work of Louis Pasteur in the late 1800s) stems from the idea that disease comes from germs and bacteria which invade the body from the outside.

Simply put, the New Biology states that there is only One Sickness and One Disease, and that this one ‘sickness’ is the over-acidification of the body due primarily to an inverted way of living, thinking, and eating.

This over-acidification leads to the over-growth in our body of micro-organisms (such as yeast and fungi) whose poisons produce the symptomologies that medical science refers to as “disease”. 

Based on Dr. Young’s theory, there’s only one sickness, and there can therefore be only one remedy and treatment, and that is to alkalize the body and break the cycle of imbalance, thus allowing us to experience the energy, vitality and true health we’re all meant to have.

What’s more, Dr Robert Young is a man for whom I have immense respect and admiration. If you are familiar with my work (through my books, eBooks, and seminars), you know that I’m definitely not one who easily buys into “miracle cures” – nor am I easily swayed by other people’s opinions or anecdotal reports. I’m extremely wary of exaggerated health claims provided by individuals or enterprises that stand to make huge profits from the proliferation of those claims.

But the more I expanded my research into this New BiologyTM, the more I was dumbfounded by the mountains of evidence showing that this therapy has already been used by so many health practitioners who have adopted Dr Young’s protocol to heal cancer and every conceivable disease.

My skepticism turned to conviction when I realized that this cure is . . .

…the only healing therapy that finally eliminates the REAL cause of cancer!

Specifically, my skepticism melted away when I saw the overwhelming evidence consisting of thousands of people that were healed of cancer once and for all.

This is BY FAR the simplest, most effective and most powerful therapy for curing cancer and creating optimal health. It is also the secret that both the American pharmaceutical industry and the medical establishment don’t want you to know.

That’s because this simple cure for virtually all diseases threatens the livelihood and the trillion-dollar earnings of the pharmaceutical and health care industries – not to mention the medical centers and physicians that make a great living from providing expensive drugs, complex medical procedures and long hospital stays.

The simple protocol which is detailed in this book represents the biggest threat to the revenues of the pharmaceutical and medical industries.  It’s a bigger threat than all the alternative healing therapies, nutritional supplements, natural foods and products COMBINED.

I believe it’s the definitive answer to the causeprevention and cureof cancer and of a great many diseases that plague the world today.

Therefore I am deeply honoured, thrilled and excited to introduce you to a research scientist who is not only a genius in his field, but a man with an immense heart. Dr Young is a man who truly cares deeply, and I am certain his knowledge and caring can make a difference not only in your life, but in the lives of all your family and loved ones. So let the journey of transformation begin!

The pH miracle for cancer by Dr. Robert O. Young (release date August 1st, 2015)

72c4e-william2b170

We’re very, very grateful to be able to share this research – this New BiologyTM – what I (Rob) refer to as a new way of living, a new way of eating, a new way of thinking.

Some of the questions we’ll be covering in this chapter include:

  • What is cancer?
  • What’s the cause of all cancer? (Is cancer a mutant cell, a virus, a mould? Or is cancer an acidic liquid?)
  • Is cancer a noun or is it actually an adjective that explains what’s happening to the cell?
  • Are tumours bad or good?
  • What role does the lymphatic system play in all this?

The focus will be on the alkaline pH of the body. The key I believe is to obtain sustainable energy.

Most of the last 25 years of my research has been focused on what is happening to the cells as it pertains specifically to the environment around those cells. And I love this quote by Ralph Waldo Emerson: “What lies behind us and what lies before us are tiny matters compared to what lies within us.” So the focus of my research has been on specifically what lies within us and, more specifically, how the internal fluids affect the health, energy, and vitality of the human cell. Dr Benjamin Rush, eminent physician and signer of the Declaration of Independence, said: “Unless we put medical freedom into the Constitution, the time will come when medicine will organize into an underground dictatorship. To restrict the art of healing to one class of men and deny equal privileges to others will constitute the Bastille of medical science. All such laws are un-American and despotic.”

As I think about my vision, the relative purpose of medicine I believe must include not just the treatment but also the prevention of illness and the promotion of health and fitness, rather than just focusing all of our attention on a specific diagnosis or even the treatment of disease. Because disease is an illusion, in reality disease is the body trying to prevent fermentation or break down of the tissue. It’s the body in preservation mode trying to maintain the homeostasis of the internal fluids of the body, which are alkaline. I believe that the ultimate purpose of medicine is to help people discover something fundamental within themselves. And that is an awareness of the true source of wellbeing, the true source of joy, the true source of contentment that we all seek which lies in one’s mind and in one’s heart – which are the emotions and the spirit. And this is important so that we can all begin to be free from the process of grasping for happiness on a physical world.

To support this approach, this theory, I believe we must begin to embrace a more spiritual vision of ourselves and of humanity as a whole, while at the right time providing great love, care, and attention to the physical body. Then, and only then, will medicine (or the treatments that medicine is current performing) help people discover this non-physical, spiritual dimension of themselves. And when this happens I believe that we can live and work with less fear. Rather than working in fear we can work in its opposite – we can work in faith. We’re going to have less stress grasping to preserve the physical body at all costs, then I believe we can truly be happy, energetic, and free.

Last year Shelley and I (Rob) had the opportunity to have a wonderful experience with Dr Carter who is the caretaker of the estate of Martin Luther King and also the protégé of M. L. King, and there he honoured Shelley and I. And the most important thing that I learned about Dr Carter was his openness to not just thinking outside the box, because we talk a lot about thinking outside the box, I would like to suggest rather than thinking outside the box as we contemplate these new theories that I am going to be presenting to you on the pH Miracle for cancer, but making the box bigger. We don’t have to think outside the box, we just need to make the box bigger to allow new technologies, new biologies, new protocols that are effectively making the difference, specifically in the prevention and treatment of cancer.

432a435a-f0c2-46da-91b5-3318575a33fd-medium

“You must be the change we want to see.”

– Ghandi 

If we want to see the cure for cancer, I believe we must be change we want to see.  We’ll have to look at it differently, not outside the box but inside the box making it bigger. Expanding our views and our perspective as it relates to cancer.

Now before we start exploring the pH Miracle for cancer, I must start up by saying what is a pH miracle. And I would suggest that a pH miracle is a natural phenomenon that is not understood currently by medical researchers, specifically in the cause and effect relationship. What is the cause? Is cancer a cause for disease? I say no, cancer is the body attempting to maintain homeostasis and cancer is the body in preservation mode trying to maintain the alkaline design of the human organism. So first we must understand that cancer is unequivocally not a disease, but a symptom or better yet an effect of gastrointestinal and metabolic acids that have built up in the blood and then these acids are thrown off into the tissues poisoning and suppressing our immune system making it increasingly difficult to maintain the alkaline pH of the internal fluids of the body. So these acids destroy the white cells’ ability to remove acids and the cells which they spoil.

What I’m simply suggesting is that cancer is not a cell, but an acidic liquid that spoils our cells that make up our tissues and organs when those acids are not properly eliminated through urination, perspiration, respiration or defecation. Let’s now look at the current medical definition of cancer. What is it? Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled it can result in death. Cancer is caused by both external factors, some of which are known and are common in our society such as tobacco, chemicals, radiation (from our cellular phones) and internal factors: hormone imbalances, immune deficiency and gene mutations – which is what they’re suggesting. These factors may act together in a sequence to promote what is called carcinogenesis. This is the classical definition of cancer, taken directly from the American Cancer Society.

So what is being suggested by current medical science is that the cancer is some mutating cell that – a transmutation of the genes – triggered by internal or external factors, this is true but what is not understood is these internal or external factors are the acids themselves. So when we’re dealing with any symptom or an effect, we need to look at the cause. Whether externally or internally, the focus traditionally has been to look at the matter rather than look at the environment around the matter. And to understand the cause is very simple just like the treatment. And the New Biology® explains the cause and effect of all sickness and disease and specifically cancer as well as how to improve the quality and quantity of life without chemical therapy, radiation or surgery.

Let me give you an example. Enervation (ie, lack of energy), muscle weakness, you’ve probably seen the commercials on television, it’s a new disease they call restless legs syndrome (RLS) for which there are drugs that supposedly treat the syndrome. They want to put everything in a disease modality – a nice little box – that has a specific treatment. Yet restless legs syndrome is weakness or loss of electrical power. It’s not a disease. But by causing a flagging of the toxic elimination from the tissue, the blood becomes charged with these metabolic acids and when it’s charged with these metabolic acids the blood has to purify itself by throwing these metabolic acids into the tissues to maintain its delicate pH balance of 7.365. This is what I call the body in preservation mode which leads to what I refer to as latent tissue acidosis. This is poison in the blood, and if that poison is not eliminated through urination, perspiration, respiration or defecation, the body has to purify itself so it throws this poison into the connective tissue. This is the disease, or is it? Not even skin challenges when the acids accumulate beyond the toleration point a crisis takes place which means that the poison or the acid is being eliminated through the skin.

Looking at the 2006 statistics for cancer, this year in America we’re looking at 1,400,000 new cases of cancer. By the way, this statistic doesn’t even include skin cancer which is actually bigger than lung cancer, breast cancer or prostate cancer. And prostate cancer is known to be the leading cause of death in men while lung cancer being the leading cause of death in women. And yet when we look at cancer, the new incidents of cancer and the new diagnoses are skin cancers because skin is the third kidney – the elimination organ. And if acids are not properly eliminated through the elimination channels, then those acids are thrown out into the tissues and this is what’s not currently recognized by medical science.

This is the reason why the blood maintains its pH by either eliminating acid through urination or throwing it into the colloidal tissue which leads to this crisis, this poisoning, this elimination through the skin, again the third kidney! And this is not a disease. The only disease is systemic, because acids flow out through your whole body. They are the waste products of metabolism. Our bodies are like cars, they’re constantly on though 24/7 and they require energy and when energy is being used, a waste product like carbon dioxide or carbon monoxide or lactic acid is being created. So acid is constantly being created which has to be eliminated. So when energy is being used to think, to move, to breathe, at the same time an acid is being created and acid needs to be eliminated. If the acid is not eliminated, it is thrown out into the colloidal connective tissue. It is our tissue that becomes the colloidal acid catcher in order to maintain the purity of the blood. The blood has to maintain the purity and this is why the blood has a constant pH. If it varies of even just one point you can have ill effects. The proper balance is 7.365. If it starts dropping or if it starts going up, the body will do whatever it can to maintain that delicate pH. This is very significant in order to understand cancer and why it’s not a cell but the spoiling of the cell and tissue by metabolic acids which are not properly eliminated through elimination because we have enervation, we don’t have the energy to move the acid out to maintain the purity of the blood, so it is then sent out into the colloidal connective tissue.

When this elimination takes place through the mucus membrane of the nose for example it’s called a cold – catarrh of the nose. And when these crises are repeated for years the mucus membrane thickens and ulcerates, and the bones enlarge, closing the passages. At this stage hay fever, asthma develops. When the tonsils or any other respiratory passages become the seat of the crisis of acidity (because the acids were not properly eliminated) then we have tonsillitis, laryngitis, bronchitis, asthma, pneumonia, and cancer. You see, it’s progressive, it’s the same thing. All that’s happening is different progressions of the same thing – just different levels of states of acidosis. When this acid is located in the cranial cavity we have dementia, Alzheimer’s, Parkinson’s, muddle thinking, forgetfulness. If the acids accumulate in the digestive area, we end up with irritable bowel syndrome, gastro intestinal problems, stenosis, colitis. And when the acids locate in the pelvic tissue, or in the breasts, we end up with micro calcifications as the body, in preservation mode, is using one of these alkaline buffers such as calcium to neutralize the acids and that’s why we have these micro calcifications in the pelvic area and in the breast. This always precedes the rotting of the tissue. Even in prostate cancer.

Hence all cancers are the expulsion of acids from the blood and then the tissue at different points and are essentially the same character evolving from the same cause, namely systemic acidosis – a crisis of toxaemia. The description can be extended to every organ of the body: the lung, the liver, the pancreas, the bowls, the brain, including the largest organs which has the highest incidents: the skin. Any organ that is enervated below the average standard (from stress of habit, from overstress at work, from worry, anxiety, fear, injury, etc.) may become the location of the crisis of systemic latent tissue acidosis. The symptoms presented differently depending upon which organ is being affected. Which is what makes it appear as if every symptom complex is a separate and distinct disease. But we need to not think outside the box, we need to think inside the box, we just need to make the box bigger.

I give thanks to this new light shed upon nomen culture naming disease by the philosophy of The New Biology, every symptom complex goes back to the one and only cause of all so called cancers, namely systemic latent tissue acidosis. To find the cause of all symptomologies – lung cancer, breast cancer, brain cancer, bowl cancer, prostate cancer – we start with colds and catarrh, and watch the pathology and is it travels from irritation to catarrh to inflammation to induration to ulceration and then to cancer: nothing more than rotting tissue. And what is causing the transformation (and not gene transmutation) is the spoiling of the cell due to the acids.

Have you ever opened a refrigerator and smelled the spoiling foods at the back? These are the acids! It’s not some germ, it’s not some virus, it’s not some mold that’s breaking this down, it’s the acids that are breaking the tissue down and giving rise to the symptomology. Mold is like a smoking gun, the bullet being the acid. And yet it’s not the bullet or the acid that kills, and surely not the smoke or some gene mutation, or some bacteria or virus, but it is the person himself or herself that is pulling lifestyle and dietary trigger which then releases the acid that then tenderizes or spoils the tissue in the weakest parts of the body.

Nature’s order is interfered with by innovating habits until acidosis is established. A vaccination as evidenced by the Spanish flu epidemic or an infection, in truth it’s literally an out-fection from the same source causing the most vulnerable organ, specifically the bowls, to take on organic changes. The organ however has nothing to do with the cause, and directing treatment to the organ is actually compounding the problem. You cannot treat disease when in reality disease is the body in preservation trying to re-establish homeostasis in a state of systemic acidosis that’s localized at the weakest part of the body.

When we realize that breast cancer is the leading cause of death in women and that these fatty tissues (breast areas) are being used by the body to bind or collect the acids in order to protect the organs that sustain life. And by the way when one does a mammogram and sees these microcalcification of the breast, this is an indication of a state of acidosis – the body’s defensive mechanism to relieve or remove or neutralize acidity that hasn’t been properly eliminated though urination, perspiration, respiration or defecation.

If we’re dealing with prostate, we’re dealing with localized acidity. If we’re dealing with lung cancer, we’re dealing with localized acidity that can be caused by external or internal forces but everything comes from within. As we take in tobacco smoke, there are acids and toxins and poisons – one being sugar which breaks down to acetaldehyde which tenderizes this tissue. Tobacco smoking is not an addiction of nicotine, it’s an addiction of sugar which causes excess acidity in a localized area. So cause is constant, ever present, always the same, only the effects change. To illustrate, a catarrh of the stomach presents first irritation, then inflammation, then ulceration and finally induration and cancer. Cancer is not at the first, it’s the culmination of deteriorating or broken tissue spoiled by an overacidic stomach.

Most Americans are challenged with the symptomology of indigestion which can include acid reflux, bloating, heartburn, burping, diarrhea, or even constipation. The proper way to study disease is to study health in every aspect. Disease is perverted health. Cancer is perverted health – any influence that lowers energy becomes disease producing.

There’s an important question now to answer. Why do we crave sugar? It’s interesting when doing an MRI or a CAT scan. What is used but radioactive sugar that is taken up by the acidic cells – not cancer cells because we don’t have cancer cells, we have acidic cells or cancerous cells: cells that have been spoiled by the environment in which they live. So sugar cravings are the body’s needs for sustainable energy. And energy can only be transported through a matrix of salt. Therefore sugar cravings are the body’s needs for salt, not sugar. And I suggest that sugar is an acid of cellular transformation – a waste product – not a product of energy by a by-product of what the body truly uses which is electrical potential in the form of electrons.

The body doesn’t use carbohydrates, the body uses electrons to run. The body is electrical. And sugar is nothing more than a waste product of cellular breakdown and transformation. Isn’t that what happens to the banana? As the banana moves from irritation to inflammation to induration and then to cancer, going from green to yellow to brown getting its “liver spots” the same way you get liver spots, through excess fermentation and rotting. We do not say the banana has cancer, we say the banana is spoiling. In the same way we shouldn’t say that the lung has cancer but rather that the lung is spoiling – it is cancerous. Cancer is not a noun but an adjective expressing the process of cellular transformation. Again, sugar is the waste product. In fact, that’s why it gets sweeter and sweeter as it ferments. Consistently in my research I see that we have a release of sugar from the breakdown of tissue. And to overcome sugar craving we don’t have to eat sugar, we need to eat more salt. And the secondary metabolites of this primary acid or sugar are acetaldehyde and ethanol alcohol. So cravings are the body’s signal that the body needs more sustainable energy. We need energy to remove the acids of metabolism – the body utilizing electrons for energy purposes. Food, drinks, sun, minerals, vitamins, drugs… are common choices made by us to achieve sustainable energy, but yet what we’re looking for are the electrons from these sources. And our choices will determine whether or not our cravings will lead to true sustainable energy which maintains the integrity of the fluids of body and therefore the integrity of the tissues, or gives us false energy which creates this over-acidic state that leads to latent tissue acidosis which begins the process of spoiling of the tissue.

Sugar stimulates and gives the body a deceptive quick-fix – it’s illusionary – whereas salt provides the matrix and gives our body the rise in sustainable energy, over a long period of time, without the high and extreme lows that come from eating an acid – whether it be sugar or any other acidic foods or drinks.

It is the skin that suffers, because if the body can’t eliminate the acids that are created through energy consumption, it throws them out of the tissues and into the lymphatic system, and that’s why the lymphatic system is so critical in the prevention of cancer and in the treatment of cancer, because it is the lymphatic system that is the vacuum cleaner of the acids that are in the interstitial fluids of the body, pulling these acids out in order to maintain the integrity of the tissue through diaphramic breathing and perspiration (that is if we’re perspiring, which is one of the most important things we need to do on a daily basis). If we can’t eliminate our acids through urination then our body urinates through the skin – which is why there is over a million cases of skin cancer a year in the United States and probably you didn’t even know that. It’s not talked about. Why? Because the etiology of skin cancer is not understood. It is unknown. Scientists don’t know what causes basal cell carcinoma, melanoma, they do not understand it because they don’t understand latent tissue acidosis and the importance of the lymphatic system as the vacuum cleaner to move the acids out via the kidneys and through perspiration. But we’re not exercising, and this is why obesity and a lack of exercise have been associated with cancer – yet when we’re moving our body we’re moving the acids out of the tissue because the lymphatic system, unlike the circulatory system, does not have a pump (the heart), it actually flows through movement. It is the diaphragm muscle that acts as a pump for the lymphatic system that moves the acids through the system – out through perspiration or back in the general circulation to be eliminated through urination.

If you don’t want cancer, if you wan to prevent it, you have to pee or eliminate your acids through urination or perspiration. And if you are a cancer sufferer you have to pee your way to health. Because cancer is not a cell, but a poisoning acidic liquid. A cancer cell is a cell that is spoiled or poisoned by the metabolic acids and gastrointestinal acids that are produced internally, or may be breathed in. That’s when the body goes into protection mode by forming fibrous materials which cross-link to encapsulate the spoiled cells and thus forming the tumour. Hence tumour is the body’s protective mechanism to encapsulate spoiled or poisoned cells from excess acids which have not been properly eliminated through urination, perspiration, defecation, and respiration. The tumour is the body’s solution to protect healthy cells and tissues. So the tumour is not the problem. Let the tumour go. Let it do its job. The focus must be placed not on the tumour but on the environment around the tumour which is full of acids, and one of the common acids which is in higher concentration around all tumours that are in an acidic body is lactic acid, because lactic acid is a by-product of sugar metabolism when we’re in a state of oxygen deprivation. So cancer is a system acidic condition that settles in the weakest parts of the body, not a local problem that metastasizes. You see metastasis is localized acids that spoil other cells much like a rotten apple spoiling the bushel of other healthy apples.

There is no such thing as a cancer cell. A cancer cell is in reality a cancerous cell, it’s an adjective expressing the spoiling cell that’s spoiling in an over-acidic environment. A cancerous cell was once a healthy cell that has been spoiled from an over-acidic lifestyle and diet and the body’s inability to move these acids through the proper channels of elimination. The only solution to the acidic liquids that poison our body cells causing the effect that medical doctors call cancer, is to change the environment. It has to be a contextual approach. We must maintain the alkaline design of the human body. This has been the great discovery of the 21st century – that the human organism is alkaline by design (every part that makes up every anatomical element that makes up our genetic material that makes up our cells, every single part has to be bathed in an alkaline fluid which needs to be changed every 48 hours).

Early in the 19th century, beginning on January 17, 1912, a famous French physiologist of the Rockefeller Institute and Nobel Prize winner, Dr. Alexis Carrel, removed a very small piece of heart muscle from an unhatched chicken embryo—still warm and living—and placed it in fresh nutrient solution in a glass flask of his design. He transferred the tissue every forty-eight hours, during which time it doubled in size and had to be trimmed before being moved to its new flask. And every time he moved it he would put it into an alkaline saline solution with the appropriate alkalizing minerals. Thirty years later the tissue was still growing. Keep in mind that the average chicken lives for 5 – 7 years. So after getting bored of singing “Happy Birthday” to the chicken heart for over thirty years he decided to pull the plug and not change the fluids every 48 hours and the heart died.

This is a very important discovery which very few people know about because it answers the question about why cells live. You see, the life expectancy of the human cell is infinite. It just becomes compromised. Once we understand that matter cannot be created nor can it be destroyed it can only change its form or function, then we realize that the environment is everything, the terrain is everything, and the cell is subservient to that. The secret to Dr. Carrel’s chicken heart surviving for thirty years lies in this knowledge, this new biology, this new way of living and thinking as we expand the box not think outside the box, that the cell is only as healthy as the fluids it is bathed in. The heart is only as healthy as the cells. If you have lung cancer, that is an expression of the environment. And the cell as it’s breaking down is the smoke of the gun.

Carrel’s experiment brought us to the modern new biology, the new understanding, the new expansion, and the new definition of cancer – that the composition of our body fluids that bath the outside of our cells must be controlled very carefully from moment to moment and day to day with no single important constituent varying more than a few percent. This can be controlled and you can do it yourself!

In 1932 Otto Warburg received his Nobel Prize in medicine for discovering the cause of cancer. He described it as a cell changing its mode of respiration, its mode of metabolism – from respiration to fermentation. He suggested that cancer was the result of acidic environment, a state of oxygen deprivation. Warburg also wrote a paper entitled, “The Prime Cause and Prevention of Cancer.” He states: “There is no disease whose prime cause is better known. Over acidity.”

When we understand this we realize that all conditions of cancer potentially can be reversed if the treatments are focused on the fluids not the cell. Therefore it doesn’t matter what the cancer is, because cancer is not the cause but the effect of an over-acidic lifestyle and diet which is the cause. It’s the person pulling the lifestyle and dietary trigger.

After 30 years of doing blood research, after looking at thousands and thousands of cancer patients, I’ve never seen healthy blood or an alkaline environment – whether testing the pH of the saliva, or the urine, or the blood, or the sweat, or the tears – they are all acidic in an over-acidic environment. And after 25 years I’ve learned that the human organism is alkaline by design and acidic by function, and if we but maintain this alkaline design of our body through an alkaline lifestyle and diet we will prevent all cancers. For the cure of cancer is not found in its treatment, because again cancer or a cancerous condition is the body in preservation mode trying to maintain alkalinity, so the cure is going to be found not in its treatment of the tissue but in maintaining the alkaline design of the human fluids of the body. As Thomas Edison said: “The doctor of the future will give no medicine, but will involve the patient in the proper use of food, fresh air and exercise.”

Order your copy of the pH Miracle for Cancer at: http://www.phoreveryoung.com

dbd24-cancer_ph_miracle_book_cover

BERKELEY Professor States: “People do not die of cancer! People die of chemotherapy and in terrible pain!”

 For 25 years, Dr. Hardin B. Jones  was studying cancer patients and came to a horrifying conclusion!

images-39
Cancer Industry is as much as it attempts to deny just that: only an industry! Doctors , pharmaceutical companies , hospitals , and other key stakeholders of the industry profit every time a patient agrees to conventional treatment , which usually involves injecting chemotherapy toxins into the body , blasting the body with ionizing radiation or cutting off parts of the body and in some barbaric cases combination of all three . It is little known that the science is covering or ignoring this, despite the fact that the medical industry claims, chemotherapy just does not work in the fight against cancer .

Dr. Hardin B. Jones, a former professor of medical physics and physiology at the University of California, Berkeley, has studied the life expectancy of cancer patients more than 25 years, when he came to the conclusion that, despite popular belief, chemotherapy does not work.

He testified that most of the cancer patients treated with chemotherapy die a horrible death. Also Dr. Jones warns that patients treated with chemotherapy die much faster and more painful than many other patients who have selected different treatment. After a great research he came to the conclusion that chemotherapy shortens the life and actually kills patients faster, and that is deliberately kept as secret because billions of dollars are in the game that cancer “industry ” turns over in their death networks.

“People who refused chemotherapy treatment live an average of 12 and a half years longer than the people who are receiving chemotherapy,” said Dr. Jones in his study, which was published in the journal of the New York Academy of Sciences. People who accepted chemotherapy die within three years of diagnosis, and many die quickly after a few weeks.”

“Patients with breast cancer who reject conventional therapy live four times longer than those who follow the system. This is something you will not hear in the mass media that will continue to spread the myth that chemotherapy is the best medicine to fight cancer! ”

A separate study published in the Journal of the American Medical Associationin 1979 discovered that many of the most common methods for diagnosing and treating breast cancer, of which nearly all are still used today, did nothing to reduce the rate of breast cancer or to increase the survival of patients with breast cancer. Two other studies, one from Israel published in 1978, and the other from Britain, which was published in The Lancet in 1980, came up with similar findings. “Overall survival of patients with primary breast cancer has not improved in the past 10 years , despite the increased use of multi- dose chemotherapy for treatment of metastasis ,” explains study Lancet , entitled “The failure of chemotherapy in the survival of patients with metastatic breast cancer. ”

“The carefully hidden truth is that many people who “died of cancer“ actually have died from treatment that included chemotherapy or radiation. Chemotherapy works by killing healthy cells in the body before they destroy the cancer that can develop very slow and in some natural ways even stop and restrain.

Most patients who have “died of cancer” actually have died of malnutrition, because cancerous cells take nutrients from the blood and destroy the immune system so the weakened body is liable to many infections against which is no longer able to defend itself.

Modern medicine has at its disposal a panacea, and the truth about cancer is skillfully hidden. This is because the price of a single treatment today costs 300,000-1,000,000$. “The majority of cancer patients die of chemotherapy. Chemotherapy does not remove breast cancer, colon cancer, or lung cancer. This fact has been documented more than ten years, but doctors still stubbornly use chemotherapy for these tumors “(Allen Levin, MD UCSF,” The Healing of Cancer).

A German epidemiologist at the “Mannheim Tumor Clinic” in Heidelberg, Dr. Ulrich Abel, did an extensive research and analysis of every major study and clinical application of chemotherapy ever undertaken in the world. His conclusions should be read by anyone who intends to do a chemotherapy treatment, written in his book “The Doctor in the House” Tim O’Shea (The Doctor Within)

Lets face it, Chemo does NOT work. According to a 2004 report by Morgan, Ward, and Barton: “The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. … survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA.”Jun 16, 2014

Consider a alkaline lifestyle and dietary change to treat this lifestyle and dietary dis-ease. Try an alkaline whole foods plant based lifestyle approach and diet to heal the core (the small and large intestines), rebuild the red blood cells and immune system, open the channels of elimination, and buffer and eliminate the acidic metabolic and dietary waste to prevent the  primary cause of all cancerous conditions.  www.phoreveryoung.com

Resources:

Pubmed Data : J Clin Oncol. 2011 Aug 8. Epub 2011 Aug 8. PMID: 21825266
Study Type : Meta Analysis

Pubmed Data : Cochrane Database Syst Rev. 2009(2):CD004845. Epub 2009 Apr 15. PMID: 19370613
Study Type : Meta Analysis

Pubmed Data : Phytother Res. 2009 Jun;23(6):785-90. PMID: 19145638
Study Type : Human Study

Pubmed Data : Med Oncol. 2006;23(4):549-52. PMID: 17303914
Study Type : Human Study

Pubmed Data : Food Chem Toxicol. 2013 Mar ;53:126-32. Epub 2012 Dec 5. PMID: 23220617
Study Type : Human Study

Pubmed Data : Eur J Cancer. 2005 Aug;41(12):1746-50. PMID: 16039110
Study Type : Human Study

Pubmed Data : Tumori. 2005 Mar-Apr;91(2):135-8. PMID: 15948540
Study Type : Human Study

Pubmed Data : Integr Cancer Ther. 2008 Sep;7(3):147-54. PMID: 18815146
Study Type : Human Study

Pubmed Data : Support Care Cancer. 2010 Jun;18(6):751-9. Epub 2009 Aug 14. PMID: 19685085
Study Type : Human Study

Pubmed Data : Exp Neurol. 2008 Dec;214(2):276-84. Epub 2008 Sep 9. PMID: 18809400
Study Type : Human Study

Pubmed Data : Food Chem Toxicol. 2008 Mar;46(3):1089-96. Epub 2007 Nov 17. PMID: 12592686
Study Type : Human Study

Pubmed Data : Cell Biochem Funct. 2007 Jul-Aug;25(4):463-72. PMID: 16906597
Study Type : Human Study

Pubmed Data : Br J Cancer. 2002 Mar 4;86(5):669-73. PMID: 11875723
Study Type : Human Study

Pubmed Data : J Orthop Sci. 2009 Sep;14(5):556-65. Epub 2009 Oct 3. PMID: 19802667
Study Type : Human Study

Pubmed Data : Br J Clin Pharmacol. 2010 Nov;70(5):656-63. PMID: 21039759
Study Type : Human Study

Pubmed Data : Nutrition. 2006 Feb;22(2):136-45. PMID: 16459226
Study Type : Human Study

Pubmed Data : J Clin Oncol. 2010 Mar 20;28(9):1547-53. Epub 2010 Feb 16. PMID: 20159816
Study Type : Human Study

Pubmed Data : Int J Paediatr Dent. 2010 Jan;20(1):15-23. PMID: 20059589
Study Type : Human Study

Pubmed Data : Melanoma Res. 2002 Feb;12(1):83-90. PMID: 11828262
Study Type : Human Study

Pubmed Data : Vet Microbiol. 2006 Oct 5;117(1):59-65. PMID: 18408619
Study Type : Human Study

Pubmed Data : J Pediatr Hematol Oncol. 2004 Oct;26(10):631-5. PMID: 15454833
Study Type : Human Study

Pubmed Data : Pediatr Blood Cancer. 2010 Sep 14. Epub 2010 Sep 14. PMID: 20842754
Study Type : Human Study

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : BMC Pharmacol Toxicol. 2014 ;15:70. Epub 2014 Dec 4. PMID: 25472655
Study Type : Human Study
Pubmed Data : J Psychosoc Oncol. 2011 Sep-Oct;29(5):499-514. PMID: 21882931
Study Type : Human Study

Pubmed Data : Ann Surg. 1998 Apr;227(4):485-91. PMID: 9563534
Study Type : Human Study

Pubmed Data : Mol Cell Biochem. 2013 Jan ;372(1-2):47-55. Epub 2012 Sep 5. PMID: 22949034
Study Type : Human Study

Pubmed Data : Phytother Res. 2002 Mar;16(2):138-42. PMID: 11933115
Study Type : Human Study

Pubmed Data : Med Oncol. 2008 Dec 9. PMID: 19067257
Study Type : Human Study

Pubmed Data : Neuro Endocrinol Lett. 2013 ;34(7):660-8. PMID: 24464005
Study Type : Human Study

Pubmed Data : J Infect Dis. 1996 Oct;174(4):747-51. PMID: 20924976
Study Type : Human Study

Pubmed Data : Medicine (Baltimore). 2015 Aug ;94(34):e1413. PMID: 26313789
Study Type : Human Study

Pubmed Data : Cancer. 2004 Sep 1;101(5):1058-64. PMID: 15329916
Study Type : Human Study

Pubmed Data : J Med Food. 2005 Fall;8(3):382-5. PMID: 3857944
Study Type : Human Study

Pubmed Data : Cancer. 2001 Aug 1;92(3):684-90. PMID: 11505416
Study Type : Human Study

Pubmed Data : Adv Hematol. 2009;2009:689639. Epub 2009 Oct 20. PMID: 19960046
Study Type : Human Study

Pubmed Data : Nutr Cancer. 2007;58(1):43-8. PMID: 17571966
Study Type : Human Study

Pubmed Data : J Biosci Bioeng. 2012 Dec 12. Epub 2012 Dec 12. PMID: 23245727
Study Type : Animal Study

Pubmed Data : Clin Cancer Res. 2012 Feb 14. Epub 2012 Feb 14. PMID: 22338017
Study Type : Animal Study

Pubmed Data : Zhongguo Zhong Yao Za Zhi. 2007 May;32(9):835-9. PMID: 17639988
Study Type : Animal Study

Pubmed Data : Phytother Res. 2005 Mar;19(3):216-21. PMID: 15934019
Study Type : Animal Study

Pubmed Data : J Agric Food Chem. 2005 Apr 6;53(7):2446-50. PMID: 16971750
Study Type : Animal Study

Pubmed Data : Chem Biol Interact. 2010 Oct 6;188(1):144-50. PMID: 20603111
Study Type : Animal Study

Pubmed Data : Chem Biol Interact. 2014 Oct 16 ;222C:106-111. Epub 2014 Oct 16. PMID: 25451569
Study Type : Animal Study
Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Evid Based Complement Alternat Med. 2015 ;2015:197459. Epub 2015 Apr 7. PMID: 25945105
Study Type : Animal Study

Pubmed Data : Med Mol Morphol. 2013 Jun ;46(2):97-103. Epub 2013 Jan 22. PMID: 23338779
Study Type : Animal Study

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Cancer Cell Int. 2014 ;14(1):92. Epub 2014 Sep 28. PMID: 25298749
Study Type : Animal Study

Pubmed Data : Can J Physiol Pharmacol. 2009 Aug;87(8):633-40. PMID: 19767888
Study Type : Animal Study

Pubmed Data : Microsc Res Tech. 2015 Mar 22. Epub 2015 Mar 22. PMID: 25810378
Study Type : Animal Study

Pubmed Data : Nutrition. 2006 Feb;22(2):136-45. PMID: 20060872
Study Type : Animal Study

Pubmed Data : Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. Epub 2007 Apr 20. PMID: 17555784
Study Type : Animal Study

Pubmed Data : J Exp Ther Oncol. 2009;8(1):43-51. PMID: 19827270
Study Type : Animal Study

Pubmed Data : Cancer Epidemiol. 2009 Oct;33(3-4):293-9. Epub 2009 Aug 20. PMID: 19699163
Study Type : Animal Study

Pubmed Data : Int J Mol Med. 2007 Jun;19(6):865-73. PMID: 17487418
Study Type : Animal Study

Pubmed Data : Nephrol Dial Transplant. 2009 Oct;24(10):3012-20. Epub 2009 May 27. PMID: 19474282
Study Type : Animal Study

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : PLoS One. 2015 ;10(7):e0127813. Epub 2015 Jul 2. PMID: 26133371
Study Type : Animal Study

Pubmed Data : J Ethnopharmacol. 2009 Oct 29;126(1):143-8. Epub 2009 Jul 28. PMID: 19643175
Study Type : Animal Study

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Pathobiology. 2008 ;75(3):156-70. PMID: 18550913
Study Type : Animal Study

Pubmed Data : Clin Chim Acta. 2007 Jan;375(1-2):82-6. Epub 2006 Jun 14. PMID: 16889761
Study Type : Animal Study

Pubmed Data : Mutat Res. 2010 Feb ;696(1):69-80. Epub 2009 Dec 28. PMID: 20038455
Study Type : Animal Study

Pubmed Data : Chem Biol Interact. 2009 Aug 14;180(3):398-406. Epub 2009 Apr 2. PMID: 19539803
Study Type : Animal Study

Pubmed Data : Xenobiotica. 2015 May 13:1-6. Epub 2015 May 13. PMID: 25970816
Study Type : Animal Study

Pubmed Data : Biofactors. 2007;29(1):55-65. PMID: 17611294
Study Type : Animal Study

Pubmed Data : Cancer. 2010 Jan 1;116(1):251-5. PMID: 19890960
Study Type : Animal Study

Pubmed Data : Biol Pharm Bull. 2006 Dec;29(12):2436-41. PMID: 17142978
Study Type : Animal Study

Pubmed Data : Am J Ind Med. 2010 Sep 30. Epub 2010 Sep 30. PMID: 14745846
Study Type : Animal Study

El cáncer se alimenta de azúcar por el Dr. Patrick Quillin

El Cancer es un hongo de la variedad CANDIDA ALBICANS.
Tullio Simoncini.

Y de que se alimenta la candida?
Principalmente de glucosa, este es su combustible.

“La glucosa es a los micro organismos lo que la gasolina es al fuego”.

Dr. Robert O. Young –

Women pH Miracle Book Cover

Las candidas proliferan rapidamente en un medio ambiente muy acido y nutrientes acidos.

Recuerda que lo dulce es sinonimo de hiperacidez.

Los azucares además de hiperacidez nos roban el oxigeno.

Evitar comer carbohidratos simples, y todo tipo de azucares y fermentos, hazlo poco a poco de manera progresiva. Nuestro organismo solo requiere el uno por ciento de glucosa.

Todo tumor canceroso en su interior tiene un nido blanco de Candida Albicans, estando encapsuladas.

Dr. Tullio Simoncini.

Por lo tanto, el cáncer se alimenta de AZUCAR!
Dr. Patrrick Quillin.

Para mas información te aconsejo que adquieras el libro la milagrosa dieta del pH y con la asesoria de un experto para iniciar con el tratamiento.

Micrografias: tomada por Fausto Guerra con un microscopio Biologico, la segunda con uno electronico. (comparativa)

http://blog.alkalinecare.com/2013/04/10/el-cancer-se-alimenta-de-azucar-por-el-dr-patrick-quillin/

 cáncer-azucar1

Patrick Quillin, Ph.D., R.D., C.N.S., es Director de Nutrición de los “Centros de Tratamiento del Cáncer en América” en Tulsa, Okla, y autor de “Vencer el Cáncer mediante la Nutrición” (Nutrition Times Press, 1998).

Fuente: Notas de Prensa

Patrick QuillinEl Dr. Patrick Quillin es un experto reconocido internacionalmente en el área de la nutrición y cáncer. Con más de 27 años de experiencia como nutricionista clínico, de los cuales 10 años los pasó como vicepresidente de Nutrición para Cancer Treatment Centers of America, donde trabajó con miles de pacientes de cáncer en un hospital.

Ha aparecido en más de 40 programas de televisión y 220 programas de radio en todo el país y es un ponente habitual en convenciones médicas, incluyendo la Asociación Americana de Médicos de Naturopatía y Medicina Integrativa. Ha sido consultor de los Institutos Nacionales de Salud, el Ejército de los EE.UU., el Breast Cancer Research Group, Scripps Clinic, La Costa Spa y United States Department of Agriculture; ha enseñado nutrición en la universidad durante más de 9 años, y ha trabajado como dietista del hospital. El Dr. Patrick Quillin está en la lista de” Quién es quién en la ciencia “.

Durante los últimos 10 años he trabajado con más de 500 pacientes con cáncer como director de nutrición de los “Centros de Tratamiento contra el cáncer en América”, en Tulsa, Okla. Me sorprende cómo no se tiene en cuenta el simple concepto de que “el cáncer se alimenta de azúcar” dentro de un plan de tratamiento integral del cáncer. De los 4 millones de pacientes con cáncer que han sido tratados hoy en América, casi a ninguno se le ofrece una terapia de nutrición con base científica más allá de recomendarles que coman “alimentos saludables”. La mayoría de los pacientes con los que trabajo no han sido asesorados nutricionalmente. Creo que muchos pacientes de cáncer mejorarían mucho si controlaran el aporte del combustible favorito de cáncer, la glucosa. Al disminuir la tasa de crecimiento del cáncer, los pacientes permiten a sus sistemas inmunológicos y a las terapias médicas (quimioterapia, radiación y cirugía para reducir la masa del tumor) vencer a la enfermedad. Controlar los niveles de glucosa mediante dietas, suplementos nutricionales, ejercicios, meditación, y medicamentos cuando sea necesario, puede ser uno de los componentes más cruciales en un programa de recuperación del cáncer. La cantinela que “el azúcar alimenta al cáncer” es simple. Sin embargo, la explicación resulta un poco más compleja.

otto warburgEn 1931 el premio Nobel en medicina German Otto Warburg, descubrió por primera vez que las células cancerígenas tienen un metabolismo energético diferente comparado al de las células sanas. El quid de las tesis de este premio Nobel era que los tumores malignos, al contrario que los tejidos normales, presentan frecuentemente un incremento en la glicólisis anaeróbica – un proceso en el que las células cancerígenas usan la glucosa como carburante y obtienen como producto de desecho ácido láctico. Posteriormente, esta gran cantidad de ácido láctico generado por la fermentación de la glucosa de las células cancerígenas es transportada al hígado. Esta conversión de glucosa en lactato genera un pH más ácido en los tejidos cancerígenos, así como fatiga generalizada derivada de la elaboración del ácido láctico. Así, los tumores grandes tienden a exhibir un pH más ácido. Este ineficiente proceso de metabolismo energético produce únicamente 2 moles de adenosín trifosfato de energía por un mol de glucosa. Extrayendo solamente alrededor del 5% (2 con respecto a 38 moles de ATP) de la energía disponible en los alimentos y en los almacenes de energía del cuerpo, el cáncer está desperdiciando energía, y el paciente se encuentra cansado y mal nutrido. Esta es la razón por la cual el 40% de los pacientes de cáncer mueren de malnutrición o cachesia.

De ahí que las terapias contra el cáncer deban regular los niveles de glucosa a través de la dieta, suplementos nutricionales, soluciones no orales para los pacientes con cachesia que han perdido el apetito, medicación, ejercicio, pérdida gradual de peso y reducción del estrés.

En este punto del proceso cancerígeno, una orientación profesional acompañada de la auto disciplina del paciente son cruciales. El objetivo no es eliminar azúcares o carbohidratos de la dieta sino mantener los niveles de glucosa en unos márgenes estrechos para conseguir matar de inanición al cáncer y fortalecer el sistema inmunológico.

El índice glicémico mide como un determinado alimento afecta los niveles de glucosa en sangre, asignando a cada alimento un número dentro de una clasificación. Cuanto menor sea la puntuación obtenida más lento será el proceso de digestión y asimilación, lo que implica una absorción más gradual de los azúcares en la sangre. De forma paralela, una puntuación elevada significa que los niveles de glucosa se incrementan de forma rápida, lo que estimula al páncreas a segregar insulina para bajar los niveles de azúcar. Esta rápida fluctuación de los niveles de azúcar en sangre es contraproducente debido al estrés que genera en el cuerpo.

El azúcar en el cuerpo y la dieta

El azúcar es un términoazucar pastel genérico usado para identificar a los carbohidratos simples, lo que incluye monosacáridos como la fructosa,  glucosa y galactosa; y disacáridos como la maltosa y la sucrosa (azúcar de mesa). Piense en estos azúcares como ladrillos de diferentes tamaños en una pared. Si la fructosa es el monosacárido dominante en la pared, se considera que el índice glicémico es más saludable, ya que este azúcar simple es absorbido lentamente en el intestino, para pasar después a convertirse en glucosa en el hígado. Lo que resulta en una lenta absorción de los alimentos que ofrece un incremento y un descenso más gradual en los niveles de insulina. Si la glucosa es el monosacárido predominante en la pared de ladrillos, el índice glicémico será más alto, y, por tanto, menos saludable para el individuo. Cuando la pared de ladrillos se rompe durante la digestión, la glucosa es impulsada a través de la pared intestinal directamente al flujo sanguíneo, elevando rápidamente los niveles de glucosa. En otras palabras, hay una “ventana de eficiencia” para la glucosa en la sangre: niveles demasiado bajos le hacen sentir a uno letárgico y pueden derivar en hipoglucemia; niveles demasiado altos crean picos hiperglucémicos característicos de los diabéticos.

En 1997 los estándares para los niveles de glucosa en sangre de la Asociación de Diabéticos Americanos establecía una cantidad de 126 mg de glucosa por decilitro en la sangre o mayor en una persona diabética. Menos de 110 mg/dL era considerado normal, entre estos dos valores se consideraba que la persona padecía de intolerancia a la glucosa.

Sin embargo, se ha estimado que las dietas paleolíticas de nuestros antepasados, que consistían en carnes magras, verduras y pequeñas cantidades de cereales, nueces, semillas y frutas, producían unos niveles de glucosa entre 60 y 90 mg/dL. Obviamente, las dietas de hoy en día con unos niveles tan altos en azúcar están teniendo efectos poco saludables en lo que concierne al azúcar en sangre. El exceso de glucosa en sangre puede contribuir a la proliferación de la cándida, deterioro de los vasos sanguíneos, enfermedades cardiacas y otros problemas. Entender y utilizar el índice glicémico es un importante aspecto a tener en cuenta al confeccionar la dieta de los pacientes con cáncer. Sin embargo, existe también evidencia que los azúcares pueden alimentar al cáncer de forma más eficiente que los almidones (formados por largas cadenas de azúcares simples), por lo que centrarse únicamente en el índice glicémico puede ser engañoso.

Un estudio con ratas alimentadas con raciones que contenían una cantidad equivalente de calorías procedentes de azúcares y almidones encontró que las ratas con una dieta alta en azúcares desarrollaban más casos de cáncer de pecho. El índice glicémico es una herramienta útil para guiar al paciente hacia una dieta más saludable, pero no es infalible. Si sólo se usa el índice glicémico se puede deducir que una taza de azúcar blanco es más sano que una patata asada. Eso es así porque el índice glicémico de una comida azucarada puede ser menor que el de un alimento rico en almidón. Para asegurarse, recomiendo tomar menos fruta, más verdura y la eliminación de los azúcares no refinados en la dieta de los pacientes con cáncer.

Lo que dice la literatura

RatonLos tumores de pecho inducidos en ratones demostraron que los tumores son sensibles a los niveles de glucosa. 68 ratones fueron inyectados con una cepa agresiva de cáncer de pecho. A continuación, se les administró dietas altas en glucosa para inducir altos niveles de azúcar en sangre (hiperglucemia), normoglucemia o bajos niveles de azúcar (hipoglucemia). Se encontró que la tasa de supervivencia dependía de las dosis: cuanto más bajo era el nivel de azúcar en sangre más elevada era la tasa de supervivencia.

Después de 70 días, 8 de los 24 ratones hiperglucémicos sobrevivieron comparado con 16 de los 24 normoglucémicos y 19 de los 20 hipoglucémicos. Lo que sugiere este estudio es que regular el consumo de azúcar es la clave para disminuir el crecimiento del cáncer de pecho.

CancerMama

En un estudio con humanos, a 10 personas sanas se les midió los niveles de glucosa en sangre en ayunas y el índice de fagocidad de los neutrófilos, lo que mide la capacidad de las células del sistema inmunológico para rodear y destruir a invasores como el cáncer. Una ingesta de 100gr de carbohidratos procedentes de la glucosa, sucrosa, miel y zumo de naranja todos disminuyeron la capacidad de los neutrófilos de engullir bacterias. El almidón demostró no tener este efecto.

Un estudio de cuatro años de duración en el Instituto Público Nacional de Protección Medioambiental en los Países Bajos comparó los conductos biliares de 111 pacientes de cáncer con 480 pacientes sanos. Se encontró que el riesgo de cáncer asociado con la ingesta de azúcares, independientemente de otras formas de energía, era más del doble en los pacientes de cáncer. Además, un estudio epidemiológico es 21 países modernos que hacen un seguimiento de morbilidad y mortalidad (Europa, Norte América, Japón y otros) reveló que la ingesta de azúcar es un factor de riesgo muy importante que contribuye a un incremento en la incidencia de cáncer de pecho, particularmente en mujeres adultas.

Limitar el consumo de azúcar puede que no sea la única línea de defensa. Por ejemplo, un extracto botánico de la planta del aguacate (Persea americana) parece resultar prometedora en el tratamiento contra el cáncer.

Aguacate Alcalinizante - Alkaline CareCuando un extracto purificado de aguacate llamado mannoheptulose se añadió a un número de células cancerígenas que fueron testadas in vitro por investigadores del Departamento de Bioquímica de la Universidad de Oxford en Gran Bretaña se encontró que inhibían la captación de glucosa de las células cancerígenas de un 25 a un 75%, e inhibían la enzima glucokinase responsable de la glicólisis. También inhibía la tasa de crecimiento de los cultivos tumores cancerígenos. Los mismos investigadores trataron a los animales de laboratorio con una dosis de mannoheptulosa de 1,7 mg/g de peso corporal durante cinco días, lo que redujo los tumores del 65 al 79%. Basándose en estos estudios, existen razones para creer que el extracto de aguacate puede ayudar a los pacientes con cáncer limitando el aporte de glucosa a los tumores cancerígenos.

Dado que las células cancerígenas derivan la mayor parte de su energía de la glucólisis anaeróbica, Joseph Gold, director del Instituto para la Investigación contra el Cáncer de Siracusa, previamente investigador en las Fuerzas Armadas de USA, encontró que una sustancia denominada sulfato de hidracina, usada en el combustible de los cohetes, podía inhibir la excesiva gluconeogénesis (conversión de los aminoácidos en azúcar) que ocurre en los pacientes con cachesia. El trabajo de Gold demostró la capacidad del sulfato de hidracina para reducir y curar la cachesia de pacientes con cáncer en estado avanzado. Un experimento controlado por placebo de 101 pacientes de cáncer que tomaron 6 mg de sulfato de hidracina 3 veces al día o un placebo demostró que después de 1 mes, el 83 por ciento de los pacientes tratados con sulfato de hidracina incrementaron su peso comparado con un 53 por ciento de los pacientes a los que se les administró un placebo. Un estudio similar por los mismos investigadores, fundado en parte por el Instituto Nacional del Cáncer en Bethesda incluyó a 65 pacientes. Los que tomaron sulfato de hidracina, y estaban en buenas condiciones físicas antes que el estudio comenzara, vivieron una media de 17 semanas más.

enfermoEn 1990 contacté con los hospitales más importantes especializados en el tratamiento del cáncer buscando alguna información del papel crucial que juega la nutrición intravenosa en los pacientes de cáncer. Alrededor del 40% fallecieron por cachesia, sin embargo, a muchos de los pacientes que se están muriendo literalmente de hambres no se les ofrece ningún soporte nutricional a parte de la solución intravenosa estándar de la UVI. Esta solución proporciona un 70% de las calorías en forma de glucosa. Muy frecuentemente, creo, estas soluciones altas en glucosa no ayudan a los pacientes cachésicos tanto como soluciones con más glucosa y menos aminoácidos y lípidos. Estas soluciones permitirían al paciente fortalecerse y no alimentarían al tumor.

El estamento médico está dejando pasar por alto el azúcar y su papel en la tumorigénesis. El dispositivo de tomografía, denominado PET, cuyo coste es de medio millón de dólares es considerado como la herramienta más moderna y puntera en la detección de tumores. El escaner PET usa glucosa radioactiva para detectar las células cancerígenas hambrientas de azúcar. Los escaners PET se usan en el seguimiento de los pacientes de cáncer, así como para evaluar que los protocolos prescritos son efectivos.

En Europa, el concepto de que el azúcar alimenta al cáncer está tan asumido que los oncologistas, usan el protocolo de Terapia Sistémica del Cáncer (SCMT). Concebida por Manfred von Ardenne en Alemania en 1965, la SCMT implica inyectar a los pacientes con glucosa para incrementar las concentraciones de la misma, lo que disminuye los valores de pH en los tejidos cancerígenos debido a la formación de ácido láctico. A su vez, esto intensifica la sensibilidad térmica de los tejidos malignos e induce el rápido crecimiento del cáncer. A continuación se somete a los pacientes a una hipertermia en todo el cuerpo para estresar aún más a las células cancerígenas, seguido de radiación o quimiotrerapia. SCMT fue testado en 103 pacientes con metástasis de cáncer o tumours primaries recurrentes en la primera fase de un estudio clínico en el Instituto Von ARdenne de Investigación Médica Aplicada en Dresde, Alemania. Los porcentajes de supervivencia de cinco años en pacientes que siguieron la terapia SCMT se incrementaron del 25 al 50 por ciento, y los de regresión del tumor se incrementaron del 30 al 50 por ciento. El protocolo induce un rápido crecimiento del cáncer, para poder tratarlo de forma más efectiva con terapias tóxicas y obtener de este modo una considerable mejora.

El irrefutable papel de la glucosa en el crecimiento y la metástasis de las células cancerígenas se puede tener en cuenta en muchas terapias. Algunas de estas incluyen dietas designadas con el índice glicémico en mente para regular los incrementos de la glucosa en la sangre, lo que mata de hambre de forma selectiva a las células cancerígenas; soluciones TPN bajas en glucosa, extracto de aguacate para inhibir la absorción de glucosa por las células cancerígenas, sulfato de hidracina para impedir la gluconeogénesis en las células cancerígenas y SCMT. Una paciente de 50 años con cáncer de pulmón, vino a nuestra clínica después de que su oncologista de Florida le hubiera dado una sentencia de muerte. Estaba dispuesta a cooperar y entendió la conexión que existe entre la nutrición y el cáncer. Cambió considerablemente su dieta, eliminando el 90 por ciento del azúcar que solía comer. Descubrió que el pan de trigo y los cereales de avena eran dulces, incluso sin azúcar añadido. Con una terapia médica restrictiva –incluyendo radiación de altas dosis focalizada a los tumores y quimioterapia fraccionada, una técnica que distribuye la dosis de quimio semanal en una infusión de 60 horas que dura días –, una actitud positiva y un programa nutricional óptimo, venció a su cáncer terminal de pulmón. La vi el otro día, han pasado cinco años y la enfermedad no ha recurrido, y además probablemente tenía mejor aspecto que el médico que la desahució.